Spire Global (SPIR) 10-Q/A 3 Mar 25 2024 Q1 Quarterly report (amended) Financial data

Document And Entity Information

Document And Entity Information - shares	3 Months Ended
	Mar. 31, 2024	Feb. 14, 2025
Document Information [Line Items]
Document Type	10-Q/A
Document Period End Date	Mar. 31, 2024
Amendment Description	Spire Global, Inc. ("we," "us," “Spire” or the “Company”) is filing this Amendment No. 1 on Form 10-Q/A (the "10-Q/A” or “Amendment No. 1”) to amend and restate certain items in the Quarterly Report on Form 10-Q/A for the three-month period ended March 31, 2024, originally filed with the Securities and Exchange Commission (the “SEC”) on May 15, 2024 (the “Original Form 10-Q”). As previously disclosed in the Current Report on Form 8-K filed with the SEC on August 27, 2024, the Company is restating its previously issued unaudited condensed consolidated financial statements as of March 31, 2024, and for the quarterly periods ended March 31, 2024 and 2023. In addition, we filed an amendment to our Annual Report on Form 10-K for the fiscal year ended December 31, 2023, with the SEC on March 3, 2025 (such report, the “Amended 2023 Form 10-K/A” and, together with this Amendment No.1, the “Amended Reports”), to provide audited restated consolidated financial statements as of and for the fiscal years ended December 31, 2023, and December 31, 2022, as well as unaudited restated condensed consolidated financial information as of the quarter ends and for the interim periods in the fiscal years ended December 31, 2023 and 2022 (collectively, and including the three-month period ended, and as of, March 31, 2024, the “Affected Periods”). All material restatement information has been included in the Amended Reports, and the Company does not intend to separately amend other filings that it has previously filed with the SEC.Accordingly, investors and other readers should rely only on the financial information and other disclosures regarding the Affected Periods in the Amended Reports and in any other future filings with the SEC (as applicable) and should not rely on any previously issued or filed reports, press releases, corporate presentations or similar communications relating to the Affected Periods.Restatement BackgroundIn August 2024, the Company began a comprehensive review of its accounting practices and procedures with respect to revenue recognition related to certain (i) contracts in its “Space as a Service” business (the “Space Services Contracts”) and (ii) contracts in its customer-funded or co-funded research and development arrangements (the “R&D Services Contracts”, and together with the Space Services Contracts, the “Space Services and R&D Services Contracts”).The Company evaluated whether any of its Space Services Contracts contain embedded leases, and the Company concluded that only one Space Services Contract contains embedded leases of satellites to the customer. This contract was historically accounted for in the same manner as other Space Services Contracts for which revenue was recognized separately for project-based deliverables, and the costs to build and launch the satellites were historically capitalized as the Company's property and equipment. The Company assessed its embedded leases in accordance with Accounting Standards Codification (“ASC”) Topic 842. Since the construction work contemplated in the contract was controlled and fully paid by the customer during the construction period, the Company accounted for its role in construction in accordance with ASC Topic 606, and the Company determined that revenue for the contract with embedded leases should have been allocated to each performance obligation and recognized separately: over time for the design/build of satellites controlled by the customer, utilizing an input method based on a cost-to-cost measure of progress over the period from initial design to launch; at the point in time when the launch occurred for launch service; over time utilizing an output method based on the number of satellite months as the measure of progress for operating the satellite; and when (or as) the underlying future services are transferred, or when the options expire, for material rights. The costs to build the customer-controlled satellites should have been recognized as cost of revenue as incurred, and any prepaid fees for launch services should have been capitalized to other current assets and expensed when the launch occurs.The Company determined that its historical accounting for Space Services Contracts that do not contain embedded leases, primarily revenue recognition for pre-space mission activities, was incorrect. It was determined that these Space Services Contracts have one performance obligation for the space services under the contract. The Company concluded that no revenue should have been recognized for pre-space mission activities and that revenue should instead be recognized over time, utilizing an output measure of progress based on satellite months, during the service period of the satellites. As part of the review, the Company also identified that in addition to space services, certain Space Services Contracts had an additional performance obligation for a customer’s material right to purchase additional satellites or services in the future at a discounted price, which resulted in the transaction price being allocated to the material rights in addition to the space service performance obligation. Revenue allocated to material rights is recognized over the period of service to which the material right relates or at the time the material right expires.The Company issued a note receivable to the customer of one of its Space Services Contracts during the Affected Periods. The Company concluded during its reevaluation of its accounting practices that an allowance for current expected credit loss related to the notes receivable should have been recorded at the inception of the note receivable and reevaluated during each following accounting period. For R&D Services Contracts, the Company determined that its previous revenue recognition practice did not accurately represent the pattern of control transfer for the related intellectual property under the contract. The Company concluded that the pattern of control transfer for the intellectual property occurs over time as the Company performs its research and development activities, and therefore its revenue recognition practice should be corrected to represent this pattern. The Company also concluded that the costs associated with the R&D Services Contracts were inappropriately included in research and development expense rather than in cost of revenue within the condensed consolidated statements of operations.As a result of its comprehensive review, the Company determined that a restatement of its previously issued consolidated financial statements for the Affected Periods were required related to consideration of embedded leases for a Space Services Contract, recognition of an allowance for current expected credit loss related to a note receivable issued to a customer, revenue recognition for Space Services and R&D Services Contracts, and income statement classification of costs related to R&D Services Contracts.The accounting errors detailed above caused misstatements to revenue, cost of revenue, research and development expense, other expense, income tax provision, accumulated other comprehensive loss, contract assets, contract liabilities, property and equipment, and allowance for current expected credit loss related to a note receivable issued to a customer on the Company’s condensed consolidated balance sheets, condensed consolidated statements of operations, condensed consolidated statements of comprehensive loss, condensed consolidated statements of changes in stockholders' equity and condensed consolidated statements of cash flows as of and for the Affected Periods.Additionally, the Company also corrected previously identified immaterial errors. Refer to Note 2 of Notes to Condensed Consolidated Financial Statements of this Form 10-Q/A for additional information and for a summary of the accounting impact of these adjustments to the Company’s unaudited condensed consolidated financial statements, as well as certain other adjustments.Internal Control Considerations In connection with the restatement of the financial statements for the Affected Periods, the Company has concluded its disclosure controls and procedures as of March 31, 2024, remained ineffective due to the unremediated material weaknesses previously disclosed in Part I, Item 4 “Controls and Procedures” of the Original Form 10-Q, as well as the identification of an additional material weakness in internal control over financial reporting related to the errors described above. Please refer to Part I, Item 4 of this Form 10-Q/A. Items Amended in this Filing •This Amendment No.1 amends and restates the following items of the Original Form 10-Q:•Part I, Item 1. "Unaudited Condensed Consolidated Financial Statements,"•Part 1, Item 2. "Management's Discussion and Analysis of Financial Condition and Results of Operations,"•Part I, Item 4. "Controls and Procedures," •Part II, Item 1. "Legal Proceedings,"•Part II, Item 1A. "Risk Factors," and•Part II, Item 6. Exhibits.This Form 10-Q/A is presented as of the filing date of the Original Form 10-Q, does not reflect events occurring after that date, and does not modify or update disclosures in any way other than as required to reflect the restatement of the Affected Periods and liquidity and going concern related disclosures included in the financial statements and elsewhere in this Form 10-Q/A. This Form 10-Q/A sets forth the Original Form 10-Q in its entirety, as amended to reflect the restatement. Among other things, forward-looking statements made in the Original Form 10-Q have not been revised to reflect events that occurred or facts that became known to the Company after the filing of the Original Form 10-Q, and such forward-looking statements should be read in their historical context. Unless the context otherwise requires, references to our “Annual Report on Form 10-K” herein refer to the Amended 2023 Form 10-K/A.In accordance with applicable SEC rules, this Form 10-Q/A includes an updated signature page and certifications of the Company’s Chief Executive Officer and Chief Financial Officer in Exhibits 31.1, 31.2 and 32.1 as required by Rule 12b-15.
Document Quarterly Report	true
Amendment Flag	true
Document Transition Report	false
Document Fiscal Year Focus	2024
Document Fiscal Period Focus	Q1
Current Fiscal Year End Date	--12-31
Entity Registrant Name	SPIRE GLOBAL, INC.
Entity File Number	001-39493
Entity Central Index Key	0001816017
Entity Tax Identification Number	85-1276957
Entity Incorporation, State or Country Code	DE
Entity Address, Address Line One	8000 Towers Crescent Drive
Entity Address, Address Line Two	Suite 1100
Entity Address, City or Town	Vienna
Entity Address, State or Province	VA
Entity Address, Postal Zip Code	22182
City Area Code	202
Local Phone Number	301-5127
Title of 12(b) Security	Class A common stock, par value of $0.0001 per share
Trading Symbol	SPIR
Security Exchange Name	NYSE
Entity Current Reporting Status	No
Entity Interactive Data Current	No
Entity Filer Category	Non-accelerated Filer
Entity Small Business	true
Entity Emerging Growth Company	true
Entity Ex Transition Period	false
Entity Shell Company	false
Common Class A [Member]
Document Information [Line Items]
Entity Common Stock, Shares Outstanding		25,734,974
Common Class B [Member]
Document Information [Line Items]
Entity Common Stock, Shares Outstanding		1,507,325

Condensed Consolidated Balance

Condensed Consolidated Balance Sheets - USD ($) $ in Thousands	Mar. 31, 2024	Dec. 31, 2023
Current assets
Cash and cash equivalents	$ 51,731	$ 29,136
Marketable securities	12,003	11,726
Accounts receivable, net (including allowance of $271 and $586 as of March 31, 2024 and December 31, 2023, respectively)	12,346	9,911
Contract assets	4,987	4,718
Other current assets	9,125	16,848
Total current assets	90,192	72,339
Property and equipment, net	59,600	60,446
Operating lease right-of-use assets	14,324	14,921
Goodwill	50,051	51,155
Customer relationships	18,467	19,363
Other intangible assets	11,994	12,660
Other long-term assets, including restricted cash	7,701	8,380
Total assets	252,329	239,264
Current liabilities
Accounts payable	5,869	8,012
Accrued wages and benefits	2,147	1,829
Contract liabilities, current portion	22,230	31,178
Other accrued expenses	11,125	8,326
Total current liabilities	41,371	49,345
Long-term debt	115,016	114,113
Contract liabilities, non-current	19,259	17,923
Contingent earnout liability	265	220
Deferred income tax liabilities	795	804
Warrant liability	10,672	5,988
Operating lease liabilities, net of current portion	12,488	13,079
Other long-term liabilities	8	8
Total liabilities	199,874	201,480
Commitments and contingencies (Note 10)
Stockholders' equity
Common stock, $0.0001 par value, 1,000,000,000 Class A and 15,000,000 Class B shares authorized, 24,315,589 Class A and 1,507,325 Class B shares issued and outstanding at March 31, 2024; 21,097,351 Class A and 1,507,325 Class B shares issued and outstanding at December 31, 2023	3	2
Additional paid-in capital	519,400	477,624
Accumulated other comprehensive loss	(6,118)	(4,556)
Accumulated deficit	(460,830)	(435,286)
Total stockholders' equity	52,455	37,784
Total liabilities and stockholders' equity	$ 252,329	$ 239,264

Condensed Consolidated Balanc_2

Condensed Consolidated Balance Sheets (Parenthetical) - USD ($) $ in Thousands	Mar. 31, 2024	Dec. 31, 2023
Accounts Receivable, Allowance for Credit Loss, Current	$ 271	$ 586
Common stock per share	$ 0.0001	$ 0.0001
Common Class A
Common stock, authorized	1,000,000,000	1,000,000,000
Common stock, Issued	24,315,589	21,097,351
Common stock, outstanding	24,315,589	21,097,351
Common Class B
Common stock per share	$ 0.001
Common stock, authorized	15,000,000	15,000,000
Common stock, Issued	1,507,325	1,507,325
Common stock, outstanding	1,507,325	1,507,325

Condensed Consolidated Statemen

Condensed Consolidated Statements of Operations - USD ($) $ in Thousands		3 Months Ended
		Mar. 31, 2024	Mar. 31, 2023
Revenue		$ 34,825	$ 23,217
Cost of revenue		25,596	13,369
Gross profit		9,229	9,848
Operating expenses:
Research and development		6,037	7,318
Sales and marketing		5,118	6,850
General and administrative		9,844	11,823
Loss on decommissioned satellites		178	0
Allowance for current expected credit loss on notes receivable		40	0
Total operating expenses		21,217	25,991
Loss from operations		(11,988)	(16,143)
Other income (expense):
Interest income		454	565
Interest expense		(5,053)	(4,578)
Change in fair value of contingent earnout liability		(45)	76
Change in fair value of warrant liabilities		(4,202)	746
Issuance of stock warrants		(2,399)	0
Foreign exchange (loss) gain		(1,786)	1,013
Other (expense) income, net		(534)	(311)
Total other income (expense), net		(13,565)	(2,489)
Loss before income taxes		(25,553)	(18,632)
Income tax (benefit) provision		(9)	23
Net loss		$ (25,544)	$ (18,655)
Net loss per share, Basic	[1]	$ (1.17)	$ (1.03)
Net loss per share, Diluted	[1]	$ (1.17)	$ (1.03)
Weighted-average shares used in computing basic net loss per share		21,813,045	18,096,363
Weighted-average shares used in computing diluted net loss per share		21,813,045	18,096,363
[1] The shares of the Company's common stock and the per share amounts for the three months ended March 31, 2023 have been retroactively adjusted to reflect the 1-for-8 reverse stock split (Note 1)

Condensed Consolidated Statem_2

Condensed Consolidated Statements of Comprehensive Loss - USD ($) $ in Thousands	3 Months Ended
	Mar. 31, 2024	Mar. 31, 2023
Net loss	$ (25,544)	$ (18,655)
Other comprehensive (loss) gain :
Foreign currency translation adjustments	(1,560)	(1,614)
Net unrealized (loss) gain on investments (net of tax)	(2)	44
Comprehensive loss	$ (27,106)	$ (20,225)

Condensed Consolidated Statem_3

Condensed Consolidated Statements of Changes in Stockholders' Equity (Unaudited) - USD ($) $ in Thousands		Total	Common Stock		Additional Paid-in Capital		Accumulated Other Comprehensive (Loss) Income	Accumulated Deficit
Beginning balance at Dec. 31, 2022		$ 91,131	$ 2	[1]	$ 455,765	[1]	$ (6,908)	$ (357,728)
Beginning balance, shares at Dec. 31, 2022	[1]		19,467,183
Release of Restricted Stock Units and Performance Stock Units, shares	[1]		261,153
Stock compensation expense		2,646			2,646	[1]
Conversion of warrants to common stock		286			286	[1]
Conversion of warrants to common stock, shares	[1]		34,728
Net Income (Loss)		(18,655)						(18,655)
Foreign currency translation adjustments		(1,614)					(1,614)
Net unrealized gain on investments (net of tax)		44					44
Ending balance at Mar. 31, 2023		73,838	$ 2	[1]	458,697	[1]	(8,478)	(376,383)
Ending balance, shares at Mar. 31, 2023	[1]		19,763,064
Beginning balance at Dec. 31, 2023		37,784	$ 2		477,624		(4,556)	(435,286)
Beginning balance, shares at Dec. 31, 2023			22,604,676
Release of Restricted Stock Units and Performance Stock Units, shares			204,511
Exercise of stock options		$ 267			267
Exercise of stock options, shares		37,536	37,536
Stock compensation expense		$ 3,628			3,628
Issuance of common stock under Securites Purchase Agreements Shares			2,976,191
Issuance of common stock under Securites Purchase Agreements Value		37,882	$ 1		37,881
Net Income (Loss)		(25,544)						(25,544)
Foreign currency translation adjustments		(1,560)					(1,560)
Net unrealized gain on investments (net of tax)		(2)					(2)
Ending balance at Mar. 31, 2024		$ 52,455	$ 3		$ 519,400		$ (6,118)	$ (460,830)
Ending balance, shares at Mar. 31, 2024			25,822,914
[1] The shares of the Company's common stock have been retroactively adjusted to reflect the 1-for-8 reverse stock split (Note 1).

Condensed Consolidated Statem_4

Condensed Consolidated Statements of Cash Flows - USD ($) $ in Thousands	3 Months Ended
	Mar. 31, 2024	Mar. 31, 2023
Cash flows from operating activities
Net loss	$ (25,544)	$ (18,655)
Adjustments to reconcile net loss to net cash used in operating activities:
Depreciation and amortization	6,837	3,916
Stock-based compensation	3,628	2,646
Amortization of operating lease right-of-use assets	809	224
Amortization of debt issuance costs	900	554
Change in fair value of warrant liabilities	4,202	(746)
Change in fair value of contingent earnout liability	45	(76)
Issuance of stock warrants	2,399	0
Deferred income tax liabilities	0	6
Loss on decommissioned satellites and impairment of assets	432	0
Other, net	228	(350)
Changes in operating assets and liabilities:
Accounts receivable, net	(2,564)	97
Contract assets	(642)	(787)
Other current assets	8,095	(688)
Other long-term assets	516	410
Accounts payable	(1,508)	(604)
Accrued wages and benefits	343	323
Contract liabilities	(7,157)	2,154
Other accrued expenses	1,003	(920)
Operating lease liabilities	(872)	(230)
Net cash used in operating activities	(8,850)	(12,726)
Cash flows from investing activities
Purchases of short-term investments	(10,920)	(13,908)
Maturities of short-term investments	10,800	11,600
Purchase of property and equipment	(7,059)	(3,213)
Net cash used in investing activities	(7,179)	(5,521)
Cash flows from financing activities
Proceeds from Securities Purchase Agreement, net	37,881	0
Proceeds from long-term debt	0	19,886
Proceeds from exercise of stock options	267	0
Net cash provided by financing activities	38,148	19,886
Effect of foreign currency translation on cash, cash equivalents and restricted cash	465	(1,846)
Net increase (decrease) in cash, cash equivalents and restricted cash	22,584	(207)
Cash, cash equivalents and restricted cash
Beginning balance	29,633	47,569
Ending balance	52,217	47,362
Supplemental disclosure of cash flow information
Cash paid for interest	3,983	3,827
Income taxes paid	15	451
Noncash operating, investing and financing activities
Property and equipment purchased but not yet paid	2,135	2,299
Right-of-use assets obtained in exchange for lease liabilities	353	1,007
Issuance of stock warrants with long-term debt (Note 8)	$ 0	$ 286

Pay vs Performance Disclosure

Pay vs Performance Disclosure - USD ($) $ in Thousands	3 Months Ended
	Mar. 31, 2024	Mar. 31, 2023
Pay vs Performance Disclosure
Net Income (Loss)	$ (25,544)	$ (18,655)

Insider Trading Arrangements

Insider Trading Arrangements	3 Months Ended
	Mar. 31, 2024
Trading Arrangements, by Individual
Rule 10b5-1 Arrangement Adopted	false
Non-Rule 10b5-1 Arrangement Adopted	false
Rule 10b5-1 Arrangement Terminated	false
Non-Rule 10b5-1 Arrangement Terminated	false

Nature of Business

Nature of Business	3 Months Ended
	Mar. 31, 2024
Organization, Consolidation and Presentation of Financial Statements [Abstract]
Nature of Business	1. Nature of Business Spire Global, Inc. (“Spire” or the “Company”), founded in August 2012, is a global provider of space-based data and analytics that offers its customers unique datasets and insights about earth from the ultimate vantage point. The Company collects this space-based data through its proprietary constellation of multi-purpose nanosatellites. The Company designs, manufacturers, integrates, and operates its own satellites and ground stations to deliver unique end-to-end comprehensive solutions. The Company offers the following three data solutions to customers: Maritime, Aviation and Weather. As a fourth solution, the Company is providing “space-as-a-service” through its Space Services solution. The Company is headquartered in Vienna, Virginia and has several wholly owned operating subsidiaries in the United States, United Kingdom, Luxembourg, Singapore, Australia, Germany, and Canada. On August 16, 2021, Spire Global Subsidiary, Inc. (formerly known as Spire Global, Inc.) (“Legacy Spire”) closed its previously announced merger with NavSight Holdings, Inc. (“NavSight”), a special purpose acquisition company. As a result, Legacy Spire continued as the surviving corporation and a wholly owned subsidiary of NavSight (the “Merger,” and such consummation, the “Closing”). NavSight then changed its name to Spire Global, Inc. and Legacy Spire changed its name to Spire Global Subsidiary, Inc. On September 14, 2022, the Company entered into an Equity Distribution Agreement (the “Equity Distribution Agreement”) with Canaccord Genuity LLC, as sales agent (the “Agent”). In accordance with the terms of the Equity Distribution Agreement, the Company may offer and sell its Class A common stock, having an aggregate offering price of up to $ 85,000 from time to time through the Agent pursuant to a registration statement on Form S-3, which became effective on September 26, 2022. Under the Equity Distribution Agreement, the Company sold (i) 2,166,389 shares of its Class A common stock during the year ended December 31, 2023 for gross proceeds of $ 8,235 and (ii) no shares during the three months ended March 31, 2024. On March 24, 2023, the Company, was notified by the New York Stock Exchange (“NYSE”) that the Company was not in compliance with Rule 802.01C of the NYSE’s Listed Company Manual (“Rule 802.01C”) relating to the minimum average closing price of the Company’s Class A common stock, par value of $ 0.0001 per share, required over a consecutive 30 trading-day period. On August 31, 2023, the Company effected a reverse stock split at a ratio of 1-for-8 (the “Reverse Stock Split”) of its common stock. In connection with the Reverse Stock Split, every eight shares of the Company’s Class A and Class B common stock issued and outstanding as of the effective date were automatically combined into one share of Class A or Class B common stock, as applicable. On September 25, 2023, the Company received formal notice from the NYSE that the Company had regained compliance with Rule 802.01C. On February 4, 2024, the Company and Signal Ocean Ltd (“Signal Ocean”) entered into a securities purchase agreement (the “SPA”) for the issuance and sale of 833,333 shares of the Company’s Class A common stock to Signal Ocean at a price of $ 12.00 per share (the “Private Placement”). The Private Placement closed on February 8, 2024, resulting in gross proceeds to the Company of $ 10.0 million. On March 21, 2024, the Company entered into a Securities Purchase Agreement (the “Purchase Agreement”) with institutional investors (the “Investors”), pursuant to which the Company issued and sold in a registered direct offering (the “Offering”), (i) an aggregate of 2,142,858 shares of Class A common stock and (ii) warrants exercisable for an aggregate of 2,142,858 shares of Class A common stock ("Securities Purchase Agreement Warrants") to the Investors. Each share of Class A common stock and accompanying Securities Purchase Agreement Warrant to purchase one share of Class A common stock was sold at an offering price of $ 14.00 . The aggregate gross proceeds to the Company from the Offering totaled $ 30,000 before deducting the placement agent’s fees and related offering expenses. The Securities Purchase Agreement Warrants have an exercise price equal to $ 14.50 per share of Class A common stock, are exercisable for a term beginning on March 25, 2024 and will expire on July 3, 2024. On March 21, 2024, the Company entered into a placement agency agreement (the “Placement Agency Agreement”) with Alliance Global Partners (“A.G.P” or the “Placement Agent”), pursuant to which the Company engaged A.G.P as the exclusive placement agent in connection with the Offering. The Company paid A.G.P a cash fee equal to 6 % of the gross proceeds from the sale of shares and Securities Purchase Agreement Warrants to the Investors, or $ 1,800 , in March 2024. The Company agreed to pay a cash fee equal to 4 % of the gross exercise price paid in cash with respect to the exercise of the Securities Purchase Agreement Warrants. The par value of the common stock remains $ 0.001 per share after the Reverse Stock Split. All share and per share information has been retroactively adjusted to reflect the impact of the Reverse Stock Split for applicable periods presented.

Restatement of Previously Issue

Restatement of Previously Issued Financial Statements	3 Months Ended
	Mar. 31, 2024
Condensed Financial Information Disclosure [Abstract]
Restatement of Previously Issued Financial Statements	2. Restatement of Previously Issued Financial Statements Description of Restatement Adjustments In August 2024, the Company began a comprehensive review of its accounting practices and procedures with respect to revenue recognition related to certain (i) contracts in its “Space as a Service” business (the “Space Services Contracts”) and (ii) contracts in its customer-funded or co-funded research and development arrangements (the “R&D Services Contracts,” and together with the Space Services Contracts, the “Space Services and R&D Services Contracts”) under applicable accounting standards and guidance. As a result of its comprehensive review, the Company determined that a restatement of its previously issued consolidated financial statements for the Affected Periods were required related to consideration of embedded leases for a Space Services Contract, recognition of an allowance for current expected credit loss related to a note receivable issued to a customer, revenue recognition for Space Services and R&D Services Contracts, and income statement classification of costs related to R&D Services Contracts. The Company previously accounted for Space Services Contracts by recognizing revenue separately for each project phase (e.g., development, manufacturing, launch and satellite operations). Because the Space Services Contracts involve bespoke satellites developed under customer requirements, the Company first evaluated whether any of the Space Services Contracts contain embedded leases. Based on this review, the Company concluded that one Space Services Contract contained embedded leases of satellites to the customer, but because the customer controls the satellites being constructed under this specific contract, it was a failed build-to-suit arrangement under Accounting Standards Codification (“ASC”) Topic 842, Leases, and therefore, should still be accounted for under ASC 606, Revenue from Contracts with Customers. The Company determined that the contract requires the transaction price to be allocated to the following performance obligations: design/build, launch, operation, and material rights for up to ten additional satellites. As a result, the Company corrected the financial statements for the Affected Periods to reflect the correct pattern of revenue recognition: over time for the design/build of satellites controlled by the customer, utilizing an input method based on a cost-to-cost measure of progress over the period from initial design to launch; at the point in time when the launch occurred for launch service; over time utilizing an output method based on the number of satellite months as the measure of progress for operating the satellite; and when (or as) the underlying future services are transferred, or when the options expire, for material rights. The Company also made the following correction to account for costs incurred for this contract: construction-related costs were expensed as incurred rather than capitalized as property and equipment, and the prepaid fees for launch services were capitalized as costs to fulfill the contract within other current assets on the condensed consolidated balance sheets, rather than capitalized as property and equipment. The capitalized prepaid launch costs will be recognized as expense upon the successful launch of the satellites. In addition, under this contract, the customer provided a $ 4,500 promissory note to the Company to cover the launch costs. Historically, the Company had not recorded an allowance for current expected credit loss (“CECL”) on the promissory note balance. Management determined that the note receivable is subject to CECL guidance and recorded an allowance for current expected credit loss on the notes receivable balance outstanding as of March 31, 2024. For the Space Services Contracts that do not contain an embedded lease, the Company concluded that, given the contractual clauses in Space Services Contracts by which each company retains its intellectual property, no control of intellectual property was transferred to the end customer during the pre-space period, and therefore, no performance obligation for the pre-space period exists. The Space Services Contracts were determined to generally only have one performance obligation for the overall space service. The transfer of control of the service to the customer starts when the satellite is in operation and the data service commences. As a result, the Company corrected the consolidated financial statements for the Affected Periods to remove revenue recognized during the pre-space period and recognize revenue over-time utilizing an output measure of progress based on satellite months during its intended service period. In addition to the one performance obligation for the space service, certain Space Services Contracts have additional performance obligations for customers’ material rights to purchase additional satellites or services in the future at a discounted price, which resulted in the transaction price being allocated to the material rights in addition to the space service performance obligation. Revenue allocated to material rights is recognized over the period of service to which the material right relates or at the time the material right expires. The Company concluded that no change was required to the accounting treatment for costs associated with these contracts as the Company's existing practice of capitalizing satellite costs within property and equipment, the capitalization of costs to obtain the contracts within other current assets, and the related recognition of expense over the expected life of the assets or term of the contracts were appropriate. For the R&D Services Contracts, the Company determined that its previous revenue recognition practice of revenue recognition on completion of each contractual milestone did not accurately represent the pattern of control transfer for the related intellectual property under the contract. The Company concluded that the pattern of control transfer for the intellectual property occurs over time as the Company performs its research and development activities. Therefore, the Company determined that revenue related to customer-funded research and development arrangements should have been recognized by using an input method based on a cost-to-cost measure of progress over the period from initial design to launch, generally resulting in earlier revenue recognition, as the Company’s performance precedes the related milestone. All costs associated with the R&D Services Contracts were reclassified from research and development to cost of revenue within gross profit on the face of the consolidated statements of operations. In the past, these costs were classified as research and development within operating expenses. The costs for the Company’s internal research and development projects will remain as research and development expense within operating expenses. As a result of the accounting errors detailed above, revenue, cost of revenue, research and development expense, other expense, income tax provision, accumulated other comprehensive loss, contract assets, contract liabilities, property and equipment, and allowance for current expected credit loss on notes receivable were determined to be incorrect on the Company’s unaudited condensed consolidated balance sheets, unaudited condensed consolidated statements of operations, unaudited condensed consolidated statements of comprehensive loss, unaudited condensed consolidated statements of stockholders' equity and unaudited condensed consolidated statements of cash flows as of March 31, 2024, and for the fiscal quarters ended March 31, 2024 and 2023. These restatements resulted in a reclassification between cash flows from operating activities and from investing activities, but they do not impact cash flows from financing activities or net increase in cash, cash equivalents and restricted cash in the unaudited condensed consolidated statements of cash flows for the fiscal quarters ended March 31, 2024 and 2023. The restatement only impacted net loss and accumulated other comprehensive loss in the unaudited condensed consolidated statements of stockholders’ equity for the fiscal quarters ended March 31, 2024 and 2023. Other Adjustments The Company historically incorrectly recorded advances made to vendors for property and equipment in other current assets before clearing it to property and equipment in the condensed consolidated balance sheets. As advances to vendors were included in other current assets, the cash flows associated with these payments were incorrectly reflected in operating activities in the condensed consolidated statements of cash flows. The Company determined that the advances made to vendors for property and equipment should be included in property and equipment. Therefore, advances to vendors were reclassified to property and equipment and the cash flows associated with the advances made were reclassified from operating activities to investing activities in the condensed consolidated statements of cash flows for the applicable Affected Periods. The Company identified that the cash balances held in certain foreign subsidiaries' accounts were remeasured incorrectly. The incorrect remeasurement impacted (i) the cash balance on the condensed consolidated balance sheets as of March 31, 2024, and (ii) the foreign currency remeasurement loss on the condensed consolidated statements of operations for the three months ended March 31, 2024. The Company corrected the remeasurement of the affected cash balances in the Affected Periods. The Company did not accrue expenses for Delaware franchise taxes in the proper periods on its consolidated balance sheets and the expenses for Delaware franchise taxes were classified as other expense, net on its consolidated statements of operations. As part of this restatement, the Company accrued for the Delaware franchise taxes in the appropriate periods and reclassified the amounts from other expense, net to general and administrative expenses. The Company identified that certain state taxes that were originally classified as other expense, net are related to state minimums or franchise-like taxes, which are based on revenues. Therefore, those amounts were incorrectly classified as other expense, and should have been classified as general and administrative expense. As part of this restatement, the Company reclassified the amounts from other expense, net to general and administrative expenses. The Company identified that a customer deposit was incorrectly classified as other accrued expenses instead of contract liability on its consolidated balance sheets. As part of this restatement, the Company reclassified the amount from other accrued expense to contract liabilities, non-current. Unaudited Condensed Consolidated Financial Statements - Restatement Reconciliation Tables The following tables reflect the impact of the restatement to the specific line items presented in the Company’s previously reported unaudited condensed consolidated financial statements as of March 31, 2024, and for the fiscal quarters ended March 31, 2024 and 2023. The impact of the restatement to the unaudited condensed consolidated statements of changes in stockholders' equity includes increases of $ 32,971 and $ 20,063 in net loss for the three months ended March 31, 2024 and March 31, 2023, respectively, and decreases of $ 116 and $ 64 in accumulated other comprehensive loss for the three months ended March 31, 2024, and March 31, 2023, respectively. The amounts in the "As Previously Reported" columns are amounts derived from the Company's previously filed unaudited condensed consolidated financial statements in the Original Form 10-Q. The amounts in the "Restatement Adjustments" columns present the impact of the following adjustments: • The change in revenue recognition timing for Space Services Contracts, • The change in revenue recognition timing for R&D Services Contracts, • The reclassification of costs related to R&D Services Contracts from research and development expense to cost of revenue, • The recognition of expense for satellite construction and launch services for the failed build-to-suit lease contract, • The recognition of the allowance for current expected credit loss related to a note receivable issued to a customer, • The impact to income tax provision as a result of the restatement adjustments above, • The impact to foreign currency translation gain or loss as a result of the restatement adjustments above, and • Other adjustments including balance sheet reclassification of fixed asset advances and customer deposits, statements of operations reclassification of department costs, a vendor dispute settlement, franchise taxes, other state taxes and cash remeasurement adjustments. The amounts in the "As Restated" columns are the updated amounts including the impacts from the restatement. Financial statement line items and subtotals that were not impacted by the restatement adjustments have been omitted for enhanced clarity. As of March 31, 2024 Unaudited Condensed Consolidated Balance Sheet Notes As Previously Reported Restatement Adjustments As Restated Cash and cash equivalents (i) $ 51,985 $ ( 254 ) $ 51,731 Contract assets (ii) $ 5,205 $ ( 218 ) $ 4,987 Other current assets (iii) $ 12,241 $ ( 3,116 ) $ 9,125 Total current assets $ 93,780 $ ( 3,588 ) $ 90,192 Property and equipment, net (iv) $ 71,853 $ ( 12,253 ) $ 59,600 Other long-term assets, including restricted cash (v) $ 7,503 $ 198 $ 7,701 Total assets $ 267,972 $ ( 15,643 ) $ 252,329 Contract liabilities, current portion (vi) $ 22,617 $ ( 387 ) $ 22,230 Other accrued expenses (vii) $ 11,309 $ ( 184 ) $ 11,125 Total current liabilities $ 41,942 $ ( 571 ) $ 41,371 Contract liabilities, non-current (viii) $ - $ 19,259 $ 19,259 Deferred income tax liabilities (ix) $ 1,058 $ ( 263 ) $ 795 Other long-term liabilities (x) $ 1,221 $ ( 1,213 ) $ 8 Total liabilities $ 182,662 $ 17,212 $ 199,874 Accumulated other comprehensive loss (xi) $ ( 6,234 ) $ 116 $ ( 6,118 ) Accumulated deficit (xii) $ ( 427,859 ) $ ( 32,971 ) $ ( 460,830 ) Total stockholders’ equity $ 85,310 $ ( 32,855 ) $ 52,455 Total liabilities and stockholders’ equity $ 267,972 $ ( 15,643 ) $ 252,329 Description of restatement adjustments in the condensed consolidated balance sheets: (i) The $ 254 decrease in cash and cash equivalents as of March 31, 2024, is related to the cash remeasurement adjustment for cash balances from certain foreign subsidiaries. (ii) The $ 218 decrease in contract assets as of March 31, 2024, is related to adjustments to correct revenue recognition for Space Services and R&D Services Contracts. (iii) The $ 3,116 decrease in other current assets as of March 31, 2024, resulted from a decrease of $ 1,858 related to advances for fixed assets that have been reclassified from other current assets to other property and equipment and a decrease of $ 1,258 related to the allowance for current expected credit loss related to the note receivable issued to a customer recorded in other current assets. (iv) The $ 12,253 decrease in property and equipment as of March 31, 2024, resulted from a decrease of $ 14,111 related to costs for customer-controlled satellites for one specific contract being expensed as cost of revenue rather than capitalized into property and equipment, partially offset by $ 1,858 of advances for fixed assets that have been reclassified from other current assets to property and equipment instead of other current assets. (v) The $ 198 increase in other long-term assets, including restricted cash as of March 31, 2024, is related to adjustments to long-term contract assets to correct revenue recognition for Space Services and R&D Services Contracts. (vi) The $ 387 decrease in contract liabilities, current portion as of March 31, 2024 is related to the correction of revenue recognition for Space Services and R&D Services Contracts. (vii) The $ 184 decrease in other accrued expenses as of March 31, 2024 resulted from a decrease of $ 182 related to a customer deposit balance reclassified from other accrued expense to contract liabilities, non-current, and a decrease of $ 52 from income tax provision change as a result of the revenue adjustments, partially offset by $ 50 Delaware franchise tax accrual. (viii) The $ 19,259 increase in contract liabilities, non-current as of March 31, 2024 resulted from an increase of $ 17,864 related to the correction of revenue recognition for Space Services and R&D Services Contracts, an increase of $ 1,213 from the historical balance of contract liabilities, non-current that was included within other long-term liabilities but now presented in its own line and an increase of $ 182 from a customer deposit balance reclassified to contract liabilities, non-current. (ix) The $ 263 decrease in deferred income tax liabilities as of March 31, 2024, is related to the impact to income tax provision as a result of the revenue adjustments. (x) The $ 1,213 decrease in other long-term liabilities as of March 31, 2024 represents the contract liabilities, non-current balance that was historically included in other long-term liabilities but is now presented in its own line. (xi) The $ 116 decrease in accumulated other comprehensive loss as of March 31, 2024, is related to the misstatements’ impact on cumulative foreign currency translation loss. (xii) The $ 32,971 increase in accumulated deficit as of March 31, 2024, is related to the cumulative adjustments made in the condensed consolidated statements of operations. Three Months Ended March 31, 2024 Three Months Ended March 31, 2023 Unaudited Condensed Consolidated Statements of Operations Notes As Previously Reported Restatement Adjustments As Restated As Previously Reported Restatement Adjustments As Restated Revenue (i) $ 25,688 $ 9,137 $ 34,825 $ 24,168 $ ( 951 ) $ 23,217 Cost of revenue (ii) $ 12,546 $ 13,050 $ 25,596 $ 10,360 $ 3,009 $ 13,369 Gross profit $ 13,142 $ ( 3,913 ) $ 9,229 $ 13,808 $ ( 3,960 ) $ 9,848 Research and development (iii) $ 9,909 $ ( 3,872 ) $ 6,037 $ 9,663 $ ( 2,345 ) $ 7,318 General and administrative (iv) $ 9,818 $ 26 $ 9,844 $ 11,770 $ 53 $ 11,823 Allowance for current expected credit loss on notes receivable (v) $ - $ 40 $ 40 $ - $ - $ - Total operating expenses $ 25,023 $ ( 3,806 ) $ 21,217 $ 28,283 $ ( 2,292 ) $ 25,991 Loss from operations $ ( 11,881 ) $ ( 107 ) $ ( 11,988 ) $ ( 14,475 ) $ ( 1,668 ) $ ( 16,143 ) Foreign exchange (loss) gain (vi) $ ( 1,538 ) $ ( 248 ) $ ( 1,786 ) $ 1,024 $ ( 11 ) $ 1,013 Other (expense) income, net (vii) $ ( 551 ) $ 17 $ ( 534 ) $ ( 762 ) $ 451 $ ( 311 ) Total other income (expense), net $ ( 13,334 ) $ ( 231 ) $ ( 13,565 ) $ ( 2,929 ) $ 440 $ ( 2,489 ) Loss before income taxes $ ( 25,215 ) $ ( 338 ) $ ( 25,553 ) $ ( 17,404 ) $ ( 1,228 ) $ ( 18,632 ) Income tax (benefit) provision (viii) $ 41 $ ( 50 ) $ ( 9 ) $ 269 $ ( 246 ) $ 23 Net loss $ ( 25,256 ) $ ( 288 ) $ ( 25,544 ) $ ( 17,673 ) $ ( 982 ) $ ( 18,655 ) Basic and diluted net loss per share (1) $ ( 1.16 ) $ ( 0.01 ) $ ( 1.17 ) $ ( 0.98 ) $ ( 0.05 ) $ ( 1.03 ) Weighted-average shares used in computing basic and (1) 21,813,045 - 21,813,045 18,096,363 - 18,096,363 (1) The shares of the Company's common stock and the per share amounts for the three months ended March 31, 2023, have been retroactively adjusted to reflect the 1-for-8 reverse stock split (Note 1). Description of restatement adjustments in the condensed consolidated statements of operations: (i) The $ 9,137 increase and $ 951 decrease in revenue for the three months ended March 31, 2024 and March 31, 2023, respectively, are related to the correction of revenue recognition for Space Services and R&D Services Contracts. (ii) Adjustments to cost of revenue: a. The $ 13,050 increase in cost of revenue for the three months ended March 31, 2024, resulted from an increase of $ 9,178 in construction costs and launch costs for customer-controlled satellites for one specific contract being expensed to cost of revenue and an increase of $ 3,872 of costs associated with R&D Services Contracts being reclassified from research and development expense to cost of revenue. b. The $ 3,009 increase in cost of revenue for the three months ended March 31, 2023 resulted from an increase of $ 2,345 of costs associated with R&D Services Contracts for one specific contract being reclassified from research and development expense to cost of revenue, an increase of $ 642 in construction costs and launch costs for customer-controlled satellites being expensed to cost of revenue, and an increase of $ 22 from the reclassification of supply chain department costs from general and administrative expense to cost of revenue. (iii) The $ 3,872 and $ 2,345 decreases in research and development expense for the three months ended March 31, 2024 and March 31, 2023, respectively, are related to costs associated with R&D Services Contracts being reclassified from research and development expense to cost of revenue. (iv) The $ 26 increase in general and administrative expenses for the three months ended March 31, 2024 resulted from an increase of $ 17 from the reclassification of other state taxes from other expense, net and an increase of $ 9 to adjust for the Delaware franchise tax accrual. The $ 53 increase in general and administrative expenses for the three months ended March 31, 2023, resulted from an increase of $ 450 from the reclassification of other state taxes from other expense, net, partially offset by a decrease of $ 377 to adjust for the Delaware franchise tax accrual and a decrease of $ 20 from the reclassification of supply chain department costs from general and administrative expense to cost of revenue. (v) The $ 40 increase in allowance for current expected credit loss on notes receivable for the three months ended March 31, 2024 is related to the additional allowance for current expected credit loss related to a $ 4,500 note receivable issued to a customer. (vi) The $ 248 and $ 11 changes in foreign exchange loss for the three months ended March 31, 2024 and March 31, 2023, respectively, are related to the cash remeasurement adjustment for cash balances from certain foreign subsidiaries. (vii) The $ 17 and $ 451 changes in other (expense) income, net for the three months ended March 31, 2024 and March 31, 2023, respectively, are related to the other state taxes reclassified to general and administrative. (viii) The $ 50 and $ 246 decreases in income tax provision for the three months ended March 31, 2024 and March 31, 2023, respectively, are related to the impact to income tax provision as a result of the revenue adjustments. Three Months Ended March 31, 2024 Three Months Ended March 31, 2023 Unaudited Condensed Consolidated Statements of Comprehensive Loss Notes As Previously Reported Restatement Adjustments As Restated As Previously Reported Restatement Adjustments As Restated Net loss $ ( 25,256 ) $ ( 288 ) $ ( 25,544 ) $ ( 17,673 ) $ ( 982 ) $ ( 18,655 ) Foreign currency translation adjustments (i) $ ( 1,747 ) $ 187 $ ( 1,560 ) $ ( 1,589 ) $ ( 25 ) $ ( 1,614 ) Comprehensive loss $ ( 27,005 ) $ ( 101 ) $ ( 27,106 ) $ ( 19,218 ) $ ( 1,007 ) $ ( 20,225 ) Description of restatement adjustments in the condensed consolidated statements of comprehensive loss: (i) The $ 187 foreign currency translation gain and $ 25 foreign currency translation loss for the three months ended March 31, 2024, and March 31, 2023, respectively, are related to the foreign currency translation impact of consolidated statements of operations adjustments (i) to (iv) above. Three Months Ended March 31, 2024 Three Months Ended March 31, 2023 Unaudited Condensed Consolidated Statements of Cash Flows Notes As Previously Reported Restatement Adjustments As Restated As Previously Reported Restatement Adjustments As Restated Net loss $ ( 25,256 ) $ ( 288 ) $ ( 25,544 ) $ ( 17,673 ) $ ( 982 ) $ ( 18,655 ) Other, net (i) $ ( 20 ) $ 248 $ 228 $ ( 110 ) $ ( 240 ) $ ( 350 ) Change in contract assets (ii) $ 624 $ ( 1,266 ) $ ( 642 ) $ ( 855 ) $ 68 $ ( 787 ) Other current assets (iii) $ 392 $ 7,703 $ 8,095 $ 117 $ ( 805 ) $ ( 688 ) Change in contract liabilities (iv) $ 775 $ ( 7,932 ) $ ( 7,157 ) $ 1,259 $ 895 $ 2,154 Other accrued expenses (v) $ 973 $ 30 $ 1,003 $ ( 548 ) $ ( 372 ) $ ( 920 ) Net cash used in operating activities $ ( 7,345 ) $ ( 1,505 ) $ ( 8,850 ) $ ( 11,290 ) $ ( 1,436 ) $ ( 12,726 ) Purchase of property and equipment (vi) $ ( 8,564 ) $ 1,505 $ ( 7,059 ) $ ( 4,649 ) $ 1,436 $ ( 3,213 ) Net cash used in investing activities $ ( 8,684 ) $ 1,505 $ ( 7,179 ) $ ( 6,957 ) $ 1,436 $ ( 5,521 ) Effect of foreign currency translation on cash, (vii) $ 711 $ ( 246 ) $ 465 $ ( 1,846 ) $ - $ ( 1,846 ) Cash, cash equivalents and restricted cash - $ 29,641 $ ( 8 ) $ 29,633 $ 47,569 $ - $ 47,569 Cash, cash equivalents and restricted cash - $ 52,471 $ ( 254 ) $ 52,217 $ 47,362 $ - $ 47,362 Description of restatement adjustments in the condensed consolidated statements of cash flows: (i) The $ 248 and $ 240 adjustments to change in other, net for the three months ended March 31, 2024 and March 31, 2023, respectively, are related to the impact to income tax provision as a result of the revenue adjustment. (ii) The $ 1,266 and $ 68 adjustments to change in contract assets for the three months ended March 31, 2024 and March 31, 2023, respectively, are related to the impact to current and non-current balances of contract assets from the correction of revenue recognition for Space Services and R&D Services Contracts. (iii) The $ 7,703 additional decrease in other current assets for the three months ended March 31, 2024 resulted from expensing the $ 7,585 prepaid launch costs capitalized into other current assets in 2023, a $ 78 net change in advances for fixed assets balance that was reclassified to property and equipment, and an additional allowance for current expected credit loss of $ 40 recorded for the $ 4,500 note receivable. The $ 805 increase in other current assets for the three months ended March 31, 2023 related to the net change in advances for fixed assets balance that is reclassified to property and equipment. (iv) The $ 7,932 adjustment to change in contract liabilities for the three months ended March 31, 2024 resulted from a $ 7,860 impact in contract liabilities from the correction of revenue recognition for Space Services and R&D Services Contracts and a $ 72 change in the customer deposit balance reclassified from other accrued expense to contract liabilities, non-current. The $ 895 adjustment to change in contract liabilities for the three months ended March 31, 2023 is related to the impact to current and non-current balances of contract liabilities from the correction of revenue recognition for Space Services and R&D Services Contracts. (v) The $ 30 decrease in other accrued expense for the three months ended March 31, 2024 resulted from a decrease of $ 52 from the impact to income tax provision as a result of the revenue adjustment, partially offset by an increase of $ 72 for change in the customer deposit balance reclassified to contract liability and an increase of $ 10 to the Delaware franchise tax accrual. The $ 372 decrease in other accrued expense for the three months ended March 31, 2023 is related to the Delaware franchise tax accrual. (vi) Adjustments to purchase of property and equipment: a. The $ 1,505 decrease in purchase of property and equipment for the three months ended March 31, 2024 resulted from a decrease of $ 9,074 related to costs incurred to design/build the customer-controlled satellites for one specific contract being expensed rather than capitalized into the Company's property and equipment and a decrease of $ 16 related to the reclassification of advances for fixed assets, partially offset by an increase of $ 7,585 from prepaid launch costs for such satellites reclassified into other current assets. b. The $ 1,436 decrease in purchase of property and equipment for the three months ended March 31, 2023 resulted from a decrease of $ 825 noncash addition to property and equipment from prior period advances that was incorrectly reflected as a cash purchase and a decrease of $ 611 related to costs incurred to design/build the customer-controlled satellites for one specific contract being expensed rather than capitalized into the Company's property and equipment. (vii) The $ 8 and $ 254 decreases in cash and cash equivalents as of December 31, 2023 and March 31, 2024, respectively, are related to the cash remeasurement adjustment for cash balances from certain foreign subsidiaries, which resulted in a $ 246 change in effect of foreign currency translation on cash, cash equivalents and restricted cash for the three months ended March 31, 2024.

Summary of Significant Accounti

Summary of Significant Accounting Policies (As Restated)	3 Months Ended
	Mar. 31, 2024
Accounting Policies [Abstract]
Summary of Significant Accounting Policies (As Restated)	3. Summary of Significant Accounting Policies Basis of Presentation The condensed consolidated financial statements and accompanying notes are unaudited and have been prepared in accordance with accounting principles generally accepted in the United States of America (“GAAP”) and regulations of the U.S. Securities and Exchange Commission (the "SEC") for interim financial reporting. Certain information and footnote disclosures normally included in consolidated financial statements prepared in accordance with GAAP have been condensed or omitted pursuant to rules and regulations applicable to interim financial reporting. The unaudited condensed consolidated financial statements were prepared on the same basis as the audited consolidated financial statements and, in the opinion of management, contain all adjustments, consisting of normal recurring adjustments necessary for a fair statement of its financial position, results of operations and cash flows for the periods indicated. These condensed consolidated financial statements should be read in conjunction with the consolidated financial statements included within the Company's Annual Report on Form 10-K for the year ended December 31, 2023. The information as of December 31, 2023 included on the condensed consolidated balance sheets was derived from the Company’s audited consolidated financial statements. All intercompany accounts and transactions have been eliminated in consolidation. Results of operations for the three months ended March 31, 2024, are not necessarily indicative of the results that may be expected for any other interim period or for the year ending December 31, 2024. Reverse Stock Split For the three months ended, and as of, March 31, 2023, reported share amounts, including issued and outstanding shares, per share amounts, and reported issued and outstanding warrants and other securities convertible into common stock in these condensed consolidated financial statements and accompanying notes have been retroactively adjusted for the Reverse Stock Split by applying the Reverse Stock Split ratio. The number of authorized shares of common stock was not impacted by the Reverse Stock Split, and therefore has not been retroactively adjusted. Liquidity Risks and Uncertainties The Company has a history of operating losses and negative cash flows from operations since inception. During the three months ended March 31, 2024, net loss was $ 25,544 , cash used in operations was $ 8,850 and the Company received net proceeds of $ 9,825 from the Private Placement and $ 28,056 from the Offering. The Company held cash and cash equivalents of $ 51,731 , excluding restricted cash of $ 486 , and investment in short-term marketable securities of $ 12,003 as of March 31, 2024. The Company’s ability to continue as a going concern for the next 12 months from the date of reissuance of these condensed consolidated financial statements is dependent upon its ability to obtain sufficient cash to meet its obligations, including the repayment of all amounts owed pursuant to the Blue Torch Financing Agreement (as amended, and as defined below in Note 7). The Company has failed to meet its leverage ratio and minimum liquidity financial covenants and SEC periodic filing requirement non-financial covenant under the Blue Torch Financing Agreement, and therefore Blue Torch Finance LLC (“Blue Torch”) has the right to accelerate and declare all or any portion of the loans outstanding under the Blue Torch Financing Agreement to be due and payable. Further, upon the filing of the Amended 2023 Form 10-K/A, the Company failed to comply with the non-financial covenant requiring the Company to have a report or opinion of its auditor without an explanatory paragraph expressing substantial doubt about its ability to continue as a going concern. Based on the Company’s current cash and cash equivalents and investment in marketable securities balances and expected future financial results, if the Transactions (as defined below) do not close, the Company will not have sufficient liquidity to continue operations for at least the next twelve months from the reissuance of these condensed consolidated financial statements. Furthermore, the Company will not have sufficient cash to repay the balance of the loans outstanding under the Blue Torch Financing Agreement in the event Blue Torch declares all or any portion of the loans to be due and payable. The Company entered into a Share Purchase Agreement (the “Purchase Agreement”) with Kpler Holding SA, a Belgian corporation (“Buyer”), pursuant to which the Company agreed to sell its maritime business to Buyer and enter into certain ancillary agreements (the “Transactions”). The maritime business to be sold pursuant to the Transactions does not include any part of the Company’s satellite network or operations. The purchase price to be paid by Buyer to the Company at the closing of the Transactions is a cash payment based upon an enterprise value of $ 233,500 , subject to certain adjustments. The Transactions also include a twelve-month transition service and data provision agreement for $ 7,500 . The Purchase Agreement provides that the closing of the Transactions is subject to the satisfaction or waiver of certain closing conditions set forth in the Purchase Agreement. On February 10, 2025, the Company filed a complaint in the Delaware Court of Chancery against Buyer seeking a grant of specific performance ordering Buyer to satisfy its obligations under the Purchase Agreement and consummate the closing in accordance with the terms of the Purchase Agreement. In the complaint, the Company also requested a declaratory judgment declaring that Buyer has breached its obligations under the Purchase Agreement and is not excused from performing its obligations under the Purchase Agreement, including proceeding with the closing. Kpler removed the matter to the District of Delaware, pursuant to a contract term in the Purchase Agreement promising not to contest removal to that court. The District of Delaware initially selected a March 4 trial date, but on February 26, 2025, the court set a trial date of May 28-30, 2025. There is no assurance as to what action the District of Delaware will take with respect to the proceeding initiated by the Company and there is no assurance as to whether or not the Transactions will be consummated on the terms contemplated or at all. The amount of any damages which may be sought or obtained from Buyer cannot be determined at this time. The Company intends to use the proceeds from the closing of the Transactions to repay all amounts owed under the Blue Torch Financing Agreement. However, as described above, there is currently no assurance that the Transactions will close or when the Transactions may close. Given the expected delay in the closing of the Transactions, the Company intends to seek additional equity or debt financing (including securities convertible or exchangeable for equity) and may seek waivers of or amendments to contractual obligations, delay, limit, reduce, or terminate certain commercial efforts, or pursue merger, disposition or other strategies, any of which could adversely affect its business, results of operations, and financial condition. There is no assurance that the Company will be successful in achieving any of the foregoing. Due to the Company’s projected cash needs, including amounts owed pursuant to the Blue Torch Financing Agreement and the Company’s breach of its covenants under the Blue Torch Financing Agreement, there is substantial doubt about its ability to continue as a going concern for a period of at least 12 months from the date of reissuance of these condensed consolidated financial statements. The condensed consolidated financial statements do not include any adjustments that might result from the outcome of this uncertainty. Macroeconomic and Geopolitical Over the past two years, the Company has been impacted by the macroeconomic environment, such as fluctuations in foreign currencies, increasing interest rates and geopolitical conflicts like the Russian invasion of Ukraine, Israel's war with Hamas and the increased tensions between China and the United States. The U.S. Dollar exhibited a modest decrease in strength against the local functional currencies of our foreign subsidiaries for the three months ended March 31, 2024, as compared to the three months ended March 31, 2023. This had a marginal positive impact on our revenue, as about one-third of the Company's sales are conducted in foreign currencies. Conversely, it had a marginal unfavorable impact on our expenses, given that a majority of the Company's workforce resides in countries other than the United States. The macroeconomic environment has caused existing or potential customers to re-evaluate their decision to purchase the Company's offerings, at times resulting in additional customer discounts, extended payment terms, longer sales cycles, and a few contract cancellations. Increasing interest rates in the three months ended March 31, 2024, compared to the three months ended March 31, 2023, resulted in higher interest expenses, as the Company’s credit facility is based on a floating interest rate. The Russian invasion of Ukraine and the continued conflict created additional global sanctions, which at times caused scheduling shifts or launch cancellations by third-party satellite launch providers and negatively impacted the availability of launch windows and our constellation replenishment efforts. If any of these factors continue or worsen, and/or if new macroeconomic or geopolitical issues arise, the Company's results and financial condition could be further negatively impacted. The Company cannot predict the timing, strength, or duration of any economic slowdown, downturn, instability, or recovery, generally or within any particular industry or geography. Any downturn of the general economy or industries in which the Company operates would adversely affect its business, financial condition, and results of operations. Use of Estimates The preparation of financial statements in conformity with GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities, and disclosures of contingent assets and liabilities at the dates of the condensed consolidated financial statements, and the reported amounts of revenues and expenses during the reporting period. Management’s significant estimates include assumptions for revenue recognition, which requires estimates of total costs used in measuring the progress of completion for the cost-based input method, allowance for current expected credit losses, valuation of certain assets and liabilities acquired from the acquisition of exactEarth in November 2021 (the “Acquisition”), realizability of deferred income tax assets, and fair value of equity awards, contingent earnout liabilities and warrant liabilities. Actual results could differ from those estimates. Based on an evaluation of the lifespans of its in-service satellites and on current capabilities to extend the useful life of in-service satellites via software updates, the Company changed the estimated useful life of its capitalized satellites and related launch costs from three to four years for depreciation purposes. The Company determined it was appropriate to make this change beginning June 2023. The change in estimated useful life did not have a material impact for the three months ended March 31, 2024. In November 2023, the Company updated the estimated useful lives for 43 capitalized satellites and related launch costs based on updated de-orbit dates. This change represents a change in accounting estimate and the impact of the change was an increase in loss from continuing operations before income taxes of approximately $ 3,009 , or $ 0.14 per basic and diluted share for the three months ended March 31, 2024. Cash, Cash Equivalents, Marketable Securities and Restricted Cash (As Restated) The Company considers all highly liquid investments with an original maturity of three months or less to be cash equivalents. Restricted cash included in Other long-term assets, including restricted cash on the condensed consolidated balance sheets, represents amounts pledged as guarantees or collateral for financing arrangements and lease agreements, as contractually required. The Company invests in highly rated securities, with the primary objective of minimizing the potential risk of principal loss. The Company’s investment policy generally requires securities to be investment grade and limits the amount of credit exposure to any one issuer. The Company’s investments in marketable debt securities have been classified and accounted for as available-for-sale. The Company classifies its marketable debt securities as either short-term or long-term based on each instrument’s underlying contractual maturity date. Unrealized gains and losses on marketable debt securities classified as available-for-sale are recognized in Accumulated other comprehensive loss. Interest on securities classified as available-for-sale is included in Interest income on the condensed consolidated statements of operations. The following table shows components of cash, cash equivalents, and restricted cash reported on the condensed consolidated balance sheets and in the condensed consolidated statements of cash flows as of the dates indicated: March 31, December 31, 2024 2023 (As Restated) Cash and cash equivalents $ 51,731 $ 29,136 Restricted cash included in Other long-term assets 486 497 $ 52,217 $ 29,633 Concentrations of Credit Risk (As Restated) Financial instruments that potentially subject the Company to concentrations of credit risk consist of cash, cash equivalents and restricted cash, marketable securities, and accounts receivable. The Company typically has cash accounts in excess of Federal Deposit Insurance Corporation insurance coverage limits. The Company has not experienced any losses on such accounts, and management believes that the Company’s risk of loss is remote. The Company has a $ 4,500 note receivable due from a single customer. The Company has established a $ 1,258 allowance of current expected credit loss for this note receivable as of March 31, 2024. The Company has a concentration of contractual revenue arrangements with various government agencies. Entities under common control are reported as a single customer. As of March 31, 2024, the Company had one customer (Customer A noted below) that accounted for 16 % of the Company’s total accounts receivable. As of December 31, 2023, the Company did not have any customers that accounted for more than 10 % of the Company’s total accounts receivable. The following customers represented 10% or more of the Company’s total revenue for each of the following periods: Three Months Ended March 31, 2024 2023 (As Restated) (As Restated) Customer A (1) 17 % 31 % Customer B 28 % * * Revenue from this customer was less than 10 % of total revenue during the period. (1) Consists of multiple U.S. government agencies, of which one government agencies represented greater than 10 % of total revenue for the three months ended March 31, 2023 . Related Parties (As Restated) In conjunction with the Company's acquisition of exactEarth in November 2021, Myriota Pty Ltd ("Myriota"), an existing Spire customer, became a related party as a result of exactEarth's approximately 13 % ownership of Myriota at the time of acquisition. As of March 31, 2024, the Company had 11.5 % ownership of Myriota. As of March 31, 2024, and December 31, 2023, $ 1,876 and $ 2,216 , respectively, of investment in Myriota were included in Other long-term assets, including restricted cash on the condensed consolidated balance sheets. The Company accounts for this investment using the equity method of accounting. The Company's share of earnings or losses on the investment is recorded on a one month lag, due to the timing of receiving financial statements from Myriota, as a component of other expense, net in the condensed consolidated statements of operations. The Company generated $ 217 and $ 225 in revenue from Myriota for the three months ended March 31, 2024 and 2023, respectively, and had $ 52 of accounts receivable from Myriota as of March 31, 2024 , and had no accounts receivable from Myriota as of December 31, 2023. Accounting Pronouncements Recently Adopted In March 2023, the Financial Accounting Standards Board (“FASB”) issued Accounting Standards Update (“ASU”) 2023-01, Leases – Common Control Arrangements (Topic 842), to improve the accounting for amortizing leasehold improvements associated with arrangements between entities under common control. The amendment requires that leasehold improvements be amortized by the lessee over the useful life of the leasehold improvements to the common control group (regardless of the lease term) as long as the lessee controls the use of the underlying asset through a lease. Additionally, leasehold improvements should be accounted for as a transfer between entities under common control through an adjustment to equity when the lessee no longer controls the use of the underlying asset. The amendments in this update are effective for financial statements issued for annual periods beginning after December 15, 2023, with early adoption permitted. The adoption of ASU 2023-01 as of January 1, 2024, did not impact the Company’s condensed consolidated financial statements. In August 2023, the FASB issued ASU 2023-05, Business Combinations – Joint Venture Formations (Subtopic 805-60): Recognition and Initial Measurement. The amendments in this ASU are intended to facilitate consistency in the application of accounting guidance upon the formation of entities qualifying as joint ventures ("JVs"). This ASU generally requires the use of business combinations accounting at the JV formation date, which would result in the contributed assets/liabilities being revalued to fair value and potentially result in the recognition of goodwill and other intangibles on the JV’s financial statements. However, this ASU does not alter the ongoing accounting for the JV’s operations. This guidance is effective for JVs with formation dates on or after January 1, 2025. The adoption of ASU 2023-05 as of January 1, 2024 did not impact the Company’s condensed consolidated financial statements. Accounting Pronouncements Not Yet Adopted In November 2023, the FASB issued ASU 2023-07, Segment Reporting - Improvements to Reportable Segment Disclosures (Topic 280), to improve reportable segment disclosure requirements, primarily through enhanced disclosures about significant segment expenses. The amendments enhance interim disclosure requirements, clarify circumstances in which an entity can disclose multiple segment measures of profit or loss, provide new segment disclosure requirements for entities within a single reportable segment, and contain other disclosure requirements. The ASU is effective for fiscal years beginning after December 15, 2023, and interim periods within fiscal years beginning after December 15, 2024. Early adoption is permitted and will be applied retrospectively to all prior periods presented in the financial statements. The Company is currently evaluating the ASU to determine its impact on the Company’s disclosures. In December 2023, the FASB issued ASU 2023-09, Income Taxes - Improvements to Income Tax Disclosures (Topic 740), to further enhance income tax disclosures to enable investors to better assess how an entity’s operations, related tax risks, tax planning, and operational opportunities affect its tax rate and prospects for future cash flows. The improvements primarily relate to the disaggregation of rate reconciliation categories and income taxes paid by jurisdiction. The other amendments improve the effectiveness and comparability of disclosures by adding disclosures of pretax income (or loss) and income tax expense (or benefit) to be consistent with SEC regulations. The ASU is effective for public business entities for annual reporting periods beginning after December 15, 2024. Early adoption is permitted and should be applied prospectively or retrospectively. The Company is currently evaluating the ASU to determine its impact on the Company’s disclosures. In March 2024, the SEC adopted final rules under SEC Release No. 33-11275, The Enhancement and Standardization of Climate-Related Disclosures for Investors, which will require registrants to provide certain climate-related information in their annual reports and registration statements. The rules will require disclosure of material climate-related risks, how the board of directors and management oversee and manage such risks, and the actual and potential impact of such risks on the registrant. It will also require disclosure about material climate-related targets and goals, and the financial impact of severe weather events and other natural conditions in the notes to audited financial statements. The disclosures will be required at the earliest in reports for the year ended December 31, 2025 (or potentially later depending on the Company's filer status at the time). The Company is currently evaluating the impact on the Company's disclosures.

Revenue, Contract Assets, Contr

Revenue, Contract Assets, Contract Liabilities and Remaining Performance Obligations	3 Months Ended
	Mar. 31, 2024
Revenue from Contract with Customer [Abstract]
Revenue, Contract Assets, Contract Liabilities and Remaining Performance Obligations (As Restated)	4. Revenue, Contract Assets, Contract Liabilities and Remaining Performance Obligations (As Restated) Disaggregation of Revenue Revenue from subscription-based contracts was $ 18,166, or 52 % of total revenue, for the three months ended March 31, 2024 , and was $ 19,600 , or 84 % of total revenue, for the three months ended March 31, 2023. Revenue from non-subscription-based contracts was $ 16,659 , or 48 % of total revenue, for the three months ended March 31, 2024 , and was $ 3,616 , or 16 % of total revenue, for the three months ended March 31, 2023. The following revenue disaggregated by geography was recognized: Three Months Ended March 31, 2024 Three Months Ended March 31, 2023 (As Restated) (As Restated) Americas (1) $ 22,680 65 % $ 11,680 50 % EMEA (2) 9,959 29 % 8,219 35 % Asia Pacific 2,186 6 % 3,318 15 % Total $ 34,825 100 % $ 23,217 100 % (1) U.S. represented 34 % and 45 % for the three months ended March 31, 2024 and 2023, respectively, and Canada represented 30 % for the three months ended March 31, 2024. (2) United Kingdom represented 13 % for each of the three months ended March 31, 2023. Contract Assets As of March 31, 2024, contract assets were $ 5,185 , of which $ 4,987 was reported in contract assets, and $ 198 in other long-term assets, including restricted cash on the Company's condensed consolidated balance sheets. As of December 31, 2023, contract assets were $ 4,917 which $ 4,718 was reported in contract assets, and $ 199 in other long-term assets, including restricted cash on the Company's condensed consolidated balance sheets. Changes in contract assets for the three months ended March 31, 2024 and 2023 were as follows: 2024 2023 (As Restated) (As Restated) Balance as of January 1 $ 4,917 $ 2,881 Contract assets recorded during the period 4,696 3,548 Reclassified to accounts receivable during the period ( 4,399 ) ( 2,765 ) Other ( 29 ) 9 Balance as of March 31 $ 5,185 $ 3,673 Contract Liabilities As of March 31, 2024, contract liabilities were $ 41,489 , of which $ 22,230 was reported in contract liabilities, current portion, and $ 19,259 was reported in other long-term liabilities on the Company’s condensed consolidated balance sheets. As of December 31, 2023, contract liabilities were $ 49,101 , of which $ 31,178 was reported in contract liabilities, current portion, and $ 17,923 was reported in other long-term liabilities on the Company’s condensed consolidated balance sheets. Changes in contract liabilities for the three months ended March 31, 2024 and 2023 were as follows: 2024 2023 (As Restated) (As Restated) Balance as of January 1 $ 49,101 $ 34,873 Contract liabilities recorded during the period 13,004 9,395 Revenue recognized during the period ( 20,317 ) ( 7,261 ) Other ( 299 ) 146 Balance as of March 31 $ 41,489 $ 37,153 Remaining Performance Obligations The Company has performance obligations associated with commitments in customer contracts for future services that have not yet been recognized as revenue. These commitments for future services exclude (i) contracts with an original term of one year or less, and (ii) cancellable contracts. As of March 31, 2024, the amount not yet recognized as revenue from these commitments was $ 203,833 . The Company expects to recognize its remaining performance obligations as of March 31, 2024, over the following periods: March 31, 2024 (As Restated) 1 to 12 months $ 72,239 35 % 13 to 24 months 34,200 17 % 25 to 36 months 27,321 13 % Remaining 70,073 34 % Total $ 203,833 100 %

Balance Sheet Components (As Re

Balance Sheet Components (As Restated)	3 Months Ended
	Mar. 31, 2024
Balance Sheet Components [Abstract]
Balance Sheet Components (As Restated)	5. Balance Sheet Components (As Restated) Other current assets consisted of the following: March 31, December 31, 2024 2023 (As Restated) Technology and other prepaid contracts $ 2,536 $ 9,874 Notes receivable 3,344 3,344 Prepaid insurance 956 1,476 Deferred contract costs 541 487 Other receivables 1,520 1,238 Other 228 429 Other current assets $ 9,125 $ 16,848 Property and equipment, net consisted of the following: March 31, December 31, 2024 2023 (As Restated) Satellites in-service $ 53,496 $ 59,751 Internally developed software 2,135 2,138 Ground stations in-service 4,440 4,444 Leasehold improvements 4,069 5,800 Machinery and equipment 5,794 4,787 Computer equipment 1,833 1,908 Computer software and website development 99 99 Furniture and fixtures 1,329 1,336 73,195 80,263 Less: Accumulated depreciation and amortization ( 37,219 ) ( 36,326 ) 35,976 43,937 Satellite, launch and ground station work in progress 21,628 16,483 Finished satellites not yet placed in-service 1,996 26 Property and equipment, net $ 59,600 $ 60,446 Depreciation and amortization expense related to property and equipment was $ 5,957 and $ 3,037 for the three months ended March 31, 2024 and 2023, respectively. The Company recorded a $ 178 loss on decommissioned satellites for the three months ended March 31, 2024. There were no satellites decommissioned or impaired in the three months ended March 31, 2023. Other accrued expenses consisted of the following: March 31, December 31, 2024 2023 (As Restated) Operating lease liabilities, current $ 3,425 $ 3,506 Warrant liability, current 1,917 — Professional services 1,359 913 Third-party operating costs 683 1,088 Corporate and sales tax 545 285 Accrued interest 911 853 Software 571 754 Other 1,714 927 Other accrued expenses $ 11,125 $ 8,326

Goodwill and Intangible Assets

Goodwill and Intangible Assets	3 Months Ended
	Mar. 31, 2024
Goodwill and Intangible Assets Disclosure [Abstract]
Goodwill and Intangible Assets	6. Goodwill and Intangible Assets The following table summarizes changes in goodwill balance: Balance at December 31, 2023 $ 51,155 Impact of foreign currency translation ( 1,104 ) Balance at March 31, 2024 $ 50,051 Intangible assets consisted of the following: March 31, 2024 Gross Carrying Amount Accumulated Amortization Customer relationships $ 22,921 $ ( 4,454 ) Developed technology 13,026 ( 2,533 ) Trade names 2,208 ( 1,030 ) Backlog 3,050 ( 3,050 ) Patents 419 ( 319 ) FCC licenses 480 ( 257 ) $ 42,104 $ ( 11,643 ) December 31, 2023 Gross Carrying Amount Accumulated Amortization Customer relationships $ 23,427 $ ( 4,064 ) Developed technology 13,313 ( 2,312 ) Trade names 2,257 ( 940 ) Backlog 3,117 ( 3,117 ) Patents 419 ( 308 ) FCC licenses 480 ( 249 ) $ 43,013 $ ( 10,990 ) As of March 31, 2024, the weighted-average amortization period for customer relationships and developed technology was 9.7 years, for trade names was 2.7 years, and for patents and FCC licenses was 6.1 years. Amortization expense related to intangible assets was $ 880 and $ 878 for the three months ended March 31, 2024 and 2023, respectively. No impairment charges were recognized for the three months ended March 31, 2024 and 2023. The patents asset balance included $ 35 and $ 57 of capitalized patent costs that will begin amortization upon the issuance of an official patent right to the Company as of March 31, 2024 and December 31, 2023, respectively. As of March 31, 2024, the expected future amortization expense of intangible assets is as follows: Years ending December 31, Remainder of 2024 $ 2,625 2025 3,491 2026 3,446 2027 3,034 2028 3,030 Thereafter 14,800 30,426 Capitalized patent costs, unissued 35 $ 30,461

Long-Term Debt

Long-Term Debt	3 Months Ended
	Mar. 31, 2024
Debt Disclosure [Abstract]
Long-Term Debt	7. Long-Term Debt Long-term debt consisted of the following: March 31, December 31, 2024 2023 Blue Torch term loan $ 118,109 $ 117,996 Other 5,017 5,128 Total long-term debt 123,126 123,124 Less: Debt issuance costs ( 8,110 ) ( 9,011 ) Non-current portion of long-term debt $ 115,016 $ 114,113 The Company recorded interest expense including amortization of deferred issuance costs from long-term debt of $ 5,053 and $ 4,562 for the three months ended March 31, 2024 and 2023, respectively. As of March 31, 2024, the scheduled principal payments of long-term debt was as follows: Years ending December 31, Remainder of 2024 $ — 2025 — 2026 118,387 2027 335 2028 335 Thereafter 4,069 Total debt payments $ 123,126 Blue Torch Credit Agreement On June 13, 2022, the Company, as borrower, and Spire Global Subsidiary, Inc. and Austin Satellite Design, LLC, as guarantors, entered into a financing agreement (the “Blue Torch Financing Agreement”) with Blue Torch Finance LLC, a Delaware limited liability company (“Blue Torch”), as administrative agent and collateral agent, and certain lenders (the “Lenders”). The Blue Torch Financing Agreement provides for, among other things, a term loan facility in an aggregate principal amount of up to $ 120,000 (the “Blue Torch Credit Facility”). A portion of the proceeds of the term loan was used to repay the Company’s then-existing $ 70,000 credit facility with FP Credit Partners, L.P., and the remainder of the proceeds of the term loan may be used for general corporate purposes. The Blue Torch Credit Facility is scheduled to mature on June 13, 2026. Subject to certain exceptions, prepayments of principal under the Blue Torch Credit Facility will be subject to early termination fees in the amount of 3.0%, 2.0%, and 1.0% of the principal prepaid if prepayment occurs within the first, second, and third years following the closing date, respectively, plus if prepayment would have occurred on or prior to the first anniversary of the closing date, a make-whole amount equal to the amount of interest that would have otherwise been payable through the maturity date of the Blue Torch Credit Facility. The $120,000 term loan was available and drawn at closing, of which $19,735 was placed in an escrow account by Blue Torch with such amount to be released upon the Company achieving certain metrics related to annualized recurring revenue and a total annualized recurring revenue leverage ratio. These metrics were achieved and the $19,735 was released from the escrow account and delivered to the Company in February 2023. The term loan accrues interest at a floating rate, to be based, at the Company's election, on either a reference rate or a 3-month Term Secured Overnight Financing Rate ("SOFR") (subject to a 1.0% floor), plus an interest rate margin of 7.0% for reference rate borrowings and 8.0% for 3-month Term SOFR borrowings, plus an incremental Term SOFR margin of 0.26161%. The Company elected the Term SOFR rate which was 13.5766 % as of March 31, 2024. Principal on the term loan is only payable at maturity and interest on the term loan is due and payable quarterly for Term SOFR borrowings. The Company is also required to pay other customary fees and costs in connection with the Blue Torch Credit Facility, including a commitment fee in an amount equal to $ 2,400 on the closing date, a $ 250 annual agency fee and an exit fee of $ 1,800 upon termination of the Blue Torch Financing Agreement. The Blue Torch Financing Agreement contains customary affirmative covenants and customary negative covenants limiting the Company's ability and the ability of its subsidiaries to, among other things, dispose of assets, undergo a change in control, merge or consolidate, make acquisitions, incur debt, incur liens, pay dividends, repurchase stock and make investments, in each case subject to certain exceptions. The Company must also comply with a maximum debt to annualized recurring revenue leverage ratio financial covenant tested monthly during the first two years of the Blue Torch Financing Agreement, a maximum debt to EBITDA leverage ratio financial covenant tested monthly during the third and fourth years of the Blue Torch Financing Agreement and a minimum liquidity financial covenant tested at all times. On September 27, 2023, the Company entered into the Waiver and Amendment No. 2 to Financing Agreement (the “Waiver and Amendment”) with Blue Torch and the Lenders, which amends the Blue Torch Financing Agreement to (a) waive an event of default under the Blue Torch Financing Agreement arising out of the total annualized recurring revenue leverage ratio being greater than the permitted ratio, (b) amend the financial covenants to provide covenant relief from the maximum debt to annualized recurring revenue leverage ratio and the maximum debt to EBITDA leverage ratio set forth in the Blue Torch Financing Agreement for future periods, and (c) provide for a second amendment exit fee. The second amendment exit fee is $ 1,800 (which is an amount equal to one and a half percent ( 1.50 %) of the aggregate outstanding principal balance of the term loans on the effective date of the Waiver and Amendment), bears interest from the date of the Waiver and Amendment at the Adjusted Term SOFR for a 3-month interest period plus the applicable margin under the Financing Agreement, and is payable by the Company in cash upon the termination of the Blue Torch Financing Agreement, either as a result of acceleration of the loans or at the final maturity date. The Waiver and Amendment required a repayment by the Company of $ 2,500 of the outstanding principal balance of the term loans and a prepayment premium of $ 50 , which were paid on October 2, 2023. The Waiver and Amendment also requires additional reporting if the Company’s liquidity level is less than $ 35,000 at any time during a month and revises the minimum liquidity covenant to require liquidity of at least $ 30,000 at all times, commencing on September 30, 2023, which in both cases represent a $ 5,000 incremental change from the original requirements . The Company was in compliance with all applicable financial covenants as of March 31, 2024. On June 13, 2022, in connection with the Blue Torch Financing Agreement, the Company issued warrants to Blue Torch, which were exercisable for an aggregate of 437,024 shares of the Company’s Class A common stock with a per share exercise price of $ 16.08 (the “2022 Blue Torch Warrants”). In addition, in connection with the closing of the financing, the Company paid Urgent Capital LLC, a Delaware limited liability company, a fee for introducing the Company to the Lenders, for the purpose of loan financing, in the amount equal to $ 600 in cash and a warrant to purchase 24,834 fully paid and non-assessable shares of the Company's Class A common stock with a per share exercise price of $ 16.88 (the “Urgent Warrants”). On September 27, 2023, in connection with the Waiver and Amendment, the Company and certain affiliates of Blue Torch amended and restated the 2022 Blue Torch Warrants to reduce the per share exercise price from $ 16.08 to $ 5.44 . The Company also concurrently issued new warrants to certain Blue Torch affiliates that are exercisable for an additional 597,082 shares of the Company’s Class A common stock at a per share exercise price of $ 5.44 (the “2023 Blue Torch Warrants" and together with the 2022 Blue Torch Warrants and the Urgent Warrants, the “Credit Agreement Warrants”). The Company evaluated the Credit Agreement Warrants and concluded that they do not meet the criteria to be classified within stockholders’ equity. The agreements governing the Credit Agreement Warrants include a provision that could result in a different settlement value for the Credit Agreement Warrants depending on their holder. Because the holder of an instrument is not an input into the pricing of a fixed-for-fixed option on the Company’s Class A common stock, the Credit Agreement Warrants are not considered to be indexed to the Company’s Class A common stock. As the Credit Agreement Warrants meet the definition of a derivative, the Company recorded these warrants as liabilities on the condensed consolidated balance sheets at fair value (Note 9) based on the Black-Scholes model as of June 13, 2022 and September 27, 2023 with inputs that include the Company’s Class A common stock price in an actively traded market, making this fair value classified as a Level 2 financial instrument. The other significant assumptions used in the model are the exercise price, expected term, volatility, interest rate, and dividend yield. Subsequent changes in their respective fair values are recognized in the condensed consolidated statements of operations at each reporting date. Changes in the fair value of the warrant liabilities will continue to be recognized until the warrants are exercised, expire, or qualify for equity classification. The Credit Agreement Warrants may be exercised on a cashless basis. The Credit Agreement Warrants are exercisable for a term beginning on the date of issuance and ending on the earlier to occur of ten years from the date of issuance or the consummation of certain of the Company's acquisitions as set forth in the Credit Agreement Warrants. The number of shares for which the Credit Agreement Warrants are exercisable and the associated exercise price are subject to certain proportional adjustments as set forth in the Credit Agreement Warrants. On April 8, 2024, the Company entered into Amendment No. 3 to Financing Agreement (the “Third Amendment”) with Blue Torch and the Lenders, which amends the Blue Torch Financing Agreement to (i) increase the maximum debt to EBITDA leverage ratio for the monthly periods ending June 30, 2024, July 31, 2024, and August 31, 2024, and to decrease the maximum permitted ratio thereafter, and (ii) amend the minimum liquidity covenant to require liquidity of at least $ 20,000 at all times, commencing on April 8, 2024, which represents a $ 10,000 decrease from the requirement in effect immediately prior to the effective date of the Third Amendment. On April 8, 2024, in accordance with the terms of the Third Amendment, the Company made a prepayment to Blue Torch of $ 10,000 in principal, plus an early termination fee of $ 200 . Government Loan In November 2021, the Company completed the Acquisition and assumed an interest free loan agreement with the Strategic Innovation Fund ("SIF") which was recorded at an amount equal to the proceeds received. Under this agreement and subsequent amendment, the Company was eligible to receive funding for certain expenditures incurred from February 13, 2018, to May 12, 2023, up to a maximum of $ 5,701 . The SIF loan agreement of $ 5,017 and $ 5,128 was included in long-term debt, non-current on the condensed consolidated balance sheets as of March 31, 2024, and December 31, 2023. Any amount outstanding under this loan is repayable in 15 annual payments beginning February 28, 2026, and has a stated interest rate of zero.

Leases

Leases	3 Months Ended
	Mar. 31, 2024
Leases [Abstract]
Leases	8. Leases Lease expenses were $ 1,157 and $ 930 for the three months ended March 31, 2024 and 2023, respectively. Aggregate variable lease expenses and short-term lease expenses were $ 239 and $ 120 for the three months ended March 31, 2024 and 2023, respectively. The following table provides the required information regarding the Company's leases for which the Company is the lessee: March 31, December 31, 2024 2023 Assets ROU assets $ 14,324 $ 14,921 Total ROU assets $ 14,324 $ 14,921 Liabilities Current $ 3,425 $ 3,506 Non-current 12,488 13,079 Total lease liabilities $ 15,913 $ 16,585 Weighted-average remaining lease term (years) 5.2 5.4 Weighted-average discount rate 8 % 8 % Approximatel y 77 % of the Company's right-of-use (“ROU”) assets and lease liabilities relate to office facilities leases, with the remaining amounts representing primarily ground station leases. As of March 31, 2024, the maturity of operating lease liabilities are as follows: Years ending December 31, Remainder of 2024 $ 3,485 2025 4,229 2026 3,820 2027 2,756 2028 1,850 Thereafter 3,538 Total lease payments 19,678 Less: Interest on lease payments ( 3,765 ) Present value of lease liabilities $ 15,913 Operating cash flows paid were $ 872 and $ 230 included in the measurement of operating lease liabilities for the three months ended March 31, 2024 and 2023, respectively, and were included in net cash used in operating activities in the condensed consolidated statements of cash flows. Amortization of ROU assets were $ 809 and $ 224 for the three months ended March 31, 2024 and 2023, respectively.

Fair Value Measurement

Fair Value Measurement	3 Months Ended
	Mar. 31, 2024
Fair Value Disclosures [Abstract]
Fair Value Measurement (As Restated)	9. Fair Value Measurement (As Restated) The Company follows the guidance in Accounting Standards Codification (“ASC”) 820, “Fair Value Measurement” for its liabilities that are re-measured and reported at fair value at the end of each reporting period. The fair value of the Company’s common stock warrant liabilities reflects management’s estimate of amounts that the Company would have received in connection with the sale of the assets or paid in connection with the transfer of the liabilities in an orderly transaction between market participants at the measurement date. The following fair value hierarchy is used to classify assets and liabilities based on the observable inputs and unobservable inputs used in order to value the assets and liabilities: Level 1: Quoted prices in active markets for identical assets or liabilities. Level 2: Significant other observable inputs other than quoted prices included in Level 1, such as quoted prices for similar assets and liabilities in active markets, quoted prices for identical or similar assets and liabilities in markets that are not active, or other inputs that are observable or can be corroborated by observable market data. Level 3: Unobservable inputs reflecting management’s assumptions, consistent with reasonably available assumptions made by other market participants. These valuations require significant judgment. The Company classifies financial instruments in Level 3 of the fair value hierarchy when there is reliance on at least one significant unobservable input to the valuation model. In addition to these unobservable inputs, the valuation models for Level 3 financial instruments typically also rely on a number of inputs that are readily observable, either directly or indirectly. The Company’s assessment of a particular input to the fair value measurement requires management to make judgments and consider factors specific to the asset or liability. The fair value hierarchy requires the use of observable market data when available in determining fair value. The Company recognizes transfers between levels within the fair value hierarchy, if any, at the end of each period. Assets and Liabilities Measured at Fair Value on a Recurring Basis The following tables present the Company’s fair value hierarchy for its financial instruments that are measured at fair value on a recurring basis. March 31, 2024 Level 1 Level 2 Level 3 Total Assets: Cash and cash equivalents: Money market funds $ 10,123 $ — $ — $ 10,123 $ 10,123 $ — $ — $ 10,123 Marketable securities: U.S. treasury bills and bonds $ 11,018 $ — $ — $ 11,018 Commercial paper — 985 — 985 $ 11,018 $ 985 $ — $ 12,003 Long-term liabilities: Credit Agreement Warrants $ — $ 10,672 $ — $ 10,672 Securities Purchase Agreement Warrants — 1,917 — 1,917 Contingent earnout liability — — 265 265 $ — $ 12,589 $ 265 $ 12,854 December 31, 2023 Level 1 Level 2 Level 3 Total Assets: Cash and cash equivalents: Money market funds $ 10,114 $ — $ — $ 10,114 $ 10,114 $ — $ — $ 10,114 Marketable securities: U.S. treasury bills and bonds $ 8,840 $ — $ — $ 8,840 Commercial paper — 1,395 — 1,395 U.S. government and agency securities — 1,491 — 1,491 $ 8,840 $ 2,886 $ — $ 11,726 Long-term liabilities: Credit Agreement Warrants $ — $ 5,988 $ — $ 5,988 Contingent earnout liability — — 220 220 $ — $ 5,988 $ 220 $ 6,208 Financial Assets The Company values its Level 1 assets, consisting of money market funds, and U.S. treasury bills and bonds, using quoted prices in active markets for identical instruments. Financial assets whose fair values that are measured on a recurring basis using Level 2 inputs consist of commercial paper, and U.S. government and agency securities. The Company measures the fair values of these assets with the help of a pricing service that either provides quoted market prices in active markets for identical or similar securities or uses observable inputs for their pricing without applying significant adjustments. Credit Agreement Warrants On June 13, 2022, in connection with the Blue Torch Financing Agreement, the Company issued the 2022 Blue Torch Warrants to Blue Torch, which were exercisable for an aggregate of 437,024 shares of the Company’s Class A common stock with a per share exercise price of $ 16.08 . Additionally, in connection with the closing of the financing, the Company issued the Urgent Warrants to Urgent Capital LLC for introducing the Company to the Lenders, which is exercisable for an aggregate of 24,834 shares of the Company's Class A common stock with a per share exercise price of $ 16.08 . On September 27, 2023, in connection with the Waiver and Amendment, the Company and certain affiliates of Blue Torch amended and restated the 2022 Blue Torch Warrants to reduce the per share exercise price from $ 16.08 to $ 5.44 . The Company also concurrently issued the 2023 Blue Torch Warrants to those affiliates that are exercisable for an additional 597,082 shares of the Company’s Class A common stock at a per share exercise price of $ 5.44 . The fair value of the Credit Agreement Warrants is estimated using the Black-Scholes model with inputs that include the Company’s Class A common stock price in an actively traded market, making this fair value classified as a Level 2 financial instrument. The other significant assumptions used in the model are the exercise price, expected term, volatility, interest rate, and expected dividend yield. The table below quantifies the significant inputs used for the Credit Agreement Warrants: March 31, December 31, 2024 2023 Fair value of the Company’s Class A common stock $ 12.00 $ 7.82 Exercise price $ 5.44 - 16.08 $ 5.44 - 16.08 Risk-free interest rate 4.20 % 3.88 % Expected volatility factor 68.8 % 55.0 % Expected dividend yield — % — % Remaining contractual term (in years) 8.2 - 9.5 8.5 - 9.7 Securities Purchase Agreement Warrants On March 21, 2024, the Company entered into the Purchase Agreement with the Investors, pursuant to which the Company issued and sold in the Offering, (i) an aggregate of 2,142,858 shares of Class A common stock and (ii) Securities Purchase Agreement Warrants exercisable for an aggregate of 2,142,858 shares of Class A common stock to the Investors. Each share of Class A common stock and accompanying Securities Purchase Agreement Warrant to purchase one share of Class A common stock was sold at an offering price of $ 14.00 . The aggregate gross proceeds to the Company from the Offering totaled $ 30,000 before deducting the placement agent’s fees and related offering expenses. The Securities Purchase Agreement Warrants have an exercise price equal to $ 14.50 per share of Class A common stock, are exercisable for a term beginning on March 25, 2024, and will expire on July 3, 2024. The fair value of the Securities Purchase Agreement Warrants is estimated using the Black-Scholes model with inputs that include the Company’s Class A common stock price in an actively traded market, making this fair value classified as a Level 2 financial instrument. The other significant assumptions used in the model are the exercise price, expected term, volatility, interest rate, and expected dividend yield. The table below quantifies the significant inputs used for the Securities Purchase Agreement Warrants: March 31, 2024 Fair value of the Company’s Class A common stock $ 12.00 Exercise price $ 14.50 Risk-free interest rate 5.46 % Expected volatility factor 68.8 % Expected dividend yield — % Remaining contractual term (in years) 0.3 Contingent Earnout Liability In connection with the Merger, eligible Spire equity holders are entitled to receive additional shares of the Company's Class A common stock upon the achievement of certain earnout triggering events. The estimated fair value of the contingent earnout liability is determined using a Monte Carlo simulation using a distribution of potential outcomes on a monthly basis over the earnout period, which is a period up to five years post-closing of the Merger, prioritizing the most reliable information available, making this fair value classified as a Level 3 liability. The assumptions utilized in the calculation are based on the achievement of certain stock price milestones, including the current price of the Company’s Class A common stock, expected volatility, risk-free interest rate, expected term and expected dividend yield. The table below quantifies the significant inputs used for the contingent earnout liability: March 31, December 31, 2024 2023 Fair value of the Company’s Class A common stock $ 12.00 $ 7.82 Risk-free interest rate 4.52 % 4.09 % Expected volatility factor 68.8 % 55.0 % Earnout expiration date August 16, 2026 August 16, 2026 The following table presents a summary of the changes in the fair value of the Company’s Level 3 financial instruments that are measured at fair value on a recurring basis: Contingent Fair value as of December 31, 2023 $ 220 Change in fair value of contingent earnout liability 45 Fair value as of March 31, 2024 $ 265 Cash and Cash Equivalents and Marketable Securities The following tables summarize the Company's cash, cash equivalents and available-for-sale securities by significant marketable securities category: March 31, 2024 Amortized Cost Unrealized Gains Unrealized Losses Fair Value Cash and cash equivalents: Cash (As Restated) $ 41,608 $ — $ — $ 41,608 Cash equivalents: Money market funds 10,123 — — 10,123 $ 51,731 $ — $ — $ 51,731 Marketable Securities: U.S. treasury bills and bonds $ 11,018 $ — $ — $ 11,018 Commercial paper 986 — ( 1 ) 985 $ 12,004 $ — $ ( 1 ) $ 12,003 December 31, 2023 Amortized Cost Unrealized Gains Unrealized Losses Fair Value Cash and cash equivalents: Cash $ 19,022 $ — $ — $ 19,022 Cash equivalents: Money market funds 10,114 — — 10,114 $ 29,136 $ — $ — $ 29,136 Marketable Securities: U.S. treasury bills and bonds $ 8,838 $ 2 $ — $ 8,840 Commercial paper 1,395 — — 1,395 U.S. government and agency securities 1,492 — ( 1 ) 1,491 $ 11,725 $ 2 $ ( 1 ) $ 11,726 The following table represents amortized cost and estimated fair value of marketable securities, by contractual maturity: March 31, 2024 Amortized Cost Fair Value Due in one year or less $ 12,004 $ 12,003 In accordance with the Company's investment policy, investments are placed in investment grade securities with high credit quality issuers, and generally limit the amount of credit exposure to any one issuer. The Company evaluates securities for impairment at the end of each reporting period. The Company did not record any impairment charges related to its available-for-sale securities during the three months ended March 31, 2024 and 2023.

Commitments and Contingencies (

Commitments and Contingencies (As Restated)	3 Months Ended
	Mar. 31, 2024
Commitments and Contingencies Disclosure [Abstract]
Commitments and Contingencies	10. Commitments and Contingencies (As Restated) L3Harris Commitment In conjunction with the Acquisition, the Company acquired the agreement (the "L3Harris Agreement") with L3Harris Technologies, Inc. ("L3Harris") to receive satellite automatic identification system ("S-AIS") data from the L3Harris AppStar payloads on-board Iridium NEXT Constellation, Iridium's Real-Time Second-Generation satellite constellation with 58 AppStar payloads. Under the Amended and Restated L3Harris Agreement dated January 21, 2020 (the "A&R L3Harris Agreement"), the Company incurs a fixed fee of $ 358 per month. The A&R L3Harris Agreement expires on August 7, 2031. Under the A&R L3Harris Agreement, the Company will pay a 30 % share of S-AIS data revenues for the portion of exactEarth annual S-AIS data revenue which is in excess of $ 16,000 . No revenue share was owed to L3Harris under the A&R L3Harris Agreement, with respect to AIS Analytics sales, as of or for the three months ended March, 2024 and 2023. The Company recognized $ 1,238 and $ 1,253 in cost of revenue on the condensed consolidated statements of operations for costs incurred to acquire exclusive access rights to data generated from satellites for the three months ended March 31, 2024 and 2023, respectively. The following table summarizes the operational fees commitment under the A&R L3Harris Agreement, which includes the fixed payment obligations to L3Harris: Years ending December 31, Remainder of 2024 $ 3,225 2025 4,300 2026 4,300 2027 4,300 2028 4,300 Thereafter 11,189 $ 31,614 Note Receivable (As Restated) The Company has outstanding a $ 4,500 note receivable plus accrued interest of $ 394 issued to a Space Services customer as of March 31, 2024. The note and accrued interest are due in October 2024. The Company is aware that the customer has been using cash in its operations and its available cash is low. Given the customer's financial performance, there is an indication that it will not have sufficient cash available to repay the note when it is due. The customer has announced that it has secured a financing arrangement with its principal shareholder that would provide it sufficient funds to repay the note and the customer has asserted to the Company its intention to repay the note. The Company believes that a loss of the entire principal value and accrued interest is reasonably possible but not probable. The Company recorded a provision for the current expected credit loss of $ 1,258 as of March 31, 2024. Litigation At times, the Company is party to various claims and legal actions arising in the normal course of business. Although the ultimate outcome of these matters is not presently determinable, management believes that the resolution of all such pending matters, based on an assessment of the current facts and circumstances, will not have a material adverse effect on the Company’s business, results of operations, financial condition or cash flows; however, there can be no assurance that the ultimate resolution of these matters will not have a material impact on the Company’s condensed consolidated financial statements in any period.

Stock Based Compensation

Stock Based Compensation	3 Months Ended
	Mar. 31, 2024
Share-Based Payment Arrangement [Abstract]
Stock-Based Compensation	11. Stock-Based Compensation In connection with the Closing, the Company adopted the 2021 Equity Incentive Plan (the “2021 Plan”) and the 2021 Employee Stock Purchase Plan (“2021 ESPP”). The number of shares available for issuance under the 2021 Plan is increased on the first day of each fiscal year, beginning on January 1, 2022, in an amount as provided in the 2021 Plan. Pursuant to this automatic increase feature of the 2021 Plan, 1,054,867 shares were added as available for issuance thereunder on January 1, 2024. As of March 31, 2024, 818,433 shares were available for issuance under the 2021 Plan. The number of shares available for issuance under the 2021 ESPP is increased on the first day of each fiscal year, beginning on January 1, 2022, in an amount as provided in the 2021 ESPP. Pursuant to this automatic increase feature of the 2021 ESPP, 210,973 shares were added as available for issuance thereunder on January 1, 2024. As of March 31, 2024, 743,659 shares were available for issuance under the 2021 ESPP. The following table summarizes stock option activity under our equity compensation plans: Number of Weighted- Weighted- (in years) Options outstanding as of December 31, 2023 2,198,552 $ 17.11 5.0 Granted — $ — Exercised ( 37,536 ) $ 7.13 Forfeited, canceled, or expired ( 166,413 ) $ 22.26 Options outstanding as of March 31, 2024 1,994,603 $ 16.87 5.1 Vested and expected to vest at March 31, 2024 1,994,603 $ 16.87 5.1 Exercisable at March 31, 2024 1,762,321 $ 16.74 4.8 The Company received $ 267 in cash proceeds from options exercised during the three months ended March 31, 2024 , and there were no options exercised during the three months ended March 31, 2023. There were no options granted during the three months ended March 31, 2024 and 2023. The following table summarizes restricted stock unit ("RSU") activity under the 2021 Plan: Number of RSUs Weighted Average Grant Date Fair Value per Share Outstanding as of December 31, 2023 1,847,583 $ 10.17 RSUs granted 1,905,380 $ 13.61 RSUs vested ( 204,511 ) $ 12.49 RSUs forfeited ( 784,990 ) $ 13.48 Outstanding as of March 31, 2024 2,763,462 $ 11.43 For RSUs with service-based vesting conditions, the fair value is calculated based upon the Company’s closing stock price on the date of grant, and the stock-based compensation expense is recognized over the applicable grant vesting term, generally four years. As of March 31, 2024, there was $ 31,078 of total unrecognized compensation expense related to options and RSUs expected to be recognized over a weighted average-period of 1.95 years. The following table summarizes the components of total stock-based compensation expense based on roles and responsibilities of the employees within the condensed consolidated statements of operations: Three Months Ended March 31, 2024 2023 Cost of revenue $ 61 $ 77 Research and development 1,018 651 Sales and marketing 675 437 General and administrative 1,874 1,481 $ 3,628 $ 2,646

Net Loss per Share (As Restated

Net Loss per Share (As Restated)	3 Months Ended
	Mar. 31, 2024
Earnings Per Share [Abstract]
Net Loss per Share (As Restated)	12. Net Loss per Share (As Restated) The following table sets forth the computation of basic and diluted net loss per share attributable to common stockholders: Three Months Ended March 31, 2024 2023 (As Restated) (As Restated) Numerator: Net loss $ ( 25,544 ) $ ( 18,655 ) Denominator: Weighted-average shares used in computing basic and diluted 21,813,045 18,096,363 Basic and diluted net loss per share $ ( 1.17 ) $ ( 1.03 ) The Company has two classes of common stock, Class A and Class B. Class B common stock has no economic rights, and therefore has been excluded from the computation of basic and diluted net loss per share. Potentially dilutive securities have been excluded from the computation of diluted net loss per share as the effect would reduce net loss per share. Therefore, the weighted-average number of common shares outstanding used to calculate both basic and diluted net loss per share is the same. The Company excluded the following potential shares of Class A common stock, presented based on amounts outstanding at each period end, from the computation of diluted net loss per share for the three months ended March 31, 2024 and 2023, because including them would have had an anti-dilutive effect: Three Months Ended March 31, 2024 2023 Stock options and 2021 ESPP 2,028,412 2,422,401 RSUs 2,763,462 1,442,755 Securities Purchase Agreement Warrants 2,142,858 — Credit Agreement Warrants 1,058,940 461,860 7,993,672 4,327,016

Subsequent Events

Subsequent Events	3 Months Ended
	Mar. 31, 2024
Subsequent Events [Abstract]
Subsequent Events	13. Subsequent Events On April 8, 2024, the Company entered into the Third Amendment with Blue Torch and the Lenders, which amends the Blue Torch Financing Agreement to (i) increase the maximum debt to EBITDA leverage ratio for the monthly periods ending June 30, 2024, July 31, 2024, and August 31, 2024, and to decrease the maximum permitted ratio thereafter, and (ii) amend the minimum liquidity covenant to require liquidity of at least $ 20,000 at all times, commencing on April 8, 2024, which represents a $ 10,000 decrease from the requirement in effect immediately prior to the effective date of the Third Amendment. On April 8, 2024, in accordance with the terms of the Third Amendment, the Company made a prepayment to Blue Torch of $ 10,000 in principal, plus an early termination fee of $ 200 . In April 2024, the Company recorded an impairment charge of $ 3,510 for a decommissioned satellite. The impairment was recognized following the Company's standard operating procedure after communication with the satellite was lost in April 2024 and was unable to be reestablished.

Summary of Significant Accoun_2

Summary of Significant Accounting Policies (Policies)	3 Months Ended
	Mar. 31, 2024
Accounting Policies [Abstract]
Basis of Presentation	Basis of Presentation The condensed consolidated financial statements and accompanying notes are unaudited and have been prepared in accordance with accounting principles generally accepted in the United States of America (“GAAP”) and regulations of the U.S. Securities and Exchange Commission (the "SEC") for interim financial reporting. Certain information and footnote disclosures normally included in consolidated financial statements prepared in accordance with GAAP have been condensed or omitted pursuant to rules and regulations applicable to interim financial reporting. The unaudited condensed consolidated financial statements were prepared on the same basis as the audited consolidated financial statements and, in the opinion of management, contain all adjustments, consisting of normal recurring adjustments necessary for a fair statement of its financial position, results of operations and cash flows for the periods indicated. These condensed consolidated financial statements should be read in conjunction with the consolidated financial statements included within the Company's Annual Report on Form 10-K for the year ended December 31, 2023. The information as of December 31, 2023 included on the condensed consolidated balance sheets was derived from the Company’s audited consolidated financial statements. All intercompany accounts and transactions have been eliminated in consolidation. Results of operations for the three months ended March 31, 2024, are not necessarily indicative of the results that may be expected for any other interim period or for the year ending December 31, 2024. Reverse Stock Split For the three months ended, and as of, March 31, 2023, reported share amounts, including issued and outstanding shares, per share amounts, and reported issued and outstanding warrants and other securities convertible into common stock in these condensed consolidated financial statements and accompanying notes have been retroactively adjusted for the Reverse Stock Split by applying the Reverse Stock Split ratio. The number of authorized shares of common stock was not impacted by the Reverse Stock Split, and therefore has not been retroactively adjusted.
Liquidity Risks and Uncertainties	Liquidity Risks and Uncertainties The Company has a history of operating losses and negative cash flows from operations since inception. During the three months ended March 31, 2024, net loss was $ 25,544 , cash used in operations was $ 8,850 and the Company received net proceeds of $ 9,825 from the Private Placement and $ 28,056 from the Offering. The Company held cash and cash equivalents of $ 51,731 , excluding restricted cash of $ 486 , and investment in short-term marketable securities of $ 12,003 as of March 31, 2024. The Company’s ability to continue as a going concern for the next 12 months from the date of reissuance of these condensed consolidated financial statements is dependent upon its ability to obtain sufficient cash to meet its obligations, including the repayment of all amounts owed pursuant to the Blue Torch Financing Agreement (as amended, and as defined below in Note 7). The Company has failed to meet its leverage ratio and minimum liquidity financial covenants and SEC periodic filing requirement non-financial covenant under the Blue Torch Financing Agreement, and therefore Blue Torch Finance LLC (“Blue Torch”) has the right to accelerate and declare all or any portion of the loans outstanding under the Blue Torch Financing Agreement to be due and payable. Further, upon the filing of the Amended 2023 Form 10-K/A, the Company failed to comply with the non-financial covenant requiring the Company to have a report or opinion of its auditor without an explanatory paragraph expressing substantial doubt about its ability to continue as a going concern. Based on the Company’s current cash and cash equivalents and investment in marketable securities balances and expected future financial results, if the Transactions (as defined below) do not close, the Company will not have sufficient liquidity to continue operations for at least the next twelve months from the reissuance of these condensed consolidated financial statements. Furthermore, the Company will not have sufficient cash to repay the balance of the loans outstanding under the Blue Torch Financing Agreement in the event Blue Torch declares all or any portion of the loans to be due and payable. The Company entered into a Share Purchase Agreement (the “Purchase Agreement”) with Kpler Holding SA, a Belgian corporation (“Buyer”), pursuant to which the Company agreed to sell its maritime business to Buyer and enter into certain ancillary agreements (the “Transactions”). The maritime business to be sold pursuant to the Transactions does not include any part of the Company’s satellite network or operations. The purchase price to be paid by Buyer to the Company at the closing of the Transactions is a cash payment based upon an enterprise value of $ 233,500 , subject to certain adjustments. The Transactions also include a twelve-month transition service and data provision agreement for $ 7,500 . The Purchase Agreement provides that the closing of the Transactions is subject to the satisfaction or waiver of certain closing conditions set forth in the Purchase Agreement. On February 10, 2025, the Company filed a complaint in the Delaware Court of Chancery against Buyer seeking a grant of specific performance ordering Buyer to satisfy its obligations under the Purchase Agreement and consummate the closing in accordance with the terms of the Purchase Agreement. In the complaint, the Company also requested a declaratory judgment declaring that Buyer has breached its obligations under the Purchase Agreement and is not excused from performing its obligations under the Purchase Agreement, including proceeding with the closing. Kpler removed the matter to the District of Delaware, pursuant to a contract term in the Purchase Agreement promising not to contest removal to that court. The District of Delaware initially selected a March 4 trial date, but on February 26, 2025, the court set a trial date of May 28-30, 2025. There is no assurance as to what action the District of Delaware will take with respect to the proceeding initiated by the Company and there is no assurance as to whether or not the Transactions will be consummated on the terms contemplated or at all. The amount of any damages which may be sought or obtained from Buyer cannot be determined at this time. The Company intends to use the proceeds from the closing of the Transactions to repay all amounts owed under the Blue Torch Financing Agreement. However, as described above, there is currently no assurance that the Transactions will close or when the Transactions may close. Given the expected delay in the closing of the Transactions, the Company intends to seek additional equity or debt financing (including securities convertible or exchangeable for equity) and may seek waivers of or amendments to contractual obligations, delay, limit, reduce, or terminate certain commercial efforts, or pursue merger, disposition or other strategies, any of which could adversely affect its business, results of operations, and financial condition. There is no assurance that the Company will be successful in achieving any of the foregoing. Due to the Company’s projected cash needs, including amounts owed pursuant to the Blue Torch Financing Agreement and the Company’s breach of its covenants under the Blue Torch Financing Agreement, there is substantial doubt about its ability to continue as a going concern for a period of at least 12 months from the date of reissuance of these condensed consolidated financial statements. The condensed consolidated financial statements do not include any adjustments that might result from the outcome of this uncertainty.
Macroeconomic and Geopolitical	Macroeconomic and Geopolitical Over the past two years, the Company has been impacted by the macroeconomic environment, such as fluctuations in foreign currencies, increasing interest rates and geopolitical conflicts like the Russian invasion of Ukraine, Israel's war with Hamas and the increased tensions between China and the United States. The U.S. Dollar exhibited a modest decrease in strength against the local functional currencies of our foreign subsidiaries for the three months ended March 31, 2024, as compared to the three months ended March 31, 2023. This had a marginal positive impact on our revenue, as about one-third of the Company's sales are conducted in foreign currencies. Conversely, it had a marginal unfavorable impact on our expenses, given that a majority of the Company's workforce resides in countries other than the United States. The macroeconomic environment has caused existing or potential customers to re-evaluate their decision to purchase the Company's offerings, at times resulting in additional customer discounts, extended payment terms, longer sales cycles, and a few contract cancellations. Increasing interest rates in the three months ended March 31, 2024, compared to the three months ended March 31, 2023, resulted in higher interest expenses, as the Company’s credit facility is based on a floating interest rate. The Russian invasion of Ukraine and the continued conflict created additional global sanctions, which at times caused scheduling shifts or launch cancellations by third-party satellite launch providers and negatively impacted the availability of launch windows and our constellation replenishment efforts. If any of these factors continue or worsen, and/or if new macroeconomic or geopolitical issues arise, the Company's results and financial condition could be further negatively impacted. The Company cannot predict the timing, strength, or duration of any economic slowdown, downturn, instability, or recovery, generally or within any particular industry or geography. Any downturn of the general economy or industries in which the Company operates would adversely affect its business, financial condition, and results of operations.
Use of Estimates	Use of Estimates The preparation of financial statements in conformity with GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities, and disclosures of contingent assets and liabilities at the dates of the condensed consolidated financial statements, and the reported amounts of revenues and expenses during the reporting period. Management’s significant estimates include assumptions for revenue recognition, which requires estimates of total costs used in measuring the progress of completion for the cost-based input method, allowance for current expected credit losses, valuation of certain assets and liabilities acquired from the acquisition of exactEarth in November 2021 (the “Acquisition”), realizability of deferred income tax assets, and fair value of equity awards, contingent earnout liabilities and warrant liabilities. Actual results could differ from those estimates. Based on an evaluation of the lifespans of its in-service satellites and on current capabilities to extend the useful life of in-service satellites via software updates, the Company changed the estimated useful life of its capitalized satellites and related launch costs from three to four years for depreciation purposes. The Company determined it was appropriate to make this change beginning June 2023. The change in estimated useful life did not have a material impact for the three months ended March 31, 2024. In November 2023, the Company updated the estimated useful lives for 43 capitalized satellites and related launch costs based on updated de-orbit dates. This change represents a change in accounting estimate and the impact of the change was an increase in loss from continuing operations before income taxes of approximately $ 3,009 , or $ 0.14 per basic and diluted share for the three months ended March 31, 2024.
Cash, Cash Equivalents, Marketable Securities and Restricted Cash (As Restated)	Cash, Cash Equivalents, Marketable Securities and Restricted Cash (As Restated) The Company considers all highly liquid investments with an original maturity of three months or less to be cash equivalents. Restricted cash included in Other long-term assets, including restricted cash on the condensed consolidated balance sheets, represents amounts pledged as guarantees or collateral for financing arrangements and lease agreements, as contractually required. The Company invests in highly rated securities, with the primary objective of minimizing the potential risk of principal loss. The Company’s investment policy generally requires securities to be investment grade and limits the amount of credit exposure to any one issuer. The Company’s investments in marketable debt securities have been classified and accounted for as available-for-sale. The Company classifies its marketable debt securities as either short-term or long-term based on each instrument’s underlying contractual maturity date. Unrealized gains and losses on marketable debt securities classified as available-for-sale are recognized in Accumulated other comprehensive loss. Interest on securities classified as available-for-sale is included in Interest income on the condensed consolidated statements of operations. The following table shows components of cash, cash equivalents, and restricted cash reported on the condensed consolidated balance sheets and in the condensed consolidated statements of cash flows as of the dates indicated: March 31, December 31, 2024 2023 (As Restated) Cash and cash equivalents $ 51,731 $ 29,136 Restricted cash included in Other long-term assets 486 497 $ 52,217 $ 29,633
Concentrations of Credit Risk	Concentrations of Credit Risk (As Restated) Financial instruments that potentially subject the Company to concentrations of credit risk consist of cash, cash equivalents and restricted cash, marketable securities, and accounts receivable. The Company typically has cash accounts in excess of Federal Deposit Insurance Corporation insurance coverage limits. The Company has not experienced any losses on such accounts, and management believes that the Company’s risk of loss is remote. The Company has a $ 4,500 note receivable due from a single customer. The Company has established a $ 1,258 allowance of current expected credit loss for this note receivable as of March 31, 2024. The Company has a concentration of contractual revenue arrangements with various government agencies. Entities under common control are reported as a single customer. As of March 31, 2024, the Company had one customer (Customer A noted below) that accounted for 16 % of the Company’s total accounts receivable. As of December 31, 2023, the Company did not have any customers that accounted for more than 10 % of the Company’s total accounts receivable. The following customers represented 10% or more of the Company’s total revenue for each of the following periods: Three Months Ended March 31, 2024 2023 (As Restated) (As Restated) Customer A (1) 17 % 31 % Customer B 28 % * * Revenue from this customer was less than 10 % of total revenue during the period. (1) Consists of multiple U.S. government agencies, of which one government agencies represented greater than 10 % of total revenue for the three months ended March 31, 2023 .
Related Parties (As Restated)	Related Parties (As Restated) In conjunction with the Company's acquisition of exactEarth in November 2021, Myriota Pty Ltd ("Myriota"), an existing Spire customer, became a related party as a result of exactEarth's approximately 13 % ownership of Myriota at the time of acquisition. As of March 31, 2024, the Company had 11.5 % ownership of Myriota. As of March 31, 2024, and December 31, 2023, $ 1,876 and $ 2,216 , respectively, of investment in Myriota were included in Other long-term assets, including restricted cash on the condensed consolidated balance sheets. The Company accounts for this investment using the equity method of accounting. The Company's share of earnings or losses on the investment is recorded on a one month lag, due to the timing of receiving financial statements from Myriota, as a component of other expense, net in the condensed consolidated statements of operations. The Company generated $ 217 and $ 225 in revenue from Myriota for the three months ended March 31, 2024 and 2023, respectively, and had $ 52 of accounts receivable from Myriota as of March 31, 2024 , and had no accounts receivable from Myriota as of December 31, 2023.
Accounting Pronouncements Recently Adopted	Accounting Pronouncements Recently Adopted In March 2023, the Financial Accounting Standards Board (“FASB”) issued Accounting Standards Update (“ASU”) 2023-01, Leases – Common Control Arrangements (Topic 842), to improve the accounting for amortizing leasehold improvements associated with arrangements between entities under common control. The amendment requires that leasehold improvements be amortized by the lessee over the useful life of the leasehold improvements to the common control group (regardless of the lease term) as long as the lessee controls the use of the underlying asset through a lease. Additionally, leasehold improvements should be accounted for as a transfer between entities under common control through an adjustment to equity when the lessee no longer controls the use of the underlying asset. The amendments in this update are effective for financial statements issued for annual periods beginning after December 15, 2023, with early adoption permitted. The adoption of ASU 2023-01 as of January 1, 2024, did not impact the Company’s condensed consolidated financial statements. In August 2023, the FASB issued ASU 2023-05, Business Combinations – Joint Venture Formations (Subtopic 805-60): Recognition and Initial Measurement. The amendments in this ASU are intended to facilitate consistency in the application of accounting guidance upon the formation of entities qualifying as joint ventures ("JVs"). This ASU generally requires the use of business combinations accounting at the JV formation date, which would result in the contributed assets/liabilities being revalued to fair value and potentially result in the recognition of goodwill and other intangibles on the JV’s financial statements. However, this ASU does not alter the ongoing accounting for the JV’s operations. This guidance is effective for JVs with formation dates on or after January 1, 2025. The adoption of ASU 2023-05 as of January 1, 2024 did not impact the Company’s condensed consolidated financial statements.
Accounting Pronouncements Not Yet Adopted	Accounting Pronouncements Not Yet Adopted In November 2023, the FASB issued ASU 2023-07, Segment Reporting - Improvements to Reportable Segment Disclosures (Topic 280), to improve reportable segment disclosure requirements, primarily through enhanced disclosures about significant segment expenses. The amendments enhance interim disclosure requirements, clarify circumstances in which an entity can disclose multiple segment measures of profit or loss, provide new segment disclosure requirements for entities within a single reportable segment, and contain other disclosure requirements. The ASU is effective for fiscal years beginning after December 15, 2023, and interim periods within fiscal years beginning after December 15, 2024. Early adoption is permitted and will be applied retrospectively to all prior periods presented in the financial statements. The Company is currently evaluating the ASU to determine its impact on the Company’s disclosures. In December 2023, the FASB issued ASU 2023-09, Income Taxes - Improvements to Income Tax Disclosures (Topic 740), to further enhance income tax disclosures to enable investors to better assess how an entity’s operations, related tax risks, tax planning, and operational opportunities affect its tax rate and prospects for future cash flows. The improvements primarily relate to the disaggregation of rate reconciliation categories and income taxes paid by jurisdiction. The other amendments improve the effectiveness and comparability of disclosures by adding disclosures of pretax income (or loss) and income tax expense (or benefit) to be consistent with SEC regulations. The ASU is effective for public business entities for annual reporting periods beginning after December 15, 2024. Early adoption is permitted and should be applied prospectively or retrospectively. The Company is currently evaluating the ASU to determine its impact on the Company’s disclosures. In March 2024, the SEC adopted final rules under SEC Release No. 33-11275, The Enhancement and Standardization of Climate-Related Disclosures for Investors, which will require registrants to provide certain climate-related information in their annual reports and registration statements. The rules will require disclosure of material climate-related risks, how the board of directors and management oversee and manage such risks, and the actual and potential impact of such risks on the registrant. It will also require disclosure about material climate-related targets and goals, and the financial impact of severe weather events and other natural conditions in the notes to audited financial statements. The disclosures will be required at the earliest in reports for the year ended December 31, 2025 (or potentially later depending on the Company's filer status at the time). The Company is currently evaluating the impact on the Company's disclosures.

Restatement of Previously Iss_2

Restatement of Previously Issued Financial Statements (Tables)	3 Months Ended
	Mar. 31, 2024
Condensed Financial Information Disclosure [Abstract]
Schedule of Unaudited Condensed Consolidated Balance Sheet	As of March 31, 2024 Unaudited Condensed Consolidated Balance Sheet Notes As Previously Reported Restatement Adjustments As Restated Cash and cash equivalents (i) $ 51,985 $ ( 254 ) $ 51,731 Contract assets (ii) $ 5,205 $ ( 218 ) $ 4,987 Other current assets (iii) $ 12,241 $ ( 3,116 ) $ 9,125 Total current assets $ 93,780 $ ( 3,588 ) $ 90,192 Property and equipment, net (iv) $ 71,853 $ ( 12,253 ) $ 59,600 Other long-term assets, including restricted cash (v) $ 7,503 $ 198 $ 7,701 Total assets $ 267,972 $ ( 15,643 ) $ 252,329 Contract liabilities, current portion (vi) $ 22,617 $ ( 387 ) $ 22,230 Other accrued expenses (vii) $ 11,309 $ ( 184 ) $ 11,125 Total current liabilities $ 41,942 $ ( 571 ) $ 41,371 Contract liabilities, non-current (viii) $ - $ 19,259 $ 19,259 Deferred income tax liabilities (ix) $ 1,058 $ ( 263 ) $ 795 Other long-term liabilities (x) $ 1,221 $ ( 1,213 ) $ 8 Total liabilities $ 182,662 $ 17,212 $ 199,874 Accumulated other comprehensive loss (xi) $ ( 6,234 ) $ 116 $ ( 6,118 ) Accumulated deficit (xii) $ ( 427,859 ) $ ( 32,971 ) $ ( 460,830 ) Total stockholders’ equity $ 85,310 $ ( 32,855 ) $ 52,455 Total liabilities and stockholders’ equity $ 267,972 $ ( 15,643 ) $ 252,329 Description of restatement adjustments in the condensed consolidated balance sheets: (i) The $ 254 decrease in cash and cash equivalents as of March 31, 2024, is related to the cash remeasurement adjustment for cash balances from certain foreign subsidiaries. (ii) The $ 218 decrease in contract assets as of March 31, 2024, is related to adjustments to correct revenue recognition for Space Services and R&D Services Contracts. (iii) The $ 3,116 decrease in other current assets as of March 31, 2024, resulted from a decrease of $ 1,858 related to advances for fixed assets that have been reclassified from other current assets to other property and equipment and a decrease of $ 1,258 related to the allowance for current expected credit loss related to the note receivable issued to a customer recorded in other current assets. (iv) The $ 12,253 decrease in property and equipment as of March 31, 2024, resulted from a decrease of $ 14,111 related to costs for customer-controlled satellites for one specific contract being expensed as cost of revenue rather than capitalized into property and equipment, partially offset by $ 1,858 of advances for fixed assets that have been reclassified from other current assets to property and equipment instead of other current assets. (v) The $ 198 increase in other long-term assets, including restricted cash as of March 31, 2024, is related to adjustments to long-term contract assets to correct revenue recognition for Space Services and R&D Services Contracts. (vi) The $ 387 decrease in contract liabilities, current portion as of March 31, 2024 is related to the correction of revenue recognition for Space Services and R&D Services Contracts. (vii) The $ 184 decrease in other accrued expenses as of March 31, 2024 resulted from a decrease of $ 182 related to a customer deposit balance reclassified from other accrued expense to contract liabilities, non-current, and a decrease of $ 52 from income tax provision change as a result of the revenue adjustments, partially offset by $ 50 Delaware franchise tax accrual. (viii) The $ 19,259 increase in contract liabilities, non-current as of March 31, 2024 resulted from an increase of $ 17,864 related to the correction of revenue recognition for Space Services and R&D Services Contracts, an increase of $ 1,213 from the historical balance of contract liabilities, non-current that was included within other long-term liabilities but now presented in its own line and an increase of $ 182 from a customer deposit balance reclassified to contract liabilities, non-current. (ix) The $ 263 decrease in deferred income tax liabilities as of March 31, 2024, is related to the impact to income tax provision as a result of the revenue adjustments. (x) The $ 1,213 decrease in other long-term liabilities as of March 31, 2024 represents the contract liabilities, non-current balance that was historically included in other long-term liabilities but is now presented in its own line. (xi) The $ 116 decrease in accumulated other comprehensive loss as of March 31, 2024, is related to the misstatements’ impact on cumulative foreign currency translation loss. (xii) The $ 32,971 increase in accumulated deficit as of March 31, 2024, is related to the cumulative adjustments made in the condensed consolidated statements of operations.
Schedule of Unaudited Condensed Consolidated Statements of Operations	Three Months Ended March 31, 2024 Three Months Ended March 31, 2023 Unaudited Condensed Consolidated Statements of Operations Notes As Previously Reported Restatement Adjustments As Restated As Previously Reported Restatement Adjustments As Restated Revenue (i) $ 25,688 $ 9,137 $ 34,825 $ 24,168 $ ( 951 ) $ 23,217 Cost of revenue (ii) $ 12,546 $ 13,050 $ 25,596 $ 10,360 $ 3,009 $ 13,369 Gross profit $ 13,142 $ ( 3,913 ) $ 9,229 $ 13,808 $ ( 3,960 ) $ 9,848 Research and development (iii) $ 9,909 $ ( 3,872 ) $ 6,037 $ 9,663 $ ( 2,345 ) $ 7,318 General and administrative (iv) $ 9,818 $ 26 $ 9,844 $ 11,770 $ 53 $ 11,823 Allowance for current expected credit loss on notes receivable (v) $ - $ 40 $ 40 $ - $ - $ - Total operating expenses $ 25,023 $ ( 3,806 ) $ 21,217 $ 28,283 $ ( 2,292 ) $ 25,991 Loss from operations $ ( 11,881 ) $ ( 107 ) $ ( 11,988 ) $ ( 14,475 ) $ ( 1,668 ) $ ( 16,143 ) Foreign exchange (loss) gain (vi) $ ( 1,538 ) $ ( 248 ) $ ( 1,786 ) $ 1,024 $ ( 11 ) $ 1,013 Other (expense) income, net (vii) $ ( 551 ) $ 17 $ ( 534 ) $ ( 762 ) $ 451 $ ( 311 ) Total other income (expense), net $ ( 13,334 ) $ ( 231 ) $ ( 13,565 ) $ ( 2,929 ) $ 440 $ ( 2,489 ) Loss before income taxes $ ( 25,215 ) $ ( 338 ) $ ( 25,553 ) $ ( 17,404 ) $ ( 1,228 ) $ ( 18,632 ) Income tax (benefit) provision (viii) $ 41 $ ( 50 ) $ ( 9 ) $ 269 $ ( 246 ) $ 23 Net loss $ ( 25,256 ) $ ( 288 ) $ ( 25,544 ) $ ( 17,673 ) $ ( 982 ) $ ( 18,655 ) Basic and diluted net loss per share (1) $ ( 1.16 ) $ ( 0.01 ) $ ( 1.17 ) $ ( 0.98 ) $ ( 0.05 ) $ ( 1.03 ) Weighted-average shares used in computing basic and (1) 21,813,045 - 21,813,045 18,096,363 - 18,096,363 (1) The shares of the Company's common stock and the per share amounts for the three months ended March 31, 2023, have been retroactively adjusted to reflect the 1-for-8 reverse stock split (Note 1). Description of restatement adjustments in the condensed consolidated statements of operations: (i) The $ 9,137 increase and $ 951 decrease in revenue for the three months ended March 31, 2024 and March 31, 2023, respectively, are related to the correction of revenue recognition for Space Services and R&D Services Contracts. (ii) Adjustments to cost of revenue: a. The $ 13,050 increase in cost of revenue for the three months ended March 31, 2024, resulted from an increase of $ 9,178 in construction costs and launch costs for customer-controlled satellites for one specific contract being expensed to cost of revenue and an increase of $ 3,872 of costs associated with R&D Services Contracts being reclassified from research and development expense to cost of revenue. b. The $ 3,009 increase in cost of revenue for the three months ended March 31, 2023 resulted from an increase of $ 2,345 of costs associated with R&D Services Contracts for one specific contract being reclassified from research and development expense to cost of revenue, an increase of $ 642 in construction costs and launch costs for customer-controlled satellites being expensed to cost of revenue, and an increase of $ 22 from the reclassification of supply chain department costs from general and administrative expense to cost of revenue. (iii) The $ 3,872 and $ 2,345 decreases in research and development expense for the three months ended March 31, 2024 and March 31, 2023, respectively, are related to costs associated with R&D Services Contracts being reclassified from research and development expense to cost of revenue. (iv) The $ 26 increase in general and administrative expenses for the three months ended March 31, 2024 resulted from an increase of $ 17 from the reclassification of other state taxes from other expense, net and an increase of $ 9 to adjust for the Delaware franchise tax accrual. The $ 53 increase in general and administrative expenses for the three months ended March 31, 2023, resulted from an increase of $ 450 from the reclassification of other state taxes from other expense, net, partially offset by a decrease of $ 377 to adjust for the Delaware franchise tax accrual and a decrease of $ 20 from the reclassification of supply chain department costs from general and administrative expense to cost of revenue. (v) The $ 40 increase in allowance for current expected credit loss on notes receivable for the three months ended March 31, 2024 is related to the additional allowance for current expected credit loss related to a $ 4,500 note receivable issued to a customer. (vi) The $ 248 and $ 11 changes in foreign exchange loss for the three months ended March 31, 2024 and March 31, 2023, respectively, are related to the cash remeasurement adjustment for cash balances from certain foreign subsidiaries. (vii) The $ 17 and $ 451 changes in other (expense) income, net for the three months ended March 31, 2024 and March 31, 2023, respectively, are related to the other state taxes reclassified to general and administrative. (viii) The $ 50 and $ 246 decreases in income tax provision for the three months ended March 31, 2024 and March 31, 2023, respectively, are related to the impact to income tax provision as a result of the revenue adjustments.
Schedule of Unaudited Condensed Consolidated Statements of Comprehensive Loss	Three Months Ended March 31, 2024 Three Months Ended March 31, 2023 Unaudited Condensed Consolidated Statements of Comprehensive Loss Notes As Previously Reported Restatement Adjustments As Restated As Previously Reported Restatement Adjustments As Restated Net loss $ ( 25,256 ) $ ( 288 ) $ ( 25,544 ) $ ( 17,673 ) $ ( 982 ) $ ( 18,655 ) Foreign currency translation adjustments (i) $ ( 1,747 ) $ 187 $ ( 1,560 ) $ ( 1,589 ) $ ( 25 ) $ ( 1,614 ) Comprehensive loss $ ( 27,005 ) $ ( 101 ) $ ( 27,106 ) $ ( 19,218 ) $ ( 1,007 ) $ ( 20,225 ) Description of restatement adjustments in the condensed consolidated statements of comprehensive loss: (i) The $ 187 foreign currency translation gain and $ 25 foreign currency translation loss for the three months ended March 31, 2024, and March 31, 2023, respectively, are related to the foreign currency translation impact of consolidated statements of operations adjustments (i) to (iv) above.
Schedule of Unaudited Condensed Consolidated Statements of Cash Flows	Three Months Ended March 31, 2024 Three Months Ended March 31, 2023 Unaudited Condensed Consolidated Statements of Cash Flows Notes As Previously Reported Restatement Adjustments As Restated As Previously Reported Restatement Adjustments As Restated Net loss $ ( 25,256 ) $ ( 288 ) $ ( 25,544 ) $ ( 17,673 ) $ ( 982 ) $ ( 18,655 ) Other, net (i) $ ( 20 ) $ 248 $ 228 $ ( 110 ) $ ( 240 ) $ ( 350 ) Change in contract assets (ii) $ 624 $ ( 1,266 ) $ ( 642 ) $ ( 855 ) $ 68 $ ( 787 ) Other current assets (iii) $ 392 $ 7,703 $ 8,095 $ 117 $ ( 805 ) $ ( 688 ) Change in contract liabilities (iv) $ 775 $ ( 7,932 ) $ ( 7,157 ) $ 1,259 $ 895 $ 2,154 Other accrued expenses (v) $ 973 $ 30 $ 1,003 $ ( 548 ) $ ( 372 ) $ ( 920 ) Net cash used in operating activities $ ( 7,345 ) $ ( 1,505 ) $ ( 8,850 ) $ ( 11,290 ) $ ( 1,436 ) $ ( 12,726 ) Purchase of property and equipment (vi) $ ( 8,564 ) $ 1,505 $ ( 7,059 ) $ ( 4,649 ) $ 1,436 $ ( 3,213 ) Net cash used in investing activities $ ( 8,684 ) $ 1,505 $ ( 7,179 ) $ ( 6,957 ) $ 1,436 $ ( 5,521 ) Effect of foreign currency translation on cash, (vii) $ 711 $ ( 246 ) $ 465 $ ( 1,846 ) $ - $ ( 1,846 ) Cash, cash equivalents and restricted cash - $ 29,641 $ ( 8 ) $ 29,633 $ 47,569 $ - $ 47,569 Cash, cash equivalents and restricted cash - $ 52,471 $ ( 254 ) $ 52,217 $ 47,362 $ - $ 47,362 Description of restatement adjustments in the condensed consolidated statements of cash flows: (i) The $ 248 and $ 240 adjustments to change in other, net for the three months ended March 31, 2024 and March 31, 2023, respectively, are related to the impact to income tax provision as a result of the revenue adjustment. (ii) The $ 1,266 and $ 68 adjustments to change in contract assets for the three months ended March 31, 2024 and March 31, 2023, respectively, are related to the impact to current and non-current balances of contract assets from the correction of revenue recognition for Space Services and R&D Services Contracts. (iii) The $ 7,703 additional decrease in other current assets for the three months ended March 31, 2024 resulted from expensing the $ 7,585 prepaid launch costs capitalized into other current assets in 2023, a $ 78 net change in advances for fixed assets balance that was reclassified to property and equipment, and an additional allowance for current expected credit loss of $ 40 recorded for the $ 4,500 note receivable. The $ 805 increase in other current assets for the three months ended March 31, 2023 related to the net change in advances for fixed assets balance that is reclassified to property and equipment. (iv) The $ 7,932 adjustment to change in contract liabilities for the three months ended March 31, 2024 resulted from a $ 7,860 impact in contract liabilities from the correction of revenue recognition for Space Services and R&D Services Contracts and a $ 72 change in the customer deposit balance reclassified from other accrued expense to contract liabilities, non-current. The $ 895 adjustment to change in contract liabilities for the three months ended March 31, 2023 is related to the impact to current and non-current balances of contract liabilities from the correction of revenue recognition for Space Services and R&D Services Contracts. (v) The $ 30 decrease in other accrued expense for the three months ended March 31, 2024 resulted from a decrease of $ 52 from the impact to income tax provision as a result of the revenue adjustment, partially offset by an increase of $ 72 for change in the customer deposit balance reclassified to contract liability and an increase of $ 10 to the Delaware franchise tax accrual. The $ 372 decrease in other accrued expense for the three months ended March 31, 2023 is related to the Delaware franchise tax accrual. (vi) Adjustments to purchase of property and equipment: a. The $ 1,505 decrease in purchase of property and equipment for the three months ended March 31, 2024 resulted from a decrease of $ 9,074 related to costs incurred to design/build the customer-controlled satellites for one specific contract being expensed rather than capitalized into the Company's property and equipment and a decrease of $ 16 related to the reclassification of advances for fixed assets, partially offset by an increase of $ 7,585 from prepaid launch costs for such satellites reclassified into other current assets. b. The $ 1,436 decrease in purchase of property and equipment for the three months ended March 31, 2023 resulted from a decrease of $ 825 noncash addition to property and equipment from prior period advances that was incorrectly reflected as a cash purchase and a decrease of $ 611 related to costs incurred to design/build the customer-controlled satellites for one specific contract being expensed rather than capitalized into the Company's property and equipment. (vii) The $ 8 and $ 254 decreases in cash and cash equivalents as of December 31, 2023 and March 31, 2024, respectively, are related to the cash remeasurement adjustment for cash balances from certain foreign subsidiaries, which resulted in a $ 246 change in effect of foreign currency translation on cash, cash equivalents and restricted cash for the three months ended March 31, 2024.

Summary of Significant Accoun_3

Summary of Significant Accounting Policies (Tables)	3 Months Ended
	Mar. 31, 2024
Accounting Policies [Abstract]
Summary of cash, cash equivalents, and restricted cash	The following table shows components of cash, cash equivalents, and restricted cash reported on the condensed consolidated balance sheets and in the condensed consolidated statements of cash flows as of the dates indicated: March 31, December 31, 2024 2023 (As Restated) Cash and cash equivalents $ 51,731 $ 29,136 Restricted cash included in Other long-term assets 486 497 $ 52,217 $ 29,633
Summary of customers whose revenue and accounts receivable balances	The following customers represented 10% or more of the Company’s total revenue for each of the following periods: Three Months Ended March 31, 2024 2023 (As Restated) (As Restated) Customer A (1) 17 % 31 % Customer B 28 % * * Revenue from this customer was less than 10 % of total revenue during the period. (1) Consists of multiple U.S. government agencies, of which one government agencies represented greater than 10 % of total revenue for the three months ended March 31, 2023 .

Revenue, Contract Assets, Con_2

Revenue, Contract Assets, Contract Liabilities and Remaining Performance Obligations (Tables)	3 Months Ended
	Mar. 31, 2024
Revenue from Contract with Customer [Abstract]
Schedule of Disaggregation of Revenue by Geography	The following revenue disaggregated by geography was recognized: Three Months Ended March 31, 2024 Three Months Ended March 31, 2023 (As Restated) (As Restated) Americas (1) $ 22,680 65 % $ 11,680 50 % EMEA (2) 9,959 29 % 8,219 35 % Asia Pacific 2,186 6 % 3,318 15 % Total $ 34,825 100 % $ 23,217 100 % (1) U.S. represented 34 % and 45 % for the three months ended March 31, 2024 and 2023, respectively, and Canada represented 30 % for the three months ended March 31, 2024. (2) United Kingdom represented 13 % for each of the three months ended March 31, 2023.
Schedule of Changes in Contract With Customer Asset	Changes in contract assets for the three months ended March 31, 2024 and 2023 were as follows: 2024 2023 (As Restated) (As Restated) Balance as of January 1 $ 4,917 $ 2,881 Contract assets recorded during the period 4,696 3,548 Reclassified to accounts receivable during the period ( 4,399 ) ( 2,765 ) Other ( 29 ) 9 Balance as of March 31 $ 5,185 $ 3,673
Schedule of Changes in Contract With Customer Liability	Changes in contract liabilities for the three months ended March 31, 2024 and 2023 were as follows: 2024 2023 (As Restated) (As Restated) Balance as of January 1 $ 49,101 $ 34,873 Contract liabilities recorded during the period 13,004 9,395 Revenue recognized during the period ( 20,317 ) ( 7,261 ) Other ( 299 ) 146 Balance as of March 31 $ 41,489 $ 37,153
Contract with Customer, Remaining Performance Obligation	The Company expects to recognize its remaining performance obligations as of March 31, 2024, over the following periods: March 31, 2024 (As Restated) 1 to 12 months $ 72,239 35 % 13 to 24 months 34,200 17 % 25 to 36 months 27,321 13 % Remaining 70,073 34 % Total $ 203,833 100 %

Balance Sheet Components (As _2

Balance Sheet Components (As Restated) (Tables)	3 Months Ended
	Mar. 31, 2024
Balance Sheet Components [Abstract]
Schedule of Other Current Assets	Other current assets consisted of the following: March 31, December 31, 2024 2023 (As Restated) Technology and other prepaid contracts $ 2,536 $ 9,874 Notes receivable 3,344 3,344 Prepaid insurance 956 1,476 Deferred contract costs 541 487 Other receivables 1,520 1,238 Other 228 429 Other current assets $ 9,125 $ 16,848
Schedule of Property and Equipment, Net	Property and equipment, net consisted of the following: March 31, December 31, 2024 2023 (As Restated) Satellites in-service $ 53,496 $ 59,751 Internally developed software 2,135 2,138 Ground stations in-service 4,440 4,444 Leasehold improvements 4,069 5,800 Machinery and equipment 5,794 4,787 Computer equipment 1,833 1,908 Computer software and website development 99 99 Furniture and fixtures 1,329 1,336 73,195 80,263 Less: Accumulated depreciation and amortization ( 37,219 ) ( 36,326 ) 35,976 43,937 Satellite, launch and ground station work in progress 21,628 16,483 Finished satellites not yet placed in-service 1,996 26 Property and equipment, net $ 59,600 $ 60,446
Schedule of Other Accrued expenses	Other accrued expenses consisted of the following: March 31, December 31, 2024 2023 (As Restated) Operating lease liabilities, current $ 3,425 $ 3,506 Warrant liability, current 1,917 — Professional services 1,359 913 Third-party operating costs 683 1,088 Corporate and sales tax 545 285 Accrued interest 911 853 Software 571 754 Other 1,714 927 Other accrued expenses $ 11,125 $ 8,326

Goodwill and Intangible Assets

Goodwill and Intangible Assets (Tables)	3 Months Ended
	Mar. 31, 2024
Goodwill and Intangible Assets Disclosure [Abstract]
Schedule of Changes in Goodwill	The following table summarizes changes in goodwill balance: Balance at December 31, 2023 $ 51,155 Impact of foreign currency translation ( 1,104 ) Balance at March 31, 2024 $ 50,051
Schedule of Finite-Lived Intangible Assets	Intangible assets consisted of the following: March 31, 2024 Gross Carrying Amount Accumulated Amortization Customer relationships $ 22,921 $ ( 4,454 ) Developed technology 13,026 ( 2,533 ) Trade names 2,208 ( 1,030 ) Backlog 3,050 ( 3,050 ) Patents 419 ( 319 ) FCC licenses 480 ( 257 ) $ 42,104 $ ( 11,643 ) December 31, 2023 Gross Carrying Amount Accumulated Amortization Customer relationships $ 23,427 $ ( 4,064 ) Developed technology 13,313 ( 2,312 ) Trade names 2,257 ( 940 ) Backlog 3,117 ( 3,117 ) Patents 419 ( 308 ) FCC licenses 480 ( 249 ) $ 43,013 $ ( 10,990 )
Schedule of Finite-Lived Intangible Assets, Future Amortization Expense	As of March 31, 2024, the expected future amortization expense of intangible assets is as follows: Years ending December 31, Remainder of 2024 $ 2,625 2025 3,491 2026 3,446 2027 3,034 2028 3,030 Thereafter 14,800 30,426 Capitalized patent costs, unissued 35 $ 30,461

Long-Term Debt (Tables)

Long-Term Debt (Tables)	3 Months Ended
	Mar. 31, 2024
Debt Disclosure [Abstract]
Summary of Long-term Debt	Long-term debt consisted of the following: March 31, December 31, 2024 2023 Blue Torch term loan $ 118,109 $ 117,996 Other 5,017 5,128 Total long-term debt 123,126 123,124 Less: Debt issuance costs ( 8,110 ) ( 9,011 ) Non-current portion of long-term debt $ 115,016 $ 114,113
Summary of Long term debt payments	As of March 31, 2024, the scheduled principal payments of long-term debt was as follows: Years ending December 31, Remainder of 2024 $ — 2025 — 2026 118,387 2027 335 2028 335 Thereafter 4,069 Total debt payments $ 123,126

Leases (Tables)

Leases (Tables)	3 Months Ended
	Mar. 31, 2024
Leases [Abstract]
Schedule of Components of Lease Expense	The following table provides the required information regarding the Company's leases for which the Company is the lessee: March 31, December 31, 2024 2023 Assets ROU assets $ 14,324 $ 14,921 Total ROU assets $ 14,324 $ 14,921 Liabilities Current $ 3,425 $ 3,506 Non-current 12,488 13,079 Total lease liabilities $ 15,913 $ 16,585 Weighted-average remaining lease term (years) 5.2 5.4 Weighted-average discount rate 8 % 8 %
Schedule of Maturity of Operating Leases	As of March 31, 2024, the maturity of operating lease liabilities are as follows: Years ending December 31, Remainder of 2024 $ 3,485 2025 4,229 2026 3,820 2027 2,756 2028 1,850 Thereafter 3,538 Total lease payments 19,678 Less: Interest on lease payments ( 3,765 ) Present value of lease liabilities $ 15,913

Fair Value Measurement (Tables)

Fair Value Measurement (Tables)	3 Months Ended
	Mar. 31, 2024
Fair Value Assets And Liabilities Measured On Recurring And Nonrecurring Basis [Line Items]
Summary of Assets and Liabilities Measured at Fair Value on Recurring Basis	The following tables present the Company’s fair value hierarchy for its financial instruments that are measured at fair value on a recurring basis. March 31, 2024 Level 1 Level 2 Level 3 Total Assets: Cash and cash equivalents: Money market funds $ 10,123 $ — $ — $ 10,123 $ 10,123 $ — $ — $ 10,123 Marketable securities: U.S. treasury bills and bonds $ 11,018 $ — $ — $ 11,018 Commercial paper — 985 — 985 $ 11,018 $ 985 $ — $ 12,003 Long-term liabilities: Credit Agreement Warrants $ — $ 10,672 $ — $ 10,672 Securities Purchase Agreement Warrants — 1,917 — 1,917 Contingent earnout liability — — 265 265 $ — $ 12,589 $ 265 $ 12,854 December 31, 2023 Level 1 Level 2 Level 3 Total Assets: Cash and cash equivalents: Money market funds $ 10,114 $ — $ — $ 10,114 $ 10,114 $ — $ — $ 10,114 Marketable securities: U.S. treasury bills and bonds $ 8,840 $ — $ — $ 8,840 Commercial paper — 1,395 — 1,395 U.S. government and agency securities — 1,491 — 1,491 $ 8,840 $ 2,886 $ — $ 11,726 Long-term liabilities: Credit Agreement Warrants $ — $ 5,988 $ — $ 5,988 Contingent earnout liability — — 220 220 $ — $ 5,988 $ 220 $ 6,208
Summary of Change in Fair Value of Level 3 Financial Instruments	The following table presents a summary of the changes in the fair value of the Company’s Level 3 financial instruments that are measured at fair value on a recurring basis: Contingent Fair value as of December 31, 2023 $ 220 Change in fair value of contingent earnout liability 45 Fair value as of March 31, 2024 $ 265
Schedule of Cash and Cash Equivalents and Marketable Securities	The following tables summarize the Company's cash, cash equivalents and available-for-sale securities by significant marketable securities category: March 31, 2024 Amortized Cost Unrealized Gains Unrealized Losses Fair Value Cash and cash equivalents: Cash (As Restated) $ 41,608 $ — $ — $ 41,608 Cash equivalents: Money market funds 10,123 — — 10,123 $ 51,731 $ — $ — $ 51,731 Marketable Securities: U.S. treasury bills and bonds $ 11,018 $ — $ — $ 11,018 Commercial paper 986 — ( 1 ) 985 $ 12,004 $ — $ ( 1 ) $ 12,003 December 31, 2023 Amortized Cost Unrealized Gains Unrealized Losses Fair Value Cash and cash equivalents: Cash $ 19,022 $ — $ — $ 19,022 Cash equivalents: Money market funds 10,114 — — 10,114 $ 29,136 $ — $ — $ 29,136 Marketable Securities: U.S. treasury bills and bonds $ 8,838 $ 2 $ — $ 8,840 Commercial paper 1,395 — — 1,395 U.S. government and agency securities 1,492 — ( 1 ) 1,491 $ 11,725 $ 2 $ ( 1 ) $ 11,726
Amortized Cost and Estimated Fair Value of Marketable Securities	The following table represents amortized cost and estimated fair value of marketable securities, by contractual maturity: March 31, 2024 Amortized Cost Fair Value Due in one year or less $ 12,004 $ 12,003
Contingent Earnout Liability
Fair Value Assets And Liabilities Measured On Recurring And Nonrecurring Basis [Line Items]
Schedule of Quantitative Information Contingent Earnout Liability	The table below quantifies the significant inputs used for the contingent earnout liability: March 31, December 31, 2024 2023 Fair value of the Company’s Class A common stock $ 12.00 $ 7.82 Risk-free interest rate 4.52 % 4.09 % Expected volatility factor 68.8 % 55.0 % Earnout expiration date August 16, 2026 August 16, 2026
Credit Agreement Warrants
Fair Value Assets And Liabilities Measured On Recurring And Nonrecurring Basis [Line Items]
Schedule of Quantitative Information Contingent Earnout Liability	The table below quantifies the significant inputs used for the Credit Agreement Warrants: March 31, December 31, 2024 2023 Fair value of the Company’s Class A common stock $ 12.00 $ 7.82 Exercise price $ 5.44 - 16.08 $ 5.44 - 16.08 Risk-free interest rate 4.20 % 3.88 % Expected volatility factor 68.8 % 55.0 % Expected dividend yield — % — % Remaining contractual term (in years) 8.2 - 9.5 8.5 - 9.7
Securities Purchase Agreement Warrants Member
Fair Value Assets And Liabilities Measured On Recurring And Nonrecurring Basis [Line Items]
Schedule of Quantitative Information Contingent Earnout Liability	The table below quantifies the significant inputs used for the Securities Purchase Agreement Warrants: March 31, 2024 Fair value of the Company’s Class A common stock $ 12.00 Exercise price $ 14.50 Risk-free interest rate 5.46 % Expected volatility factor 68.8 % Expected dividend yield — % Remaining contractual term (in years) 0.3

Commitments and Contingencies_2

Commitments and Contingencies (As Restated) (Tables)	3 Months Ended
	Mar. 31, 2024
Commitments and Contingencies Disclosure [Abstract]
Schedule of Operational Fees Commitment includes Fixed Payments	The following table summarizes the operational fees commitment under the A&R L3Harris Agreement, which includes the fixed payment obligations to L3Harris: Years ending December 31, Remainder of 2024 $ 3,225 2025 4,300 2026 4,300 2027 4,300 2028 4,300 Thereafter 11,189 $ 31,614

Stock Based Compensation (Table

Stock Based Compensation (Tables)	3 Months Ended
	Mar. 31, 2024
Share-Based Payment Arrangement [Abstract]
Summary of Stock Option Activity	The following table summarizes stock option activity under our equity compensation plans: Number of Weighted- Weighted- (in years) Options outstanding as of December 31, 2023 2,198,552 $ 17.11 5.0 Granted — $ — Exercised ( 37,536 ) $ 7.13 Forfeited, canceled, or expired ( 166,413 ) $ 22.26 Options outstanding as of March 31, 2024 1,994,603 $ 16.87 5.1 Vested and expected to vest at March 31, 2024 1,994,603 $ 16.87 5.1 Exercisable at March 31, 2024 1,762,321 $ 16.74 4.8
Summary of Restricted Stock Units Activity	The following table summarizes restricted stock unit ("RSU") activity under the 2021 Plan: Number of RSUs Weighted Average Grant Date Fair Value per Share Outstanding as of December 31, 2023 1,847,583 $ 10.17 RSUs granted 1,905,380 $ 13.61 RSUs vested ( 204,511 ) $ 12.49 RSUs forfeited ( 784,990 ) $ 13.48 Outstanding as of March 31, 2024 2,763,462 $ 11.43
Schedule of Stock Based Compensation Expense Based on Roles and Responsibilities of Employees	The following table summarizes the components of total stock-based compensation expense based on roles and responsibilities of the employees within the condensed consolidated statements of operations: Three Months Ended March 31, 2024 2023 Cost of revenue $ 61 $ 77 Research and development 1,018 651 Sales and marketing 675 437 General and administrative 1,874 1,481 $ 3,628 $ 2,646

Net Loss per Share (Tables)

Net Loss per Share (Tables)	3 Months Ended
	Mar. 31, 2024
Earnings Per Share [Abstract]
Schedule of Earnings Per Share Basic and Diluted Attributable to Common Stockholders	The following table sets forth the computation of basic and diluted net loss per share attributable to common stockholders: Three Months Ended March 31, 2024 2023 (As Restated) (As Restated) Numerator: Net loss $ ( 25,544 ) $ ( 18,655 ) Denominator: Weighted-average shares used in computing basic and diluted 21,813,045 18,096,363 Basic and diluted net loss per share $ ( 1.17 ) $ ( 1.03 )
Schedule of Antidilutive Securities Excluded from Computation of Earnings Per Share	The Company excluded the following potential shares of Class A common stock, presented based on amounts outstanding at each period end, from the computation of diluted net loss per share for the three months ended March 31, 2024 and 2023, because including them would have had an anti-dilutive effect: Three Months Ended March 31, 2024 2023 Stock options and 2021 ESPP 2,028,412 2,422,401 RSUs 2,763,462 1,442,755 Securities Purchase Agreement Warrants 2,142,858 — Credit Agreement Warrants 1,058,940 461,860 7,993,672 4,327,016

Nature of Business - Additional

Nature of Business - Additional Information (Detail) - USD ($) $ / shares in Units, $ in Thousands					3 Months Ended		12 Months Ended
	Mar. 21, 2024	Feb. 08, 2024	Feb. 04, 2024	Sep. 14, 2022	Mar. 31, 2024	Mar. 31, 2023	Dec. 31, 2023	Sep. 27, 2023	Mar. 24, 2023
Organization Consolidation And Presentation Of Financial Statements [Line Items]
Common stock, par value per share					$ 0.0001		$ 0.0001		$ 0.0001
Excess Stock, Shares Issued					0
Proceeds from Securities Purchase Agreement, net					$ 37,881	$ 0
Warrants exercisable								597,082
Warrant exercise price								$ 5.44
Securities Purchase Agreement Warrants Member
Organization Consolidation And Presentation Of Financial Statements [Line Items]
Warrant exercise price	$ 14.5
Securities Purchase Agreement [Member]
Organization Consolidation And Presentation Of Financial Statements [Line Items]
Sale of Stock, Price Per Share			$ 12
Alliance Global Partners | Securities Purchase Agreement Warrants Member
Organization Consolidation And Presentation Of Financial Statements [Line Items]
Proceeds from Securities Purchase Agreement, net	$ 1,800
Alliance Global Partners | Placement Agency Agreement
Organization Consolidation And Presentation Of Financial Statements [Line Items]
Cash Fee Equal of Gross Proceeds	6%
Cash Fee Equal of Gross Exercise Price	4%
Common Class A | Securities Purchase Agreement Warrants Member
Organization Consolidation And Presentation Of Financial Statements [Line Items]
Proceeds from Securities Purchase Agreement, net	$ 30,000
Warrants exercisable	2,142,858
Warrant exercise price	$ 14
Common Class A | Securities Purchase Agreement [Member]
Organization Consolidation And Presentation Of Financial Statements [Line Items]
Proceeds from Securities Purchase Agreement, net		$ 10,000
Common stock, Sale of stock	2,142,858		833,333
Common Class A | Equity Distribution Agreement
Organization Consolidation And Presentation Of Financial Statements [Line Items]
Proceeds from Securities Purchase Agreement, net					$ 8,235
Common stock, Sale of stock							2,166,389
Common Class A | Canaccord Genuity LLC | Equity Distribution Agreement
Organization Consolidation And Presentation Of Financial Statements [Line Items]
Aggregate offering price				$ 85,000
Common Class B
Organization Consolidation And Presentation Of Financial Statements [Line Items]
Common stock, par value per share					$ 0.001

Restatement of Previously Iss_3

Restatement of Previously Issued Financial Statements (Additional Information) (Details) - USD ($) $ in Thousands	3 Months Ended
	Mar. 31, 2024	Mar. 31, 2023	Dec. 31, 2023
Condensed Balance Sheet Statements, Captions [Line Items]
Launch Cost	$ 4,500
Net Income (Loss)	(25,544)	$ (18,655)
Accumulated other comprehensive loss	(6,118)		$ (4,556)
Accumulated Deficit
Condensed Balance Sheet Statements, Captions [Line Items]
Net Income (Loss)	(25,544)	(18,655)
Restatement Adjustments [Member]
Condensed Balance Sheet Statements, Captions [Line Items]
Net Income (Loss)	(32,971)	(20,063)
Accumulated other comprehensive loss	$ 116	$ 64

Restatement of Previously Iss_4

Restatement of Previously Issued Financial Statements - Schedule of Unaudited Condensed Consolidated Balance Sheet (Details) - USD ($) $ in Thousands		Mar. 31, 2024	Dec. 31, 2023	Mar. 31, 2023	Dec. 31, 2022
Condensed Balance Sheet Statements, Captions [Line Items]
Cash and cash equivalents		$ 51,731	$ 29,136
Contract assets		4,987	4,718
Other current assets		9,125	16,848
Total current assets		90,192	72,339
Property and equipment, net		59,600	60,446
Other long-term assets, including restricted cash		7,701	8,380
Total assets		252,329	239,264
Contract liabilities, current portion		22,230	31,178
Other accrued expenses		11,125	8,326
Total current liabilities		41,371	49,345
Contract liabilities, non-current		19,259	17,923
Deferred income tax liabilities		795	804
Other long-term liabilities		8	8
Total liabilities		199,874	201,480
Accumulated other comprehensive loss		(6,118)	(4,556)
Accumulated deficit		(460,830)	(435,286)
Total stockholders equity		52,455	37,784	$ 73,838	$ 91,131
Total liabilities and stockholders equity		252,329	$ 239,264
As Previously Reported [Member]
Condensed Balance Sheet Statements, Captions [Line Items]
Cash and cash equivalents	[1]	51,985
Contract assets	[2]	5,205
Other current assets	[3]	12,241
Total current assets		93,780
Property and equipment, net	[4]	71,853
Other long-term assets, including restricted cash	[5]	7,503
Total assets		267,972
Contract liabilities, current portion	[6]	22,617
Other accrued expenses	[7]	11,309
Total current liabilities		41,942
Contract liabilities, non-current	[8]	0
Deferred income tax liabilities	[9]	1,058
Other long-term liabilities	[10]	1,221
Total liabilities		182,662
Accumulated other comprehensive loss	[11]	(6,234)
Accumulated deficit	[12]	(427,859)
Total stockholders equity		85,310
Total liabilities and stockholders equity		267,972
Restatement Adjustments [Member]
Condensed Balance Sheet Statements, Captions [Line Items]
Cash and cash equivalents	[1]	(254)
Contract assets	[2]	(218)
Other current assets	[3]	(3,116)
Total current assets		(3,588)
Property and equipment, net	[4]	(12,253)
Other long-term assets, including restricted cash	[5]	198
Total assets		(15,643)
Contract liabilities, current portion	[6]	(387)
Other accrued expenses	[7]	(184)
Total current liabilities		(571)
Contract liabilities, non-current	[8]	19,259
Deferred income tax liabilities	[9]	(263)
Other long-term liabilities	[10]	(1,213)
Total liabilities		17,212
Accumulated other comprehensive loss	[11]	116
Accumulated deficit	[12]	(32,971)
Total stockholders equity		(32,855)
Total liabilities and stockholders equity		(15,643)
As Restated [Member]
Condensed Balance Sheet Statements, Captions [Line Items]
Cash and cash equivalents	[1]	51,731
Contract assets	[2]	4,987
Other current assets	[3]	9,125
Total current assets		90,192
Property and equipment, net	[4]	59,600
Other long-term assets, including restricted cash	[5]	7,701
Total assets		252,329
Contract liabilities, current portion	[6]	22,230
Other accrued expenses	[7]	11,125
Total current liabilities		41,371
Contract liabilities, non-current	[8]	19,259
Deferred income tax liabilities	[9]	795
Other long-term liabilities	[10]	8
Total liabilities		199,874
Accumulated other comprehensive loss	[11]	(6,118)
Accumulated deficit	[12]	(460,830)
Total stockholders equity		52,455
Total liabilities and stockholders equity		$ 252,329
[1] The $ 254 decrease in cash and cash equivalents as of March 31, 2024, is related to the cash remeasurement adjustment for cash balances from certain foreign subsidiaries. The $ 218 decrease in contract assets as of March 31, 2024, is related to adjustments to correct revenue recognition for Space Services and R&D Services Contracts. The $ 3,116 decrease in other current assets as of March 31, 2024, resulted from a decrease of $ 1,858 related to advances for fixed assets that have been reclassified from other current assets to other property and equipment and a decrease of $ 1,258 related to the allowance for current expected credit loss related to the note receivable issued to a customer recorded in other current assets. The $ 12,253 decrease in property and equipment as of March 31, 2024, resulted from a decrease of $ 14,111 related to costs for customer-controlled satellites for one specific contract being expensed as cost of revenue rather than capitalized into property and equipment, partially offset by $ 1,858 of advances for fixed assets that have been reclassified from other current assets to property and equipment instead of other current assets. The $ 198 increase in other long-term assets, including restricted cash as of March 31, 2024, is related to adjustments to long-term contract assets to correct revenue recognition for Space Services and R&D Services Contracts. The $ 387 decrease in contract liabilities, current portion as of March 31, 2024 is related to the correction of revenue recognition for Space Services and R&D Services Contracts. The $ 184 decrease in other accrued expenses as of March 31, 2024 resulted from a decrease of $ 182 related to a customer deposit balance reclassified from other accrued expense to contract liabilities, non-current, and a decrease of $ 52 from income tax provision change as a result of the revenue adjustments, partially offset by $ 50 Delaware franchise tax accrual. The $ 19,259 increase in contract liabilities, non-current as of March 31, 2024 resulted from an increase of $ 17,864 related to the correction of revenue recognition for Space Services and R&D Services Contracts, an increase of $ 1,213 from the historical balance of contract liabilities, non-current that was included within other long-term liabilities but now presented in its own line and an increase of $ 182 from a customer deposit balance reclassified to contract liabilities, non-current. The $ 263 decrease in deferred income tax liabilities as of March 31, 2024, is related to the impact to income tax provision as a result of the revenue adjustments. The $ 1,213 decrease in other long-term liabilities as of March 31, 2024 represents the contract liabilities, non-current balance that was historically included in other long-term liabilities but is now presented in its own line. The $ 116 decrease in accumulated other comprehensive loss as of March 31, 2024, is related to the misstatements’ impact on cumulative foreign currency translation loss. The $ 32,971 increase in accumulated deficit as of March 31, 2024, is related to the cumulative adjustments made in the condensed consolidated statements of operations.

Restatement of Previously Iss_5

Restatement of Previously Issued Financial Statements - Schedule of Unaudited Condensed Consolidated Balance Sheet (Parenthetical) (Details) - USD ($) $ in Thousands		3 Months Ended
		Mar. 31, 2024	Mar. 31, 2023	Dec. 31, 2023
Condensed Balance Sheet Statements, Captions [Line Items]
Cash and cash equivalents		$ 51,731		$ 29,136
Contract assets		4,987		4,718
Other current assets		9,125		16,848
Allowance for accounts receivable		1,258
Property and equipment, net		59,600		60,446
Cost of revenue		25,596	$ 13,369
Other long-term assets, including restricted cash		7,701		8,380
Contract liabilities, current portion		22,230		31,178
Other accrued expenses		11,125		8,326
Income tax (benefit) provision		(9)	23
Contract liabilities, non-current		19,259		17,923
Deferred income tax liabilities		795		804
Accumulated other comprehensive loss		(6,118)		(4,556)
Accumulated deficit		460,830		$ 435,286
Restatement Adjustments [Member]
Condensed Balance Sheet Statements, Captions [Line Items]
Cash and cash equivalents	[1]	(254)
Contract assets	[2]	(218)
Other current assets	[3]	(3,116)
Allowance for accounts receivable		(1,258)
Advances for fixed assets		(1,858)
Property and equipment, net	[4]	(12,253)
Cost of revenue	[5]	13,050	3,009
Other long-term assets, including restricted cash	[6]	198
Contract liabilities, current portion	[7]	(387)
Other accrued expenses	[8]	(184)
Income tax (benefit) provision	[9]	(50)	$ (246)
Contract liabilities, non-current	[10]	19,259
Revenue Recognition For Space Services		17,864
Historical balance of contract liabilities		1,213
Deferred income tax liabilities	[11]	(263)
Other Long-term Liabilities		(1,213)
Accumulated other comprehensive loss	[12]	116
Accumulated deficit	[13]	32,971
Restatement Adjustments [Member] | Customer Deposit [Member]
Condensed Balance Sheet Statements, Captions [Line Items]
Other accrued expenses		182
Income tax (benefit) provision		52
Contract liabilities, non-current		182
Restatement Adjustments [Member] | Property, Plant and Equipment [Member]
Condensed Balance Sheet Statements, Captions [Line Items]
Cost of revenue		14,111
Income tax (benefit) provision		$ 50
[1] The $ 254 decrease in cash and cash equivalents as of March 31, 2024, is related to the cash remeasurement adjustment for cash balances from certain foreign subsidiaries. The $ 218 decrease in contract assets as of March 31, 2024, is related to adjustments to correct revenue recognition for Space Services and R&D Services Contracts. The $ 3,116 decrease in other current assets as of March 31, 2024, resulted from a decrease of $ 1,858 related to advances for fixed assets that have been reclassified from other current assets to other property and equipment and a decrease of $ 1,258 related to the allowance for current expected credit loss related to the note receivable issued to a customer recorded in other current assets. The $ 12,253 decrease in property and equipment as of March 31, 2024, resulted from a decrease of $ 14,111 related to costs for customer-controlled satellites for one specific contract being expensed as cost of revenue rather than capitalized into property and equipment, partially offset by $ 1,858 of advances for fixed assets that have been reclassified from other current assets to property and equipment instead of other current assets. The $ 13,050 increase in cost of revenue for the three months ended March 31, 2024, resulted from an increase of $ 9,178 in construction costs and launch costs for customer-controlled satellites for one specific contract being expensed to cost of revenue and an increase of $ 3,872 of costs associated with R&D Services Contracts being reclassified from research and development expense to cost of revenue. b. The $ 3,009 increase in cost of revenue for the three months ended March 31, 2023 resulted from an increase of $ 2,345 of costs associated with R&D Services Contracts for one specific contract being reclassified from research and development expense to cost of revenue, an increase of $ 642 in construction costs and launch costs for customer-controlled satellites being expensed to cost of revenue, and an increase of $ 22 from the reclassification of supply chain department costs from general and administrative expense to cost of revenue. The $ 198 increase in other long-term assets, including restricted cash as of March 31, 2024, is related to adjustments to long-term contract assets to correct revenue recognition for Space Services and R&D Services Contracts. The $ 387 decrease in contract liabilities, current portion as of March 31, 2024 is related to the correction of revenue recognition for Space Services and R&D Services Contracts. The $ 184 decrease in other accrued expenses as of March 31, 2024 resulted from a decrease of $ 182 related to a customer deposit balance reclassified from other accrued expense to contract liabilities, non-current, and a decrease of $ 52 from income tax provision change as a result of the revenue adjustments, partially offset by $ 50 Delaware franchise tax accrual. The $ 50 and $ 246 decreases in income tax provision for the three months ended March 31, 2024 and March 31, 2023, respectively, are related to the impact to income tax provision as a result of the revenue adjustments. The $ 19,259 increase in contract liabilities, non-current as of March 31, 2024 resulted from an increase of $ 17,864 related to the correction of revenue recognition for Space Services and R&D Services Contracts, an increase of $ 1,213 from the historical balance of contract liabilities, non-current that was included within other long-term liabilities but now presented in its own line and an increase of $ 182 from a customer deposit balance reclassified to contract liabilities, non-current. The $ 263 decrease in deferred income tax liabilities as of March 31, 2024, is related to the impact to income tax provision as a result of the revenue adjustments. The $ 116 decrease in accumulated other comprehensive loss as of March 31, 2024, is related to the misstatements’ impact on cumulative foreign currency translation loss. The $ 32,971 increase in accumulated deficit as of March 31, 2024, is related to the cumulative adjustments made in the condensed consolidated statements of operations.

Restatement of Previously Iss_6

Restatement of Previously Issued Financial Statements - Schedule of Unaudited Condensed Consolidated Statements of Operations (Details) - USD ($) $ / shares in Units, $ in Thousands		3 Months Ended
		Mar. 31, 2024	Mar. 31, 2023
Condensed Income Statements, Captions [Line Items]
Revenue		$ 34,825	$ 23,217
Cost of revenue		25,596	13,369
Gross profit		9,229	9,848
Research and development		6,037	7,318
General and administrative		9,844	11,823
Allowance for current expected credit loss on notes receivable		40	0
Total operating expenses		21,217	25,991
Loss from operations		(11,988)	(16,143)
Foreign exchange (loss) gain		(1,786)	1,013
Other (expense) income, net		(534)	(311)
Total other income (expense), net		(13,565)	(2,489)
Loss before income taxes		(25,553)	(18,632)
Income tax (benefit) provision		(9)	23
Net loss		$ (25,544)	$ (18,655)
Basic net loss per share	[1]	$ (1.17)	$ (1.03)
Diluted net loss per share	[1]	$ (1.17)	$ (1.03)
Weighted Average Number of Shares Outstanding, Basic		21,813,045	18,096,363
Weighted Average Number of Shares Outstanding, Diluted		21,813,045	18,096,363
As Previously Reported [Member]
Condensed Income Statements, Captions [Line Items]
Revenue	[2]	$ 25,688	$ 24,168
Cost of revenue	[3]	12,546	10,360
Gross profit		13,142	13,808
Research and development	[4]	9,909	9,663
General and administrative	[5]	9,818	11,770
Allowance for current expected credit loss on notes receivable	[6]	0	0
Total operating expenses		25,023	28,283
Loss from operations		(11,881)	(14,475)
Foreign exchange (loss) gain	[7]	(1,538)	1,024
Other (expense) income, net	[8]	(551)	(762)
Total other income (expense), net		(13,334)	(2,929)
Loss before income taxes		(25,215)	(17,404)
Income tax (benefit) provision	[9]	41	269
Net loss		$ (25,256)	$ (17,673)
Basic net loss per share	[10]	$ (1.16)	$ (0.98)
Diluted net loss per share	[10]	$ (1.16)	$ (0.98)
Weighted Average Number of Shares Outstanding, Basic	[10]	21,813,045	18,096,363
Weighted Average Number of Shares Outstanding, Diluted	[10]	21,813,045	18,096,363
Restatement Adjustments [Member]
Condensed Income Statements, Captions [Line Items]
Revenue	[2]	$ 9,137	$ (951)
Cost of revenue	[3]	13,050	3,009
Gross profit		(3,913)	(3,960)
Research and development	[4]	(3,872)	(2,345)
General and administrative	[5]	26	53
Allowance for current expected credit loss on notes receivable	[6]	40	0
Total operating expenses		(3,806)	(2,292)
Loss from operations		(107)	(1,668)
Foreign exchange (loss) gain	[7]	(248)	(11)
Other (expense) income, net	[8]	17	451
Total other income (expense), net		(231)	440
Loss before income taxes		(338)	(1,228)
Income tax (benefit) provision	[9]	(50)	(246)
Net loss		$ (288)	$ (982)
Basic net loss per share	[10]	$ (0.01)	$ (0.05)
Diluted net loss per share	[10]	$ (0.01)	$ (0.05)
Weighted Average Number of Shares Outstanding, Basic	[10]	0	0
Weighted Average Number of Shares Outstanding, Diluted	[10]	0	0
As Restated [Member]
Condensed Income Statements, Captions [Line Items]
Revenue	[2]	$ 34,825	$ 23,217
Cost of revenue	[3]	25,596	13,369
Gross profit		9,229	9,848
Research and development	[4]	6,037	7,318
General and administrative	[5]	9,844	11,823
Allowance for current expected credit loss on notes receivable	[6]	40	0
Total operating expenses		21,217	25,991
Loss from operations		(11,988)	(16,143)
Foreign exchange (loss) gain	[7]	(1,786)	1,013
Other (expense) income, net	[8]	(534)	(311)
Total other income (expense), net		(13,565)	(2,489)
Loss before income taxes		(25,553)	(18,632)
Income tax (benefit) provision	[9]	(9)	23
Net loss		$ (25,544)	$ (18,655)
Basic net loss per share	[10]	$ (1.17)	$ (1.03)
Diluted net loss per share	[10]	$ (1.17)	$ (1.03)
Weighted Average Number of Shares Outstanding, Basic	[10]	21,813,045	18,096,363
Weighted Average Number of Shares Outstanding, Diluted	[10]	21,813,045	18,096,363
[1] The shares of the Company's common stock and the per share amounts for the three months ended March 31, 2023 have been retroactively adjusted to reflect the 1-for-8 reverse stock split (Note 1) The $ 9,137 increase and $ 951 decrease in revenue for the three months ended March 31, 2024 and March 31, 2023, respectively, are related to the correction of revenue recognition for Space Services and R&D Services Contracts. The $ 13,050 increase in cost of revenue for the three months ended March 31, 2024, resulted from an increase of $ 9,178 in construction costs and launch costs for customer-controlled satellites for one specific contract being expensed to cost of revenue and an increase of $ 3,872 of costs associated with R&D Services Contracts being reclassified from research and development expense to cost of revenue. b. The $ 3,009 increase in cost of revenue for the three months ended March 31, 2023 resulted from an increase of $ 2,345 of costs associated with R&D Services Contracts for one specific contract being reclassified from research and development expense to cost of revenue, an increase of $ 642 in construction costs and launch costs for customer-controlled satellites being expensed to cost of revenue, and an increase of $ 22 from the reclassification of supply chain department costs from general and administrative expense to cost of revenue. The $ 3,872 and $ 2,345 decreases in research and development expense for the three months ended March 31, 2024 and March 31, 2023, respectively, are related to costs associated with R&D Services Contracts being reclassified from research and development expense to cost of revenue. The $ 26 increase in general and administrative expenses for the three months ended March 31, 2024 resulted from an increase of $ 17 from the reclassification of other state taxes from other expense, net and an increase of $ 9 to adjust for the Delaware franchise tax accrual. The $ 53 increase in general and administrative expenses for the three months ended March 31, 2023, resulted from an increase of $ 450 from the reclassification of other state taxes from other expense, net, partially offset by a decrease of $ 377 to adjust for the Delaware franchise tax accrual and a decrease of $ 20 from the reclassification of supply chain department costs from general and administrative expense to cost of revenue. The $ 40 increase in allowance for current expected credit loss on notes receivable for the three months ended March 31, 2024 is related to the additional allowance for current expected credit loss related to a $ 4,500 note receivable issued to a customer. The $ 248 and $ 11 changes in foreign exchange loss for the three months ended March 31, 2024 and March 31, 2023, respectively, are related to the cash remeasurement adjustment for cash balances from certain foreign subsidiaries. The $ 17 and $ 451 changes in other (expense) income, net for the three months ended March 31, 2024 and March 31, 2023, respectively, are related to the other state taxes reclassified to general and administrative. The $ 50 and $ 246 decreases in income tax provision for the three months ended March 31, 2024 and March 31, 2023, respectively, are related to the impact to income tax provision as a result of the revenue adjustments. (1) The shares of the Company's common stock and the per share amounts for the three months ended March 31, 2023, have been retroactively adjusted to reflect the 1-for-8 reverse stock split (Note 1).

Restatement of Previously Iss_7

Restatement of Previously Issued Financial Statements - Schedule of Unaudited Condensed Consolidated Statements of Operations (Parenthetical) (Details) - USD ($) $ in Thousands		3 Months Ended
		Mar. 31, 2024	Mar. 31, 2023
Condensed Income Statements, Captions [Line Items]
Revenue		$ 34,825	$ 23,217
Cost of revenue		25,596	13,369
Research and development		6,037	7,318
General and administrative		9,844	11,823
Allowance for current expected credit loss on notes receivable		40	0
Proceeds from sale of notes receivable		4,500
Foreign exchange (loss) gain		(1,786)	1,013
Other (expense) income, net		(534)	(311)
Income tax (benefit) provision		(9)	23
Restatement Adjustments [Member]
Condensed Income Statements, Captions [Line Items]
Revenue	[1]	9,137	(951)
Cost of revenue	[2]	13,050	3,009
Construction costs and Launch costs		9,178	642
Research and development	[3]	(3,872)	(2,345)
General and administrative	[4]	26	53
Reclassification of state income tax		17	450
Reclassification of supply chain department costs			22
Allowance for current expected credit loss on notes receivable	[5]	40	0
Proceeds from sale of notes receivable		4,500
Foreign exchange (loss) gain	[6]	(248)	(11)
Other (expense) income, net	[7]	17	451
Income tax (benefit) provision	[8]	(50)	(246)
Research and Development Expense [Member] | Restatement Adjustments [Member]
Condensed Income Statements, Captions [Line Items]
Research and development		3,872	2,345
Delaware Franchise Tax [Member] | Restatement Adjustments [Member]
Condensed Income Statements, Captions [Line Items]
General and administrative		9
Reclassification of supply chain department costs		$ 20	$ 377
[1] The $ 9,137 increase and $ 951 decrease in revenue for the three months ended March 31, 2024 and March 31, 2023, respectively, are related to the correction of revenue recognition for Space Services and R&D Services Contracts. The $ 13,050 increase in cost of revenue for the three months ended March 31, 2024, resulted from an increase of $ 9,178 in construction costs and launch costs for customer-controlled satellites for one specific contract being expensed to cost of revenue and an increase of $ 3,872 of costs associated with R&D Services Contracts being reclassified from research and development expense to cost of revenue. b. The $ 3,009 increase in cost of revenue for the three months ended March 31, 2023 resulted from an increase of $ 2,345 of costs associated with R&D Services Contracts for one specific contract being reclassified from research and development expense to cost of revenue, an increase of $ 642 in construction costs and launch costs for customer-controlled satellites being expensed to cost of revenue, and an increase of $ 22 from the reclassification of supply chain department costs from general and administrative expense to cost of revenue. The $ 3,872 and $ 2,345 decreases in research and development expense for the three months ended March 31, 2024 and March 31, 2023, respectively, are related to costs associated with R&D Services Contracts being reclassified from research and development expense to cost of revenue. The $ 26 increase in general and administrative expenses for the three months ended March 31, 2024 resulted from an increase of $ 17 from the reclassification of other state taxes from other expense, net and an increase of $ 9 to adjust for the Delaware franchise tax accrual. The $ 53 increase in general and administrative expenses for the three months ended March 31, 2023, resulted from an increase of $ 450 from the reclassification of other state taxes from other expense, net, partially offset by a decrease of $ 377 to adjust for the Delaware franchise tax accrual and a decrease of $ 20 from the reclassification of supply chain department costs from general and administrative expense to cost of revenue. The $ 40 increase in allowance for current expected credit loss on notes receivable for the three months ended March 31, 2024 is related to the additional allowance for current expected credit loss related to a $ 4,500 note receivable issued to a customer. The $ 248 and $ 11 changes in foreign exchange loss for the three months ended March 31, 2024 and March 31, 2023, respectively, are related to the cash remeasurement adjustment for cash balances from certain foreign subsidiaries. The $ 17 and $ 451 changes in other (expense) income, net for the three months ended March 31, 2024 and March 31, 2023, respectively, are related to the other state taxes reclassified to general and administrative. The $ 50 and $ 246 decreases in income tax provision for the three months ended March 31, 2024 and March 31, 2023, respectively, are related to the impact to income tax provision as a result of the revenue adjustments.

Restatement of Previously Iss_8

Restatement of Previously Issued Financial Statements - Schedule of Unaudited Condensed Consolidated Statements of Comprehensive Loss (Details) - USD ($) $ in Thousands		3 Months Ended
		Mar. 31, 2024	Mar. 31, 2023
Condensed Statement of Income Captions [Line Items]
Net loss		$ (25,544)	$ (18,655)
Foreign currency translation adjustments		1,560	1,614
Comprehensive loss		(27,106)	(20,225)
As Previously Reported [Member]
Condensed Statement of Income Captions [Line Items]
Net loss		(25,256)	(17,673)
Foreign currency translation adjustments	[1]	1,747	1,589
Comprehensive loss		(27,005)	(19,218)
Restatement Adjustments [Member]
Condensed Statement of Income Captions [Line Items]
Net loss		(288)	(982)
Foreign currency translation adjustments	[1]	(187)	(25)
Comprehensive loss		(101)	(1,007)
As Restated [Member]
Condensed Statement of Income Captions [Line Items]
Net loss		(25,544)	(18,655)
Foreign currency translation adjustments	[1]	1,560	1,614
Comprehensive loss		$ (27,106)	$ (20,225)
[1] The $ 187 foreign currency translation gain and $ 25 foreign currency translation loss for the three months ended March 31, 2024, and March 31, 2023, respectively, are related to the foreign currency translation impact of consolidated statements of operations adjustments (i) to (iv) above.

Restatement of Previously Iss_9

Restatement of Previously Issued Financial Statements - Schedule of Unaudited Condensed Consolidated Statements of Comprehensive Loss (Parenthetical) (Details) - USD ($) $ in Thousands		3 Months Ended
		Mar. 31, 2024	Mar. 31, 2023
Condensed Statement of Income Captions [Line Items]
Foreign currency translation adjustments		$ (1,560)	$ (1,614)
Restatement Adjustments [Member]
Condensed Statement of Income Captions [Line Items]
Foreign currency translation adjustments	[1]	$ 187	$ 25
[1] The $ 187 foreign currency translation gain and $ 25 foreign currency translation loss for the three months ended March 31, 2024, and March 31, 2023, respectively, are related to the foreign currency translation impact of consolidated statements of operations adjustments (i) to (iv) above.

Restatement of Previously Is_10

Restatement of Previously Issued Financial Statements - Schedule of Unaudited Condensed Consolidated Statements of Cash Flows (Details) - USD ($) $ in Thousands		3 Months Ended
		Mar. 31, 2024	Mar. 31, 2023
Condensed Cash Flow Statements, Captions [Line Items]
Net loss		$ (25,544)	$ (18,655)
Other, net		228	(350)
Change in contract assets		(642)	(787)
Other current assets		(8,095)	688
Change in contract liabilities		(7,157)	2,154
Other accrued expenses		1,003	(920)
Net cash used in operating activities		(8,850)	(12,726)
Purchase of property and equipment		(7,059)	(3,213)
Net cash used in investing activities		(7,179)	(5,521)
Effect of foreign currency translation on cash, cash equivalents and restricted cash		465	(1,846)
Beginning balance		29,633	47,569
Ending balance		52,217	47,362
As Previously Reported [Member]
Condensed Cash Flow Statements, Captions [Line Items]
Net loss		(25,256)	(17,673)
Other, net	[1]	(20)	(110)
Change in contract assets	[2]	624	(855)
Other current assets	[3]	392	117
Change in contract liabilities	[4]	775	1,259
Other accrued expenses	[5]	973	(548)
Net cash used in operating activities		(7,345)	(11,290)
Purchase of property and equipment	[6]	(8,564)	(4,649)
Net cash used in investing activities		(8,684)	(6,957)
Effect of foreign currency translation on cash, cash equivalents and restricted cash	[7]	711	(1,846)
Beginning balance		29,641	47,569
Ending balance		52,471	47,362
Restatement Adjustments [Member]
Condensed Cash Flow Statements, Captions [Line Items]
Net loss		(288)	(982)
Other, net	[1]	248	(240)
Change in contract assets	[2]	(1,266)	68
Other current assets	[3]	7,703	(805)
Change in contract liabilities	[4]	(7,932)	895
Other accrued expenses	[5]	30	(372)
Net cash used in operating activities		(1,505)	(1,436)
Purchase of property and equipment	[6]	1,505	1,436
Net cash used in investing activities		1,505	1,436
Effect of foreign currency translation on cash, cash equivalents and restricted cash	[7]	(246)	0
Beginning balance		(8)	0
Ending balance		(254)	0
As Restated [Member]
Condensed Cash Flow Statements, Captions [Line Items]
Net loss		(25,544)	(18,655)
Other, net	[1]	(228)	(350)
Change in contract assets	[2]	(642)	(787)
Other current assets	[3]	8,095	(688)
Change in contract liabilities	[4]	(7,157)	2,154
Other accrued expenses	[5]	1,003	(920)
Net cash used in operating activities		(8,850)	(12,726)
Purchase of property and equipment	[6]	(7,059)	(3,213)
Net cash used in investing activities		(7,179)	(5,521)
Effect of foreign currency translation on cash, cash equivalents and restricted cash	[7]	465	(1,846)
Beginning balance		29,633	47,569
Ending balance		$ 52,217	$ 47,362
[1] The $ 248 and $ 240 adjustments to change in other, net for the three months ended March 31, 2024 and March 31, 2023, respectively, are related to the impact to income tax provision as a result of the revenue adjustment. The $ 1,266 and $ 68 adjustments to change in contract assets for the three months ended March 31, 2024 and March 31, 2023, respectively, are related to the impact to current and non-current balances of contract assets from the correction of revenue recognition for Space Services and R&D Services Contracts. The $ 7,703 additional decrease in other current assets for the three months ended March 31, 2024 resulted from expensing the $ 7,585 prepaid launch costs capitalized into other current assets in 2023, a $ 78 net change in advances for fixed assets balance that was reclassified to property and equipment, and an additional allowance for current expected credit loss of $ 40 recorded for the $ 4,500 note receivable. The $ 805 increase in other current assets for the three months ended March 31, 2023 related to the net change in advances for fixed assets balance that is reclassified to property and equipment. The $ 7,932 adjustment to change in contract liabilities for the three months ended March 31, 2024 resulted from a $ 7,860 impact in contract liabilities from the correction of revenue recognition for Space Services and R&D Services Contracts and a $ 72 change in the customer deposit balance reclassified from other accrued expense to contract liabilities, non-current. The $ 895 adjustment to change in contract liabilities for the three months ended March 31, 2023 is related to the impact to current and non-current balances of contract liabilities from the correction of revenue recognition for Space Services and R&D Services Contracts. The $ 30 decrease in other accrued expense for the three months ended March 31, 2024 resulted from a decrease of $ 52 from the impact to income tax provision as a result of the revenue adjustment, partially offset by an increase of $ 72 for change in the customer deposit balance reclassified to contract liability and an increase of $ 10 to the Delaware franchise tax accrual. The $ 372 decrease in other accrued expense for the three months ended March 31, 2023 is related to the Delaware franchise tax accrual. (vi) Adjustments to purchase of property and equipment: The $ 1,505 decrease in purchase of property and equipment for the three months ended March 31, 2024 resulted from a decrease of $ 9,074 related to costs incurred to design/build the customer-controlled satellites for one specific contract being expensed rather than capitalized into the Company's property and equipment and a decrease of $ 16 related to the reclassification of advances for fixed assets, partially offset by an increase of $ 7,585 from prepaid launch costs for such satellites reclassified into other current assets. b. The $ 1,436 decrease in purchase of property and equipment for the three months ended March 31, 2023 resulted from a decrease of $ 825 noncash addition to property and equipment from prior period advances that was incorrectly reflected as a cash purchase and a decrease of $ 611 related to costs incurred to design/build the customer-controlled satellites for one specific contract being expensed rather than capitalized into the Company's property and equipment. The $ 8 and $ 254 decreases in cash and cash equivalents as of December 31, 2023 and March 31, 2024, respectively, are related to the cash remeasurement adjustment for cash balances from certain foreign subsidiaries, which resulted in a $ 246 change in effect of foreign currency translation on cash, cash equivalents and restricted cash for the three months ended March 31, 2024.

Restatement of Previously Is_11

Restatement of Previously Issued Financial Statements - Schedule of Unaudited Condensed Consolidated Statements of Cash Flows (Parenthetical) (Details) - USD ($) $ in Thousands		3 Months Ended
		Mar. 31, 2024	Mar. 31, 2023	Dec. 31, 2023	Dec. 31, 2022
Condensed Cash Flow Statements, Captions [Line Items]
Other, net		$ 228	$ (350)
Change in contract assets		642	787
Other current assets		(8,095)	688
Allowance for accounts receivable		1,258
Proceeds from sale of notes receivable		4,500
Change in contract liabilities		7,157	(2,154)
Other accrued expenses		1,003	(920)
Purchase of property and equipment		(7,059)	(3,213)
Effect of foreign currency translation on cash, cash equivalents and restricted cash		465	(1,846)
Cash and cash equivalents		52,217	47,362	$ 29,633	$ 47,569
Restatement Adjustments [Member]
Condensed Cash Flow Statements, Captions [Line Items]
Other, net	[1]	248	(240)
Change in contract assets	[2]	1,266	(68)
Other current assets	[3]	7,703	(805)
Allowance for accounts receivable		(1,258)
Prepaid launch costs		7,585
Proceeds from sale of notes receivable		4,500
Change in contract liabilities	[4]	7,932	(895)
Other accrued expenses	[5]	30	(372)
Reclassification of state income tax		17	450
Purchase of property and equipment	[6]	1,505	1,436
Property, Plant and Equipment, Preproduction Design and Development Costs		(9,074)	611
Property, Plant and Equipment, Additions		(16)	(825)
Effect of foreign currency translation on cash, cash equivalents and restricted cash	[7]	(246)	0
Cash and cash equivalents		(254)	$ 0	$ (8)	$ 0
Other Current Assets [Member] | Restatement Adjustments [Member]
Condensed Cash Flow Statements, Captions [Line Items]
Allowance for accounts receivable		40
Prepaid launch costs		7,585
Advances for fixed assets balance		78
Delaware Franchise Tax [Member] | Restatement Adjustments [Member]
Condensed Cash Flow Statements, Captions [Line Items]
Other accrued expenses		10
Other Accrued Expense [Member] | Restatement Adjustments [Member]
Condensed Cash Flow Statements, Captions [Line Items]
Reclassification of state income tax		(52)
Other Accrued Expense [Member] | Restatement Adjustments [Member] | Customer Deposit [Member]
Condensed Cash Flow Statements, Captions [Line Items]
Change in contract liabilities		(72)
Research and Development [Member] | Restatement Adjustments [Member]
Condensed Cash Flow Statements, Captions [Line Items]
Change in contract liabilities		$ (7,860)
[1] The $ 248 and $ 240 adjustments to change in other, net for the three months ended March 31, 2024 and March 31, 2023, respectively, are related to the impact to income tax provision as a result of the revenue adjustment. The $ 1,266 and $ 68 adjustments to change in contract assets for the three months ended March 31, 2024 and March 31, 2023, respectively, are related to the impact to current and non-current balances of contract assets from the correction of revenue recognition for Space Services and R&D Services Contracts. The $ 7,703 additional decrease in other current assets for the three months ended March 31, 2024 resulted from expensing the $ 7,585 prepaid launch costs capitalized into other current assets in 2023, a $ 78 net change in advances for fixed assets balance that was reclassified to property and equipment, and an additional allowance for current expected credit loss of $ 40 recorded for the $ 4,500 note receivable. The $ 805 increase in other current assets for the three months ended March 31, 2023 related to the net change in advances for fixed assets balance that is reclassified to property and equipment. The $ 7,932 adjustment to change in contract liabilities for the three months ended March 31, 2024 resulted from a $ 7,860 impact in contract liabilities from the correction of revenue recognition for Space Services and R&D Services Contracts and a $ 72 change in the customer deposit balance reclassified from other accrued expense to contract liabilities, non-current. The $ 895 adjustment to change in contract liabilities for the three months ended March 31, 2023 is related to the impact to current and non-current balances of contract liabilities from the correction of revenue recognition for Space Services and R&D Services Contracts. The $ 30 decrease in other accrued expense for the three months ended March 31, 2024 resulted from a decrease of $ 52 from the impact to income tax provision as a result of the revenue adjustment, partially offset by an increase of $ 72 for change in the customer deposit balance reclassified to contract liability and an increase of $ 10 to the Delaware franchise tax accrual. The $ 372 decrease in other accrued expense for the three months ended March 31, 2023 is related to the Delaware franchise tax accrual. (vi) Adjustments to purchase of property and equipment: The $ 1,505 decrease in purchase of property and equipment for the three months ended March 31, 2024 resulted from a decrease of $ 9,074 related to costs incurred to design/build the customer-controlled satellites for one specific contract being expensed rather than capitalized into the Company's property and equipment and a decrease of $ 16 related to the reclassification of advances for fixed assets, partially offset by an increase of $ 7,585 from prepaid launch costs for such satellites reclassified into other current assets. b. The $ 1,436 decrease in purchase of property and equipment for the three months ended March 31, 2023 resulted from a decrease of $ 825 noncash addition to property and equipment from prior period advances that was incorrectly reflected as a cash purchase and a decrease of $ 611 related to costs incurred to design/build the customer-controlled satellites for one specific contract being expensed rather than capitalized into the Company's property and equipment. The $ 8 and $ 254 decreases in cash and cash equivalents as of December 31, 2023 and March 31, 2024, respectively, are related to the cash remeasurement adjustment for cash balances from certain foreign subsidiaries, which resulted in a $ 246 change in effect of foreign currency translation on cash, cash equivalents and restricted cash for the three months ended March 31, 2024.

Summary of Significant Accoun_4

Summary of Significant Accounting Policies - Additional Information (Details) - USD ($) $ / shares in Units, $ in Thousands	1 Months Ended	3 Months Ended		12 Months Ended
	Nov. 30, 2023	Mar. 31, 2024	Mar. 31, 2023	Dec. 31, 2023	Nov. 13, 2024	Nov. 30, 2021
Accounting Policies [Line Items]
Net Income (Loss)		$ (25,544)	$ (18,655)
Net cash used in operating activities		(8,850)	(12,726)
Cash and cash equivalents at carrying value		51,731
Restricted cash		486		$ 497
Investment in marketable securities		12,003
Proceeds from sale of notes receivable		4,500
Allowance for accounts receivable		$ 1,258
Increase in loss from continuing operations before income taxes	$ 3,009
Increase in loss from continuing operations, basic		$ 0.14
Increase in loss from continuing operations, diluted		$ 0.14
Net proceeds from SPA		$ 9,825
Net proceeds from placement agreement		$ 28,056
Customer Concentration Risk | Customer One [Member] | Accounts Receivable
Accounting Policies [Line Items]
Concentration risk percentage		16%		10%
Myriota [Member]
Accounting Policies [Line Items]
Investment in related party		$ 1,876		$ 2,216
Related Party
Accounting Policies [Line Items]
Revenue		217	$ 225
Outstanding accounts receivable		$ 52		$ 0
Share Purchase Agreement [Member] | Option 2 [Member]
Accounting Policies [Line Items]
Transition service and data provision agreement					$ 7,500
Share Purchase Agreement [Member] | Customer Two [Member]
Accounting Policies [Line Items]
Cash payment based upon an enterprise value					$ 233,500
Borrowed Convertible Notes Payable [Member] | Myriota [Member]
Accounting Policies [Line Items]
Equity method investment, ownership percentage		11.50%				13%
Maximum
Accounting Policies [Line Items]
Cash equivalents terms		3 months

Summary of Significant Accoun_5

Summary of Significant Accounting Policies - Summary of Cash, Cash Equivalents, and Restricted Cash (Detail) - USD ($) $ in Thousands	Mar. 31, 2024	Dec. 31, 2023
Accounting Policies [Abstract]
Cash and cash equivalents	$ 51,731	$ 29,136
Restricted cash included in Other long-term assets	486	497
Cash, cash equivalents, restricted cash and short-term investments	$ 52,217	$ 29,633

Summary of Significant Accoun_6

Summary of Significant Accounting Policies - Summary of Customers Whose Revenue and Accounts Receivable Balances (Detail) - Customer Concentration Risk - Revenue Benchmark		3 Months Ended
		Mar. 31, 2024	Mar. 31, 2023
Concentration Risk [Line Items]
Concentration risk percentage		100%	100%
Customer B
Concentration Risk [Line Items]
Concentration risk percentage	[1]	17%	31%
Customer C
Concentration Risk [Line Items]
Concentration risk percentage		28%
[1] Consists of multiple U.S. government agencies, of which one government agencies represented greater than 10 % of total revenue for the three months ended March 31, 2023

Summary of Significant Accoun_7

Summary of Significant Accounting Policies - Total Revenue For Periods (Parenthetical) (Details) - Customer Concentration Risk - Revenue Benchmark		3 Months Ended
		Mar. 31, 2024	Mar. 31, 2023
Product Information [Line Items]
Concentration risk percentage		100%	100%
Customer A | Minimum
Product Information [Line Items]
Concentration risk percentage		10%	10%
Customer B
Product Information [Line Items]
Concentration risk percentage	[1]	17%	31%
Customer B | Maximum
Product Information [Line Items]
Concentration risk percentage			10%
Customer B | Minimum
Product Information [Line Items]
Concentration risk percentage		10%
Customer C
Product Information [Line Items]
Concentration risk percentage		28%
[1] Consists of multiple U.S. government agencies, of which one government agencies represented greater than 10 % of total revenue for the three months ended March 31, 2023

Revenue, Contract Assets, Con_3

Revenue, Contract Assets, Contract Liabilities and Remaining Performance Obligations - Additional Information (Detail) - USD ($) $ in Thousands	3 Months Ended
	Mar. 31, 2024	Mar. 31, 2023	Dec. 31, 2023	Dec. 31, 2022
Revenue From Contract With Customer [Line Items]
Revenue	$ 34,825	$ 23,217
Contract assets current and non current	5,185	3,673	$ 4,917	$ 2,881
Contract with customer asset current	4,987		4,718
Contract with customer liability	41,489	37,153	49,101	$ 34,873
Contract liabilities, current portion	22,230		31,178
Contract liabilities, non-current	19,259		17,923
Other long-term liabilities	8		8
Other asset long-term	198		$ 199
Revenue remaining performance obligation amount	$ 203,833
Revenue remaining performance obligation percentage	100%
Revenue Benchmark | Customer Concentration Risk
Revenue From Contract With Customer [Line Items]
Revenue	$ 34,825	$ 23,217
Concentration risk percentage	100%	100%
Subscription Based Contracts | Revenue Benchmark | Customer Concentration Risk
Revenue From Contract With Customer [Line Items]
Revenue	$ 18,166	$ 19,600
Concentration risk percentage	52%	84%
Non Subscription Based Contracts | Revenue Benchmark | Customer Concentration Risk
Revenue From Contract With Customer [Line Items]
Revenue	$ 16,659	$ 3,616
Concentration risk percentage	48%	16%

Revenue, Contract Assets, Con_4

Revenue, Contract Assets, Contract Liabilities and Remaining Performance Obligations - Schedule of Disaggregation of Revenue by Geography (Detail) - USD ($) $ in Thousands		3 Months Ended
		Mar. 31, 2024	Mar. 31, 2023
Disaggregation Of Revenue [Line Items]
Revenue		$ 34,825	$ 23,217
Customer Concentration Risk | Revenue Benchmark
Disaggregation Of Revenue [Line Items]
Revenue		$ 34,825	$ 23,217
Concentration risk percentage		100%	100%
EMEA | Customer Concentration Risk | Revenue Benchmark
Disaggregation Of Revenue [Line Items]
Revenue	[1]	$ 9,959	$ 8,219
Concentration risk percentage	[1]	29%	35%
Americas | Customer Concentration Risk | Revenue Benchmark
Disaggregation Of Revenue [Line Items]
Revenue	[2]	$ 22,680	$ 11,680
Concentration risk percentage	[2]	65%	50%
Asia Pacific | Customer Concentration Risk | Revenue Benchmark
Disaggregation Of Revenue [Line Items]
Revenue		$ 2,186	$ 3,318
Concentration risk percentage		6%	15%
[1] United Kingdom represented 13 % for each of the three months ended March 31, 2023. U.S. represented 34 % and 45 % for the three months ended March 31, 2024 and 2023, respectively, and Canada represented 30 % for the three months ended March 31, 2024.

Revenue, Contract Assets, Con_5

Revenue, Contract Assets, Contract Liabilities and Remaining Performance Obligations - Schedule of Disaggregation of Revenue by Geography (Parenthetical) (Detail)	3 Months Ended
	Mar. 31, 2024	Mar. 31, 2023
UNITED STATES
Disaggregation Of Revenue [Line Items]
Concentration Customer Risk, Percentage	34%	45%
UNITED KINGDOM
Disaggregation Of Revenue [Line Items]
Concentration Customer Risk, Percentage		13%
CanadaTaxAuthorityMember
Disaggregation Of Revenue [Line Items]
Concentration Customer Risk, Percentage	30%

Revenue, Contract Assets, Con_6

Revenue, Contract Assets, Contract Liabilities and Remaining Performance Obligations - Schedule of Changes in Contract Assets (Detail) - USD ($) $ in Thousands	3 Months Ended
	Mar. 31, 2024	Mar. 31, 2023
Change in Contract with Customer, Asset [Abstract]
Balance at the beginning of the year	$ 4,917	$ 2,881
Contract assets recorded during the period	4,696	3,548
Reclassified to accounts receivable during the period	(4,399)	(2,765)
Other	(29)	9
Balance at the end of the year	$ 5,185	$ 3,673

Revenue, Contract Assets, Con_7

Revenue, Contract Assets, Contract Liabilities and Remaining Performance Obligations - Schedule of Changes in Contract Liabilities (Detail) - USD ($) $ in Thousands	3 Months Ended
	Mar. 31, 2024	Mar. 31, 2023
Change in Contract with Customer, Liability [Abstract]
Balance at the beginning of the year	$ 49,101	$ 34,873
Contract liabilities recorded during the period	13,004	9,395
Revenue recognized during the period	(20,317)	(7,261)
Other	(299)	146
Balance at the end of the year	$ 41,489	$ 37,153

Revenue, Contract Assets, Con_8

Revenue, Contract Assets, Contract Liabilities and Remaining Performance Obligations (As Restated) - Contract with Customer, Performance Obligation (Details) $ in Thousands	Mar. 31, 2024 USD ($)
Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction [Line Items]
Revenue remaining performance obligation amount	$ 203,833
Revenue remaining performance obligation percentage	100%
1 to 12 months [Member]
Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction [Line Items]
Revenue remaining performance obligation amount	$ 72,239
Revenue remaining performance obligation percentage	35%
13 to 24 months [Member]
Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction [Line Items]
Revenue remaining performance obligation amount	$ 34,200
Revenue remaining performance obligation percentage	17%
25 to 36 months [Member]
Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction [Line Items]
Revenue remaining performance obligation amount	$ 27,321
Revenue remaining performance obligation percentage	13%
Remaining [Member]
Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction [Line Items]
Revenue remaining performance obligation amount	$ 70,073
Revenue remaining performance obligation percentage	34%

Balance Sheet Components (As _3

Balance Sheet Components (As Restated) - Summary of Other Current Assets (Detail) - USD ($) $ in Thousands	Mar. 31, 2024	Dec. 31, 2023
Balance Sheet Components [Abstract]
Technology and other prepaid contracts	$ 2,536	$ 9,874
Notes receivable	3,344	3,344
Prepaid insurance	956	1,476
Deferred contract costs	541	487
Other receivables	1,520	1,238
Other	228	429
Other current assets	$ 9,125	$ 16,848

Balance Sheet Components (As _4

Balance Sheet Components (As Restated) - Schedule of Property and Equipment, Net (Details) - USD ($) $ in Thousands	Mar. 31, 2024	Dec. 31, 2023
Property Plant And Equipment [Line Items]
Property, plant and equipment, gross, total	$ 73,195	$ 80,263
Less: Accumulated depreciation and amortization	(37,219)	(36,326)
Total Property And Equipment Before Net Adjustment	35,976	43,937
Property and equipment, net	59,600	60,446
Satellite In Service
Property Plant And Equipment [Line Items]
Property, plant and equipment, gross, total	53,496	59,751
Internally Developed Software
Property Plant And Equipment [Line Items]
Property, plant and equipment, gross, total	2,135	2,138
Ground Stations In Service
Property Plant And Equipment [Line Items]
Property, plant and equipment, gross, total	4,440	4,444
Leasehold Improvements
Property Plant And Equipment [Line Items]
Property, plant and equipment, gross, total	4,069	5,800
Machinery and Equipment
Property Plant And Equipment [Line Items]
Property, plant and equipment, gross, total	5,794	4,787
Computer Equipment
Property Plant And Equipment [Line Items]
Property, plant and equipment, gross, total	1,833	1,908
Computer software and website development
Property Plant And Equipment [Line Items]
Property, plant and equipment, gross, total	99	99
Furniture and Fixtures
Property Plant And Equipment [Line Items]
Property, plant and equipment, gross, total	1,329	1,336
Satellite Launch And Ground Station Work In Progress
Property Plant And Equipment [Line Items]
Total	21,628	16,483
Finished Satellites not yet placed in-service
Property Plant And Equipment [Line Items]
Total	$ 1,996	$ 26

Balance Sheet Components (As _5

Balance Sheet Components (As Restated) - Schedule of Other Accrued Expenses (Details) - USD ($) $ in Thousands	Mar. 31, 2024	Dec. 31, 2023
Balance Sheet Components [Abstract]
Operating lease liabilities, current	$ 3,425	$ 3,506
Warrant liability, current	1,917	0
Professional services	$ 1,359	$ 913
Operating Lease, Liability, Current, Statement of Financial Position [Extensible Enumeration]	Liabilities, Current	Liabilities, Current
Third-party operating costs	$ 683	$ 1,088
Corporate and sales tax	545	285
Accrued interest	911	853
Software	571	754
Other	1,714	927
Other accrued expenses	$ 11,125	$ 8,326

Balance Sheet Components (As _6

Balance Sheet Components (As Restated) - Additional Information (Details) - USD ($) $ in Thousands	3 Months Ended
	Mar. 31, 2024	Mar. 31, 2023
Impairment Effects on Earnings Per Share [Line Items]
Depreciation and amortization	$ 6,837	$ 3,916
Decommissioned satellite	178	0
Property Plant And Equipment Member
Impairment Effects on Earnings Per Share [Line Items]
Depreciation and amortization	$ 5,957	$ 3,037

Goodwill and Intangible Asset_2

Goodwill and Intangible Assets - Schedule of Changes in Goodwill (Details) $ in Thousands	3 Months Ended
	Mar. 31, 2024 USD ($)
Goodwill and Intangible Assets Disclosure [Abstract]
Goodwill, Beginning Balance	$ 51,155
Impact of foreign currency translation	(1,104)
Goodwill, Ending Balance	$ 50,051

Goodwill and Intangible Asset_3

Goodwill and Intangible Assets - Schedule of Intangible Assets (Details) - USD ($) $ in Thousands	Mar. 31, 2024	Dec. 31, 2023
Indefinite-Lived Intangible Assets [Line Items]
Finite-Lived Intangible Assets, Gross	$ 42,104	$ 43,013
Less: Accumulated amortization	(11,643)	(10,990)
Trade Names [Member]
Indefinite-Lived Intangible Assets [Line Items]
Finite-Lived Intangible Assets, Gross	2,208	2,257
Less: Accumulated amortization	(1,030)	(940)
Patents [Member]
Indefinite-Lived Intangible Assets [Line Items]
Finite-Lived Intangible Assets, Gross	419	419
Less: Accumulated amortization	(319)	(308)
Customer Relationships [Member]
Indefinite-Lived Intangible Assets [Line Items]
Finite-Lived Intangible Assets, Gross	22,921	23,427
Less: Accumulated amortization	(4,454)	(4,064)
Developed Technology [Member]
Indefinite-Lived Intangible Assets [Line Items]
Finite-Lived Intangible Assets, Gross	13,026	13,313
Less: Accumulated amortization	(2,533)	(2,312)
Backlog [Member]
Indefinite-Lived Intangible Assets [Line Items]
Finite-Lived Intangible Assets, Gross	3,050	3,117
Less: Accumulated amortization	(3,050)	(3,117)
FCC Licenses [Member]
Indefinite-Lived Intangible Assets [Line Items]
Finite-Lived Intangible Assets, Gross	480	480
Less: Accumulated amortization	$ (257)	$ (249)

Goodwill and Intangible Asset_4

Goodwill and Intangible Assets - Additional Information (Details) - USD ($) $ in Thousands	3 Months Ended
	Mar. 31, 2024	Mar. 31, 2023	Dec. 31, 2023
Finite Lived Intangible Assets By Major Class [Line Items]
Intangible assets recognized impairment charges	$ 0	$ 0
Capitalized patent costs, unissued	35		$ 57
Amortization of Intangible Assets	$ 880	$ 878
Customer Relationships [Member]
Finite Lived Intangible Assets By Major Class [Line Items]
Weighted average amortization period	9 years 8 months 12 days
FCC Licenses [Member]
Finite Lived Intangible Assets By Major Class [Line Items]
Weighted average amortization period	6 years 1 month 6 days
Trade Names [Member]
Finite Lived Intangible Assets By Major Class [Line Items]
Weighted average amortization period	2 years 8 months 12 days

Goodwill and Intangible Asset_5

Goodwill and Intangible Assets - Schedule of Annual Amortization of Intangible Assets (Detail) - USD ($) $ in Thousands	Mar. 31, 2024	Dec. 31, 2023
Goodwill and Intangible Assets Disclosure [Abstract]
Remainder of 2024	$ 2,625
2025	3,491
2026	3,446
2027	3,034
2028	3,030
Thereafter	14,800
Total	30,426
Capitalized patent costs, unissued	35	$ 57
Intangible assets, net	$ 30,461

Long-Term Debt - Summary of Lon

Long-Term Debt - Summary of Long-term Debt (Detail) - USD ($) $ in Thousands	Mar. 31, 2024	Dec. 31, 2023
Debt Instrument [Line Items]
Total long-term debt	$ 123,126	$ 123,124
Less: Debt issuance costs	(8,110)	(9,011)
Non-current portion of long-term debt	115,016	114,113
Blue Torch term loan [Member]
Debt Instrument [Line Items]
Total long-term debt	118,109	117,996
Other [Member]
Debt Instrument [Line Items]
Total long-term debt	$ 5,017	$ 5,128

Long-Term Debt - Scheduled Prin

Long-Term Debt - Scheduled Principal Payments Of Long-Term Debt (Details) $ in Thousands	Mar. 31, 2024 USD ($)
Debt Disclosure [Abstract]
Remainder of 2024	$ 0
2025	0
2026	118,387
2027	335
2028	335
Thereafter	4,069
Total debt payments	$ 123,126

Long-Term Debt - Additional Inf

Long-Term Debt - Additional Information (Detail) $ / shares in Units, $ in Thousands					1 Months Ended	3 Months Ended
	Apr. 08, 2024 USD ($)	Feb. 08, 2024 USD ($)	Oct. 02, 2023 USD ($)	Jun. 13, 2022 USD ($) $ / shares shares	Nov. 30, 2021 Installments	Mar. 31, 2024 USD ($)	Mar. 31, 2023 USD ($)	Dec. 31, 2023 USD ($)	Sep. 27, 2023 USD ($) $ / shares shares
Debt Instrument [Line Items]
Interest expense long term debt						$ 5,053	$ 4,562
Class of Warrant or Right, Outstanding | shares									597,082
Warrant exercise price | $ / shares									$ 5.44
Long-term debt						115,016		$ 114,113
Number of Tranches | Installments					15
Exact Earth Acquisition [Member]
Debt Instrument [Line Items]
Long-term debt						5,017		$ 5,128
Blue Torch Term Loan Facility [Member]
Debt Instrument [Line Items]
Company's Total Liquidity						35,000
Minimum liquidity	$ 20,000					30,000
Incremental Change in LIquidity						$ 5,000
Decrease in liquidity		$ 10,000
Line of Credit Facility, Maximum Borrowing Capacity				$ 120,000
Line of Credit Facility, Description						The $120,000 term loan was available and drawn at closing, of which $19,735 was placed in an escrow account by Blue Torch with such amount to be released upon the Company achieving certain metrics related to annualized recurring revenue and a total annualized recurring revenue leverage ratio. These metrics were achieved and the $19,735 was released from the escrow account and delivered to the Company in February 2023. The term loan accrues interest at a floating rate, to be based, at the Company's election, on either a reference rate or a 3-month Term Secured Overnight Financing Rate ("SOFR") (subject to a 1.0% floor), plus an interest rate margin of 7.0% for reference rate borrowings and 8.0% for 3-month Term SOFR borrowings, plus an incremental Term SOFR margin of 0.26161%.
Warrant to urgent capital llc [Member]
Debt Instrument [Line Items]
Class of Warrant or Right, Outstanding | shares									597,082
Warrant exercise price | $ / shares									$ 5.44
Credit Agreement With Fp Credit Partners Lp | Blue Torch Term Loan Facility [Member]
Debt Instrument [Line Items]
Proceeds term loan				$ 70,000
Description of credit facility				Subject to certain exceptions, prepayments of principal under the Blue Torch Credit Facility will be subject to early termination fees in the amount of 3.0%, 2.0%, and 1.0% of the principal prepaid if prepayment occurs within the first, second, and third years following the closing date, respectively, plus if prepayment would have occurred on or prior to the first anniversary of the closing date, a make-whole amount equal to the amount of interest that would have otherwise been payable through the maturity date of the Blue Torch Credit Facility.
Common Stock Warrant [Member] | Blue Torch Term Loan Facility [Member]
Debt Instrument [Line Items]
Class of Warrant or Right, Outstanding | shares				437,024
Common Stock Warrant [Member] | Warrant to urgent capital llc [Member]
Debt Instrument [Line Items]
Class of Warrant or Right, Outstanding | shares				24,834
Warrant exercise price | $ / shares				$ 16.88
Blue Torch Warrants [Member]
Debt Instrument [Line Items]
Warrant exercise price | $ / shares				$ 16.08
Blue Torch Warrants [Member] | Maximum [Member]
Debt Instrument [Line Items]
Warrant exercise price | $ / shares									16.08
Blue Torch Warrants [Member] | Minimum [Member]
Debt Instrument [Line Items]
Warrant exercise price | $ / shares									$ 5.44
Warrant [Member] | Introducing Fee
Debt Instrument [Line Items]
Deferred Finance Costs Gross				$ 600
Line of Credit [Member]
Debt Instrument [Line Items]
Line of Credit Facility, Maximum Borrowing Capacity						$ 5,701
Line of Credit [Member] | Blue Torch Term Loan Facility [Member]
Debt Instrument [Line Items]
Long term debt interest rate									1.50%
Outstanding principal balance of the term loans			$ 2,500
Line of Credit [Member] | Blue Torch Term Loan Facility [Member] | Secured Overnight Financing Rate (SOFR) [Member]
Debt Instrument [Line Items]
Long term debt interest rate						13.5766%
Line of Credit [Member] | Commitment Fee | Blue Torch Term Loan Facility [Member]
Debt Instrument [Line Items]
Deferred Finance Costs Gross						$ 2,400
Line of Credit [Member] | Agency Fee | Blue Torch Term Loan Facility [Member]
Debt Instrument [Line Items]
Deferred Finance Costs Gross						250
Line of Credit [Member] | Exit Fee | Blue Torch Term Loan Facility [Member]
Debt Instrument [Line Items]
Deferred Finance Costs Gross	$ 200					$ 1,800			$ 1,800
Line of Credit [Member] | Blue Torch Warrants [Member]
Debt Instrument [Line Items]
Prepayment premium		$ 10,000	$ 50

Leases - Schedule of Components

Leases - Schedule of Components of Lease Expense (Details) - USD ($) $ in Thousands	Mar. 31, 2024	Dec. 31, 2023
Assets
ROU assets	$ 14,324	$ 14,921
Total ROU assets	14,324	14,921
Liabilities
Current	$ 3,425	$ 3,506
Operating Lease Liability Current Statement Of Financial Position Extensible List	Total current liabilities	Total current liabilities
Non-current	$ 12,488	$ 13,079
Total lease liabilities	$ 15,913	$ 16,585
Weighted-average remaining lease term (years)	5 years 2 months 12 days	5 years 4 months 24 days
Weighted-average discount rate	8%	8%

Leases - Additional Information

Leases - Additional Information (Details) - USD ($) $ in Thousands	3 Months Ended
	Mar. 31, 2024	Mar. 31, 2023
Lessee, Lease, Description [Line Items]
Percentage of majority of ROU assets and lease liabilities relate to office facilities leases	77%
Operating lease payments	$ 872	$ 230
Lease liabilities arising from obtaining right-of-use assets	809	224
Short term and variable lease cost	239	120
Operating lease expense	$ 1,157	$ 930

Leases - Schedule of Maturity o

Leases - Schedule of Maturity of Operating Leases (Details) - USD ($) $ in Thousands	Mar. 31, 2024	Dec. 31, 2023
Leases [Abstract]
Remainder of 2024	$ 3,485
2025	4,229
2026	3,820
2027	2,756
2028	1,850
Thereafter	3,538
Total lease payments	19,678
Less: Interest on lease payments	(3,765)
Present value of lease liabilities	$ 15,913	$ 16,585

Fair Value Measurement - Summar

Fair Value Measurement - Summary of Assets and Liabilities Measured at Fair Value on Recurring Basis (Detail) - USD ($) $ in Thousands	Mar. 31, 2024	Dec. 31, 2023
Commercial Paper | Investments
Fair Value Assets And Liabilities Measured On Recurring And Nonrecurring Basis [Line Items]
Marketable Securities, Fair Value Disclosure	$ 985	$ 1,395
Fair Value, Recurring
Fair Value Assets And Liabilities Measured On Recurring And Nonrecurring Basis [Line Items]
Assets, Fair Value Disclosure	10,123	10,114
Fair Value, Recurring | Investments
Fair Value Assets And Liabilities Measured On Recurring And Nonrecurring Basis [Line Items]
Marketable Securities, Fair Value Disclosure	12,003	11,726
Fair Value, Recurring | Long-term Liabilities [Member]
Fair Value Assets And Liabilities Measured On Recurring And Nonrecurring Basis [Line Items]
Liabilities, Fair Value Disclosure	12,854	6,208
Fair Value, Recurring | Money Market Funds
Fair Value Assets And Liabilities Measured On Recurring And Nonrecurring Basis [Line Items]
Assets, Fair Value Disclosure	10,123	10,114
Fair Value, Recurring | Commercial Paper | Investments
Fair Value Assets And Liabilities Measured On Recurring And Nonrecurring Basis [Line Items]
Marketable Securities, Fair Value Disclosure	985	1,395
Fair Value, Recurring | U.S. government and agency securities | Investments
Fair Value Assets And Liabilities Measured On Recurring And Nonrecurring Basis [Line Items]
Marketable Securities, Fair Value Disclosure		1,491
Fair Value, Recurring | U.S. treasury bills and bonds | Investments
Fair Value Assets And Liabilities Measured On Recurring And Nonrecurring Basis [Line Items]
Marketable Securities, Fair Value Disclosure	11,018	8,840
Fair Value, Recurring | Credit Agreement Warrants | Long-term Liabilities [Member]
Fair Value Assets And Liabilities Measured On Recurring And Nonrecurring Basis [Line Items]
Liabilities, Fair Value Disclosure	10,672	5,988
Fair Value, Recurring | Securities Purchase Agreement Warrants Member | Long-term Liabilities [Member]
Fair Value Assets And Liabilities Measured On Recurring And Nonrecurring Basis [Line Items]
Liabilities, Fair Value Disclosure	1,917
Fair Value, Recurring | Contingent Earnout Liability | Long-term Liabilities [Member]
Fair Value Assets And Liabilities Measured On Recurring And Nonrecurring Basis [Line Items]
Liabilities, Fair Value Disclosure	265	220
Fair Value, Recurring | Fair Value, Inputs, Level 1
Fair Value Assets And Liabilities Measured On Recurring And Nonrecurring Basis [Line Items]
Assets, Fair Value Disclosure	10,123	10,114
Fair Value, Recurring | Fair Value, Inputs, Level 1 | Investments
Fair Value Assets And Liabilities Measured On Recurring And Nonrecurring Basis [Line Items]
Marketable Securities, Fair Value Disclosure	11,018	8,840
Fair Value, Recurring | Fair Value, Inputs, Level 1 | Long-term Liabilities [Member]
Fair Value Assets And Liabilities Measured On Recurring And Nonrecurring Basis [Line Items]
Liabilities, Fair Value Disclosure	0	0
Fair Value, Recurring | Fair Value, Inputs, Level 1 | Money Market Funds
Fair Value Assets And Liabilities Measured On Recurring And Nonrecurring Basis [Line Items]
Assets, Fair Value Disclosure	10,123	10,114
Fair Value, Recurring | Fair Value, Inputs, Level 1 | Commercial Paper | Investments
Fair Value Assets And Liabilities Measured On Recurring And Nonrecurring Basis [Line Items]
Marketable Securities, Fair Value Disclosure	0	0
Fair Value, Recurring | Fair Value, Inputs, Level 1 | U.S. government and agency securities | Investments
Fair Value Assets And Liabilities Measured On Recurring And Nonrecurring Basis [Line Items]
Marketable Securities, Fair Value Disclosure		0
Fair Value, Recurring | Fair Value, Inputs, Level 1 | U.S. treasury bills and bonds | Investments
Fair Value Assets And Liabilities Measured On Recurring And Nonrecurring Basis [Line Items]
Marketable Securities, Fair Value Disclosure	11,018	8,840
Fair Value, Recurring | Fair Value, Inputs, Level 1 | Credit Agreement Warrants | Long-term Liabilities [Member]
Fair Value Assets And Liabilities Measured On Recurring And Nonrecurring Basis [Line Items]
Liabilities, Fair Value Disclosure	0	0
Fair Value, Recurring | Fair Value, Inputs, Level 1 | Securities Purchase Agreement Warrants Member | Long-term Liabilities [Member]
Fair Value Assets And Liabilities Measured On Recurring And Nonrecurring Basis [Line Items]
Liabilities, Fair Value Disclosure	0
Fair Value, Recurring | Fair Value, Inputs, Level 1 | Contingent Earnout Liability | Long-term Liabilities [Member]
Fair Value Assets And Liabilities Measured On Recurring And Nonrecurring Basis [Line Items]
Liabilities, Fair Value Disclosure	0	0
Fair Value, Recurring | Fair Value, Inputs, Level 2
Fair Value Assets And Liabilities Measured On Recurring And Nonrecurring Basis [Line Items]
Assets, Fair Value Disclosure	0	0
Fair Value, Recurring | Fair Value, Inputs, Level 2 | Investments
Fair Value Assets And Liabilities Measured On Recurring And Nonrecurring Basis [Line Items]
Marketable Securities, Fair Value Disclosure	985	2,886
Fair Value, Recurring | Fair Value, Inputs, Level 2 | Long-term Liabilities [Member]
Fair Value Assets And Liabilities Measured On Recurring And Nonrecurring Basis [Line Items]
Liabilities, Fair Value Disclosure	12,589	5,988
Fair Value, Recurring | Fair Value, Inputs, Level 2 | Money Market Funds
Fair Value Assets And Liabilities Measured On Recurring And Nonrecurring Basis [Line Items]
Assets, Fair Value Disclosure	0	0
Fair Value, Recurring | Fair Value, Inputs, Level 2 | Commercial Paper | Investments
Fair Value Assets And Liabilities Measured On Recurring And Nonrecurring Basis [Line Items]
Marketable Securities, Fair Value Disclosure	985	1,395
Fair Value, Recurring | Fair Value, Inputs, Level 2 | U.S. government and agency securities | Investments
Fair Value Assets And Liabilities Measured On Recurring And Nonrecurring Basis [Line Items]
Marketable Securities, Fair Value Disclosure		1,491
Fair Value, Recurring | Fair Value, Inputs, Level 2 | U.S. treasury bills and bonds | Investments
Fair Value Assets And Liabilities Measured On Recurring And Nonrecurring Basis [Line Items]
Marketable Securities, Fair Value Disclosure	0	0
Fair Value, Recurring | Fair Value, Inputs, Level 2 | Credit Agreement Warrants | Long-term Liabilities [Member]
Fair Value Assets And Liabilities Measured On Recurring And Nonrecurring Basis [Line Items]
Liabilities, Fair Value Disclosure	10,672	5,988
Fair Value, Recurring | Fair Value, Inputs, Level 2 | Securities Purchase Agreement Warrants Member | Long-term Liabilities [Member]
Fair Value Assets And Liabilities Measured On Recurring And Nonrecurring Basis [Line Items]
Liabilities, Fair Value Disclosure	1,917
Fair Value, Recurring | Fair Value, Inputs, Level 2 | Contingent Earnout Liability | Long-term Liabilities [Member]
Fair Value Assets And Liabilities Measured On Recurring And Nonrecurring Basis [Line Items]
Liabilities, Fair Value Disclosure	0	0
Fair Value, Recurring | Fair Value, Inputs, Level 3
Fair Value Assets And Liabilities Measured On Recurring And Nonrecurring Basis [Line Items]
Assets, Fair Value Disclosure	0	0
Fair Value, Recurring | Fair Value, Inputs, Level 3 | Investments
Fair Value Assets And Liabilities Measured On Recurring And Nonrecurring Basis [Line Items]
Marketable Securities, Fair Value Disclosure	0	0
Fair Value, Recurring | Fair Value, Inputs, Level 3 | Long-term Liabilities [Member]
Fair Value Assets And Liabilities Measured On Recurring And Nonrecurring Basis [Line Items]
Liabilities, Fair Value Disclosure	265	220
Fair Value, Recurring | Fair Value, Inputs, Level 3 | Money Market Funds
Fair Value Assets And Liabilities Measured On Recurring And Nonrecurring Basis [Line Items]
Assets, Fair Value Disclosure	0	0
Fair Value, Recurring | Fair Value, Inputs, Level 3 | Commercial Paper | Investments
Fair Value Assets And Liabilities Measured On Recurring And Nonrecurring Basis [Line Items]
Marketable Securities, Fair Value Disclosure	0	0
Fair Value, Recurring | Fair Value, Inputs, Level 3 | U.S. government and agency securities | Investments
Fair Value Assets And Liabilities Measured On Recurring And Nonrecurring Basis [Line Items]
Marketable Securities, Fair Value Disclosure		0
Fair Value, Recurring | Fair Value, Inputs, Level 3 | U.S. treasury bills and bonds | Investments
Fair Value Assets And Liabilities Measured On Recurring And Nonrecurring Basis [Line Items]
Marketable Securities, Fair Value Disclosure	0	0
Fair Value, Recurring | Fair Value, Inputs, Level 3 | Credit Agreement Warrants | Long-term Liabilities [Member]
Fair Value Assets And Liabilities Measured On Recurring And Nonrecurring Basis [Line Items]
Liabilities, Fair Value Disclosure	0	0
Fair Value, Recurring | Fair Value, Inputs, Level 3 | Securities Purchase Agreement Warrants Member | Long-term Liabilities [Member]
Fair Value Assets And Liabilities Measured On Recurring And Nonrecurring Basis [Line Items]
Liabilities, Fair Value Disclosure	0
Fair Value, Recurring | Fair Value, Inputs, Level 3 | Contingent Earnout Liability | Long-term Liabilities [Member]
Fair Value Assets And Liabilities Measured On Recurring And Nonrecurring Basis [Line Items]
Liabilities, Fair Value Disclosure	$ 265	$ 220

Fair Value Measurement - Additi

Fair Value Measurement - Additional Information (Detail) - USD ($) $ / shares in Units, $ in Thousands		3 Months Ended
	Mar. 21, 2024	Mar. 31, 2024	Mar. 31, 2023	Sep. 27, 2023	Jun. 13, 2022
Fair Value Assets And Liabilities Measured On Recurring And Nonrecurring Basis [Line Items]
Warrant exercise price				$ 5.44
Class of Warrant or Right, Outstanding				597,082
Proceeds from issuance of common stock under the Equity Distribution Agreement, net		$ 37,881	$ 0
Securities Purchase Agreement Warrants Member
Fair Value Assets And Liabilities Measured On Recurring And Nonrecurring Basis [Line Items]
Warrant exercise price	$ 14.5
Securities Purchase Agreement Warrants Member | Common Class A [Member]
Fair Value Assets And Liabilities Measured On Recurring And Nonrecurring Basis [Line Items]
Warrant exercise price	$ 14
Aggregate offering shares	2,142,858
Class of Warrant or Right, Outstanding	2,142,858
Proceeds from issuance of common stock under the Equity Distribution Agreement, net	$ 30,000
2022 Blue Torch Warrants Member
Fair Value Assets And Liabilities Measured On Recurring And Nonrecurring Basis [Line Items]
Warrant exercise price					$ 16.08
Class of Warrant or Right, Outstanding					437,024
2022 Blue Torch Warrants Member | Maximum
Fair Value Assets And Liabilities Measured On Recurring And Nonrecurring Basis [Line Items]
Warrant exercise price				$ 16.08
2022 Blue Torch Warrants Member | Minimum
Fair Value Assets And Liabilities Measured On Recurring And Nonrecurring Basis [Line Items]
Warrant exercise price				$ 5.44
Warrant to urgent capital llc [Member]
Fair Value Assets And Liabilities Measured On Recurring And Nonrecurring Basis [Line Items]
Warrant exercise price					$ 16.08
Class of Warrant or Right, Outstanding					24,834

Fair Value Measurement - Schedu

Fair Value Measurement - Schedule of Quantitative Information Regarding Warrant Liability (Detail)	Mar. 31, 2024	Dec. 31, 2023
Credit Agreement Warrants | Measurement Input, Common Stock Fair Value
Fair Value Assets And Liabilities Measured On Recurring And Nonrecurring Basis Valuation Techniques [Line Items]
Warrants and Rights Outstanding, Measurement Input	12	7.82
Credit Agreement Warrants | Measurement Input, Risk Free Interest Rate
Fair Value Assets And Liabilities Measured On Recurring And Nonrecurring Basis Valuation Techniques [Line Items]
Warrants and Rights Outstanding, Measurement Input	4.2	3.88
Credit Agreement Warrants | Measurement Input, Price Volatility
Fair Value Assets And Liabilities Measured On Recurring And Nonrecurring Basis Valuation Techniques [Line Items]
Warrants and Rights Outstanding, Measurement Input	68.8	55
Credit Agreement Warrants | Measurement Input, Expected Dividend Rate
Fair Value Assets And Liabilities Measured On Recurring And Nonrecurring Basis Valuation Techniques [Line Items]
Warrants and Rights Outstanding, Measurement Input	0	0
Credit Agreement Warrants | Minimum | Measurement Input, Exercise Price
Fair Value Assets And Liabilities Measured On Recurring And Nonrecurring Basis Valuation Techniques [Line Items]
Warrants and Rights Outstanding, Measurement Input	5.44	5.44
Credit Agreement Warrants | Minimum | Measurement Input, Expected Term
Fair Value Assets And Liabilities Measured On Recurring And Nonrecurring Basis Valuation Techniques [Line Items]
Remaining contractual term (in years)	8 years 2 months 12 days	8 years 6 months
Credit Agreement Warrants | Maximum | Measurement Input, Exercise Price
Fair Value Assets And Liabilities Measured On Recurring And Nonrecurring Basis Valuation Techniques [Line Items]
Warrants and Rights Outstanding, Measurement Input	16.08	16.08
Credit Agreement Warrants | Maximum | Measurement Input, Expected Term
Fair Value Assets And Liabilities Measured On Recurring And Nonrecurring Basis Valuation Techniques [Line Items]
Remaining contractual term (in years)	9 years 6 months	9 years 8 months 12 days
Securities Purchase Agreement Warrants Member | Measurement Input, Common Stock Fair Value
Fair Value Assets And Liabilities Measured On Recurring And Nonrecurring Basis Valuation Techniques [Line Items]
Warrants and Rights Outstanding, Measurement Input	12
Securities Purchase Agreement Warrants Member | Measurement Input, Exercise Price
Fair Value Assets And Liabilities Measured On Recurring And Nonrecurring Basis Valuation Techniques [Line Items]
Warrants and Rights Outstanding, Measurement Input	14.5
Securities Purchase Agreement Warrants Member | Measurement Input, Risk Free Interest Rate
Fair Value Assets And Liabilities Measured On Recurring And Nonrecurring Basis Valuation Techniques [Line Items]
Warrants and Rights Outstanding, Measurement Input	5.46
Securities Purchase Agreement Warrants Member | Measurement Input, Price Volatility
Fair Value Assets And Liabilities Measured On Recurring And Nonrecurring Basis Valuation Techniques [Line Items]
Warrants and Rights Outstanding, Measurement Input	68.8
Securities Purchase Agreement Warrants Member | Measurement Input, Expected Dividend Rate
Fair Value Assets And Liabilities Measured On Recurring And Nonrecurring Basis Valuation Techniques [Line Items]
Warrants and Rights Outstanding, Measurement Input	0
Securities Purchase Agreement Warrants Member | Measurement Input, Expected Term
Fair Value Assets And Liabilities Measured On Recurring And Nonrecurring Basis Valuation Techniques [Line Items]
Remaining contractual term (in years)	3 months 18 days
Contingent Earnout Liability
Fair Value Assets And Liabilities Measured On Recurring And Nonrecurring Basis Valuation Techniques [Line Items]
Earnout expiration date	Aug. 16, 2026	Aug. 16, 2026
Contingent Earnout Liability | Measurement Input, Common Stock Fair Value
Fair Value Assets And Liabilities Measured On Recurring And Nonrecurring Basis Valuation Techniques [Line Items]
Warrants and Rights Outstanding, Measurement Input	12	7.82
Contingent Earnout Liability | Measurement Input, Risk Free Interest Rate
Fair Value Assets And Liabilities Measured On Recurring And Nonrecurring Basis Valuation Techniques [Line Items]
Warrants and Rights Outstanding, Measurement Input	4.52	4.09
Contingent Earnout Liability | Measurement Input, Price Volatility
Fair Value Assets And Liabilities Measured On Recurring And Nonrecurring Basis Valuation Techniques [Line Items]
Warrants and Rights Outstanding, Measurement Input	68.8	55

Fair Value Measurement - Summ_2

Fair Value Measurement - Summary of Change in Fair Value of The Warrant Liabilities (Detail) - Fair Value, Inputs, Level 3 - Contingent Earnout Liability $ in Thousands	3 Months Ended
	Mar. 31, 2024 USD ($)
Fair Value Liabilities Measured On Recurring Basis Unobservable Input Reconciliation [Line Items]
Beginning balance	$ 220
Change in fair value of contingent earnout liability	45
Ending balance	$ 265

Fair Value Measurement - Sche_2

Fair Value Measurement - Schedule of Cash and Cash Equivalents and Investments (Details) - USD ($) $ in Thousands	Mar. 31, 2024	Dec. 31, 2023
Debt Securities, Available-for-Sale [Line Items]
Cash and cash equivalents at carrying value	$ 51,731
Investments
Debt Securities, Available-for-Sale [Line Items]
Cash and cash equivalents at carrying value	12,004	$ 11,725
Cash and Cash Equivalents, Fair Value Disclosure	12,003	11,726
Marketable Securities, Unrealized Gains	0	2
Marketable Securities, Unrealized Losses	(1)	(1)
Cash and Cash Equivalents
Debt Securities, Available-for-Sale [Line Items]
Cash and cash equivalents at carrying value	51,731	29,136
Cash and Cash Equivalents, Fair Value Disclosure	51,731	29,136
Marketable Securities, Unrealized Gains	0	0
Marketable Securities, Unrealized Losses	0	0
U.S. treasury bills and bonds | Investments
Debt Securities, Available-for-Sale [Line Items]
Cash and cash equivalents at carrying value	11,018	8,838
Cash and Cash Equivalents, Fair Value Disclosure	11,018	8,840
Marketable Securities, Unrealized Gains	0	2
Marketable Securities, Unrealized Losses	0	0
U.S government and agency securities | Investments
Debt Securities, Available-for-Sale [Line Items]
Marketable Securities, Amortized Cost		1,492
Marketable Securities, Unrealized Gains		0
Marketable Securities, Unrealized Losses		(1)
Marketable Securities, Fair Value Disclosure		1,491
Cash | Cash and Cash Equivalents
Debt Securities, Available-for-Sale [Line Items]
Cash and cash equivalents at carrying value	41,608	19,022
Cash and Cash Equivalents, Fair Value Disclosure	41,608	19,022
Marketable Securities, Unrealized Gains	0	0
Marketable Securities, Unrealized Losses	0	0
Money Market Funds | Cash and Cash Equivalents
Debt Securities, Available-for-Sale [Line Items]
Cash and cash equivalents at carrying value	10,123	10,114
Cash and Cash Equivalents, Fair Value Disclosure	10,123	10,114
Marketable Securities, Unrealized Gains	0	0
Marketable Securities, Unrealized Losses	0	0
Commercial Paper | Investments
Debt Securities, Available-for-Sale [Line Items]
Marketable Securities, Amortized Cost	986	1,395
Marketable Securities, Unrealized Gains	0	0
Marketable Securities, Unrealized Losses	(1)	0
Marketable Securities, Fair Value Disclosure	$ 985	$ 1,395

Fair Value Measurement - Amorti

Fair Value Measurement - Amortized Cost and Estimated Fair Value of Marketable Securities (Details) - Due in one year or less $ in Thousands	Mar. 31, 2024 USD ($)
Debt Securities, Available-for-Sale [Line Items]
Amortized Cost	$ 12,004
Fair Value	$ 12,003

Commitments and Contingencies_3

Commitments and Contingencies (As Restated) - Additional Information (Details) - USD ($) $ in Thousands	3 Months Ended
	Mar. 31, 2024	Mar. 31, 2023
Cost of revenue	$ 25,596	$ 13,369
Outstanding notes receivable	4,500
Accrued interest	394
Provision for credit losses, current	1,258
A&R L3Harris Agreement [Member]
Fixed fees	$ 358
Percentage of share payable	30%
Cost of revenue	$ 1,238	1,253
A&R L3Harris Agreement [Member] | Excess Revenue [Member]
Revenue	$ 16,000	$ 16,000

Commitments and Contingencies_4

Commitments and Contingencies (As Restated) - Schedule of Operational Fees Commitment includes Fixed Payments (Details) - A&R L3Harris Agreement [Member] $ in Thousands	Mar. 31, 2024 USD ($)
Remainder of 2024	$ 3,225
2025	4,300
2026	4,300
2027	4,300
2028	4,300
Thereafter	11,189
Operating Fees Payments Due, Total	$ 31,614

Stock Based Compensation - Addi

Stock Based Compensation - Additional Information (Detail) - USD ($) $ in Thousands		3 Months Ended
	Jan. 01, 2024	Mar. 31, 2024	Mar. 31, 2023
Defined Benefit Plan Disclosure [Line Items]
Stock Issued During Period, Value, Stock Options Exercised		$ 267
Proceeds from Stock Options Exercised		$ 267	$ 0
Number of options outstanding, Granted		0	0
Restricted Stock Units (RSUs)
Defined Benefit Plan Disclosure [Line Items]
Unrecognized stock-based compensation expense		$ 31,078
Unrecognized stock-based compensation expense, weighted-average recognition period		1 year 11 months 12 days
2021 Equity Incentive Plan
Defined Benefit Plan Disclosure [Line Items]
Number of shares issued under share-based payment arrangement	1,054,867	818,433
2021 ESPP
Defined Benefit Plan Disclosure [Line Items]
Number of shares issued under share-based payment arrangement	210,973	743,659

Stock Based Compensation - Summ

Stock Based Compensation - Summary of Stock Option Activity (Details) - $ / shares	3 Months Ended		12 Months Ended
	Mar. 31, 2024	Mar. 31, 2023	Dec. 31, 2023
Share-Based Payment Arrangement [Abstract]
Number of options outstanding, beginning balance	2,198,552
Number of options outstanding, Granted	0	0
Number of options outstanding ,Exercised	(37,536)
Number of options outstanding, Forfeited, canceled, or expired	(166,413)
Number of options outstanding, ending balance	1,994,603		2,198,552
Number of options outstanding, vested and expected to vest	1,994,603
Number of option outstanding Exercisable	1,762,321
Weighted- Average Exercise Price, beginning balance	$ 17.11
Weighted- Average Exercise Price, Granted	0
Weighted- Average Exercise Price, Exercised	7.13
Weighted- Average Exercise Price, Forfeited, canceled, or expired	22.26
Weighted- Average Exercise Price, ending balance	16.87		$ 17.11
Weighted- Average Exercise Price, Vested and expected to vest	16.87
Weighted- Average Exercise Price, Exercisable	$ 16.74
Weighted- Average Remaining Contractual Term (in years)	5 years 1 month 6 days		5 years
Vested and expected to vest weighted- average remaining contractual term (in years)	5 years 1 month 6 days
Exercisable weighted- average remaining contractual term (in years)	4 years 9 months 18 days

Stock Based Compensation - Su_2

Stock Based Compensation - Summary of Restricted Stock Units Activity (Detail) - Restricted Stock Units (RSUs)	3 Months Ended
	Mar. 31, 2024 $ / shares shares
Share Based Compensation Arrangement By Share Based Payment Award [Line Items]
Number of Shares, Beginning Balance | shares	1,847,583
Number of Shares, granted | shares	1,905,380
Number of Shares, vested | shares	(204,511)
Number of Shares, forfeited | shares	(784,990)
Number of Shares, Ending Balance | shares	2,763,462
Weighted Average Grant Date Fair Value per Share, Beginning Balance | $ / shares	$ 10.17
Weighted Average Grant Date Fair Value per Share, granted | $ / shares	13.61
Weighted Average Grant Date Fair Value per Share, vested | $ / shares	12.49
Weighted Average Grant Date Fair Value per Share, forfeited | $ / shares	13.48
Weighted Average Grant Date Fair Value per Share, Ending Balance | $ / shares	$ 11.43

Stock-Based Compensation - Summ

Stock-Based Compensation - Summary of the Stock Based Compensation Expense based on Roles and Responsibilities of the Employees (Detail) - USD ($) $ in Thousands	3 Months Ended
	Mar. 31, 2024	Mar. 31, 2023
Employee Service Share Based Compensation Allocation Of Recognized Period Costs [Line Items]
Share-based Payment Arrangement, Expense	$ 3,628	$ 2,646
Cost of Revenue
Employee Service Share Based Compensation Allocation Of Recognized Period Costs [Line Items]
Share-based Payment Arrangement, Expense	61	77
Research and Development [Member]
Employee Service Share Based Compensation Allocation Of Recognized Period Costs [Line Items]
Share-based Payment Arrangement, Expense	1,018	651
Sales and Marketing
Employee Service Share Based Compensation Allocation Of Recognized Period Costs [Line Items]
Share-based Payment Arrangement, Expense	675	437
General and Administrative
Employee Service Share Based Compensation Allocation Of Recognized Period Costs [Line Items]
Share-based Payment Arrangement, Expense	$ 1,874	$ 1,481

Net Loss per Share - Schedule o

Net Loss per Share - Schedule of Earnings Per Share Basic and Diluted Attributable to Common Stockholders (Detail) - USD ($) $ / shares in Units, $ in Thousands		3 Months Ended
		Mar. 31, 2024	Mar. 31, 2023
Numerator:
Net loss		$ (25,544)	$ (18,655)
Denominator:
Weighted-average shares used in computing basic net loss per share		21,813,045	18,096,363
Weighted-average shares used in computing diluted net loss per share		21,813,045	18,096,363
Basic net loss per share	[1]	$ (1.17)	$ (1.03)
Diluted net loss per share	[1]	$ (1.17)	$ (1.03)
[1] The shares of the Company's common stock and the per share amounts for the three months ended March 31, 2023 have been retroactively adjusted to reflect the 1-for-8 reverse stock split (Note 1)

Net Loss per Share - Schedule_2

Net Loss per Share - Schedule of Antidilutive Securities Excluded from Computation of Earnings Per Share (Detail) - shares	3 Months Ended
	Mar. 31, 2024	Mar. 31, 2023
Antidilutive Securities Excluded From Computation Of Earnings Per Share [Line Items]
Antidilutive securities excluded from computation of earnings per share, amount	7,993,672	4,327,016
Stock Options and 2021 ESPP to Purchase Class A Common Stock [Member]
Antidilutive Securities Excluded From Computation Of Earnings Per Share [Line Items]
Antidilutive securities excluded from computation of earnings per share, amount	2,028,412	2,422,401
RSUs [Member]
Antidilutive Securities Excluded From Computation Of Earnings Per Share [Line Items]
Antidilutive securities excluded from computation of earnings per share, amount	2,763,462	1,442,755
Securities Purchase Agreement Warrants Member
Antidilutive Securities Excluded From Computation Of Earnings Per Share [Line Items]
Antidilutive securities excluded from computation of earnings per share, amount	2,142,858	0
Credit Agreement Warrants [Member]
Antidilutive Securities Excluded From Computation Of Earnings Per Share [Line Items]
Antidilutive securities excluded from computation of earnings per share, amount	1,058,940	461,860

Subsequent Events (Additional I

Subsequent Events (Additional Information) (Details) - Subsequent Event [Member] - USD ($) $ in Thousands		1 Months Ended
	Apr. 08, 2024	Apr. 30, 2024
Subsequent Event [Line Items]
Impairment charges		$ 3,510
Third Amendment [Member]
Subsequent Event [Line Items]
Amount Decrease From Requied Liquidity	$ 10,000
Principal Prepayment	10,000
Early termination fee	200
Third Amendment [Member] | Minimum [Member]
Subsequent Event [Line Items]
Liquidity covenant to require liquidity Amount	$ 20,000